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ABSTRACT 
 
Macroalgae are an abundant and diverse group of organisms. Their 
polysaccharides are successfully utilised in industry due to their rheological 
properties, but the diverse and unique functional metabolites in macroalgae 
are still poorly exploited. This holds a lot of promise for health and 
nutritional applications. However, the variability across taxa and shifting 
metabolites in response to environmental conditions has resulted in an 
inconsistent or complex story of nutritional and health opportunities from 
macroalgae. In addition, the methods used to analyse metabolites from 
sources other than macroalgae may not be directly transferable, due to 
peculiarities of the algal organic tissue matrix. Therefore standardising the 
methods for characterisation of important macroalgal metabolite profiles 
and the cultivation effects on metabolites of target taxa are two of the aims 
of this work. Consistent and validated metabolic and compositional 
metabolite profiles will be required to deliver traceable, quality-controlled 
biomass with optimal chemistries for applications in health and nutrition.  
South Eastern Australia is a diversity hot spot for algal flora and species 
endemism, yet it is poorly understood which species should be targeted for 
cultivation towards food and health markets. Here for the first time, typical
Abstract 
  x 
macroalgae of the Eastern temperate coastal zone of New South Wales 
(NSW), Australia were explored including the taxa Hormosira banksii, 
Phyllospora comosa, Myriogloea sciurus, Ecklonia radiata, Solieria 
robusta and the green macroalgae Ulva.1 Particular attention was directed 
towards their fatty acid (FA) profiles, anti-inflammatory, anti-oxidant and 
cell toxicity or functionality. In doing so, robust methods were tested and 
developed to establish optimal protocols for effective metabolite extraction 
and characterisation.  
All taxa showed variable FA profiles with Ulva sp. representing the most 
desirable (n-6/n-3 ratio of 0.4) and the only species to contain the FA 
C22:6n-3 in this research. All non-polar extracts strongly inhibited the 
production of the inflammatory-mediator nitric oxide (NO). Furthermore, it 
was demonstrated for the first time that Ulva extracts were non-toxic on a 
primary cell line whilst selectively exhibiting toxicity against pancreatic 
cancer cells in vitro.  
Application of an optimised extraction protocol revealed nutrients to be the 
key growth factor for the quality and quantity of Ulva FA. Neutral lipids can 
be increased by nutrient starvation, however at a detriment to FA quality. 
Under optimal growth (high nutrients) Ulva yields 56 mg of lipids per gram 
of dried biomass (mg.g-1 d.w) that is rich in polyunsaturated fatty acids 
(PUFA, 54%) with a low n-6/n-3 ratio (0.2) and high levels of C18:4n-3, 
                                                
1 Species name withheld for proprietary reasons 
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C20:5n-3 and C22:5n-3. The standardised preparation of samples was a 
vital consideration as analysis of dried biomass, when compared to a fresh 
extraction protocol, resulted in a loss of 84% in yield and therefore a 
substantial underestimation of lipid content. 
Under optimal growth conditions, Ulva can further yield 1.5 mg.g-1 d.w total 
chlorophyll, 0.1 mg.g-1 d.w carotenoids, 1.6 mg.g-1 d.w phenolics and 0.2 
mg.g-1 d.w flavonoids. Low nutrient growth conditions reduced the presence 
of pigments by 98%, phenolics by 34% and anti-oxidant activity by 87%, 
whilst substantially increasing flavonoid content (5-fold). All extracts from 
cultivated Ulva samples inhibited NO (≥76%) although acetone extracts 
demonstrated higher inhibition (94 - 97%) than ethanol extracts (76 - 91%). 
Furthermore all pigment and phenolic yields were strongly influenced by 
extraction solvent (e.g. acetone versus ethanol). 
These results together present quantitative yields for two major and bio-
functionally important metabolite classes from macroalgae (FA and 
phenolics). The highest yield of FA with a nutritionally favourable profile 
was 5.6% d.w. in Ulva sp. when extracted using chloroform and methanol 
(2/1 v/v). Furthermore, when extracted with ethanol (100%) a yield of 4.1% 
d.w. total FA can be achieved along with the highest yielding phenolic 
content (0.2% d.w.) under optimised culture. This FA yield (% d.w.) for 
Ulva is one of the highest yields reported in the literature. Thus the FA 
content of this Australian cultivated macroalgal biomass together with its 
Abstract 
  xii 
high phenolic content and anti-inflammatory activities has the potential for 
applications in food and health markets. This is an essential step forward in 
delivering robust and reliable methods of production and analysis that can 
be applied to deliver regulatory standards and nutritional or health claims 
from macroalgal biomass. 
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PREFACE 
The work presented in this thesis is part of a collaboration with industry partner Venus 
Shell Systems Pty. Ltd.3 This is a local company based in Nowra (NSW, Australia) that 
grows quality controlled seaweed biomass targeted for use in high value products. 
Venus Shell Systems collaborates with Manildra Group Pty. Ltd (Bomaderry, NSW, 
Australia), which is home to the largest flour mill in Australia.  Manildra Group strives 
for constant innovation to supply industries with a diverse product range from food, 
health ingredients, fuel and energy.4 As a result of this innovation carbon dioxide (CO2) 
waste product from the Manildra plant is piped and pumped directly into the algal 
cultivations, promoting a clean and sustainable industry practice. Venus Shell Systems 
is also a partner of Blue Biotech Shoalhaven, an innovative industry group that has been 
established to promote local innovation within the community (Shoalhaven, NSW, 
Australia) and member businesses in aquatic biotechnology.5 All research presented 
within this thesis contributes to the future product development opportunities that are 
currently being scoped by Venus Shell Systems. 
The macroalgae investigated within this thesis include species collected from the South 
East coast of Australia, along with a cultivated Australian Ulva sp. (Chlorophyta). 
                                                
3 http://www.venusshellsystems.com.au 
4 http://www.manildra.com.au 
5 http://www.bluebiotech.com.au 
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The cultivated Ulva is provided by Venus Shell Systems and is cultured using 
proprietary methods. Therefore the specific cultivation details and species information 
are withheld. 
This thesis consists of seven chapters with the work presented in journal article style. 
Chapter 1 offers a general introduction to macroalgae and macroalgal chemistries, 
highlighting the reported bioactivities of algal metabolites and extracts. It presents the 
current state of the seaweed industry and the areas for future growth and expansion and 
presents the aims of this thesis. 
Following on from the introduction, Chapter 2 is a published book chapter that covers 
the rationale and methods of two anti-cancer screening assays, one of which is routinely 
used and referred to throughout this thesis, presented in thesis format. Following on, 
each subsequent chapter (Chapters 3-6) is presented as a complete manuscript and is a 
combination of both published (final accepted versions) and prepared manuscripts in 
thesis format. The status of each manuscript will be defined in the foreword to each 
chapter.  
The foreword to each chapter will link the separate works together. Where necessary, 
further unpublished findings that resulted from that body of work will be incorporated 
as part of the relevant chapter and presented immediately after the manuscript titled 
“Further Investigations”. 
After the presentation of each manuscript (Chapter 3-6) a general discussion with 
future recommendations is provided (Chapter 7). This is followed by a brief 
Preface 
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Conclusion and the Appendices. Due to the journal article style of this thesis 
references are provided at the end of each chapter. 
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Seaweed 
Seaweeds inhabit the rocky intertidal and subtidal coastal zones all over the world 
(Figure 1). Seaweed refers to all large macroalgal species that are either classified as 
belonging to the class Ochrophyta or Phaeophyta (brown macroalgae), Rhodophyta (red 
macroalgae) or Chlorophyta (green macroalgae). The aquatic environment of marine 
macroalgae	 is competitive and constantly changing with many abiotic stressors. 
Combined with complex reproduction cycles marine macroalgal species are highly 
diversified with an estimated 72,500 species described [1]. This has resulted in 
macroalgae exhibiting a large array of chemical constituents known as secondary 
metabolites [2, 3] and includes terpenes, phenols, fatty acids (FA), lipopetides, amides, 
alkaloids, terpenoids, lactones, pyrroles and sterols [4, 5]. 
 
Figure 1 (i) Diversity hot spot for macroalgae at Seven Mile Beach, Gerringong, South East Coast of 
NSW, Australia (04/04/2011); (ii) freshly washed ashore samples of Ecklonia Radiata and Phyllospora 
comosa being collected from a drained intertidal rock swimming pool (iii) Hormosira banksii inhabiting 
the intertidal rock pools (iv) Ecklonia radiata (bottom left) and Phyllospora comosa (top). 
i ii 
iii iv 
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Metabolites are classified as either secondary or primary. Primary metabolites include 
carbohydrates, proteins and nucleic acids. These compounds occur via fundamental 
biosynthetic pathways and are essential for survival. In contrast, secondary metabolites 
are derived from these primary metabolites and occur via highly variable biosynthetic 
pathways and shift more readily in response to environmental pressures [6-8]. 
Secondary metabolites have many roles in chemical signalling and can exhibit varying 
degrees of bioactivity. Bioactivity has been defined as metabolic or physiological 
response as a result of a molecule or ion binding to a ligand [9]. As macroalgae are 
abundant and very easy to collect, they have been extensively explored in natural 
product research. Their isolated secondary metabolites and/or extracts exhibit an array 
of beneficial in vitro and in vivo biological activities. This is often accompanied with 
minimal toxicities [10-12] when compared to other marine organisms, such as 
dinoflagellates (harmful algae blooms) [13] or deep-sea marine organisms [14]. 
However, some macroalgal species do also produce toxins, such as domoic acid in 
Chondria armata (Rhodophyceae) [15] and caulerpin in Caulerpa taxifolia 
(Chlorophyceae) [16]. Thus as the opportunities for macroalgal cultivation increase, 
improved knowledge of the diverse metabolites is of importance for both nutritional 
safety, as well as natural product opportunities. 
Considering the diversity of macroalgae only a handful of species have been thoroughly 
investigated for isolation of their metabolites and determination of bioactivity (Table 1). 
Such species include Laurencia sp. and other species from the order Ceramiales 
(Rhodophyta); Sargassum and Dictyota sp. from the order Fucales and Dictyotales, 
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respectively (Phaeophyta); and Ulva and Caulerpa sp. from the order Ulvales and 
Bryopsidales, respectively (Chlorophyta). As chlorophyta are less explored, this 
presents opportunities for further investigations (Figure 2). 
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Reported biological activities from macroalgae include anti-hypertensive, anti-oxidant, 
anti-inflammatory, anti-allergic, anti-viral, anti-bacterial, cytotoxic, anti-mitogenic, 
anti-cancer, anti-tumour, anti-thrombic and anti-coagulant activities [22-24]. As such, it 
is frequently proposed that macroalgae either as a whole, a concentrated extract or an 
individual macroalgal compound, have the potential for commercial applications as 
bioactive ingredients in a range of areas including food products [25-27]. 
 
Figure 2 The % distribution of reported bioactives across each of the three phyla of marine macroalgae as 
summarised from seven extensive review publications  [10-12, 17-20]. 
Seaweed industry 
Currently the demand for seaweed product exceeds the supply of wild harvest. In 2014, 
farmed algae produced 23.8 million tonnes with 1.1 million tonnes collected from wild 
harvest [28]. To date, algal cultivation has an estimated total output of 27 million tonnes 
annually with an estimated global net worth of US$6 billion [28, 29]. Thirty-one 
countries are officially recognised as producers from algae aquaculture, yet it is 
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estimated up to 50 countries actively participate in algae farming [29, 30]. However, the 
majority of this cultivated algae production comes from just eight countries, with China 
dominating (Figure 3) [30].  
 
Figure 3 Global cultivated algal production. Represented countries with recorded algal production 
farming [30]. 
The production in these countries is now well established and is scaling to meet the 
fluctuating supply and demand, with the total world production of farmed seaweeds 
doubling from 2000 to 2012 [28]. Considering the diversity of defined seaweed species 
[1], the global seaweed demand is met with the cultivation of just a few select species 
(Table 2). In particular, Kappaphycus alvarezii and Eucheuma aquaculture in Indonesia 
was a major contributor to a recent growth in statistics of world aquatic plant production 
and are a major source of carrageenan [29]. These species dominate international trade 
and are primarily concerned with raw materials for phycocolloid extraction [31]. 
58.4% 20.6% 
9.5% 
4.7% 
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Phycocolloids are polysaccharides and include alginates (Phaeophyta) and agars and 
carrageenans (Rhodophyta), able to form highly viscous gels for use as gelling, 
thickening and stabilizing agents in the food and pharmaceutical industries [32, 33]. 
Therefore, in considering current markets alongside the large number of macroalgal 
species that have been defined and their reported bioactives, there exists a unique 
opportunity to expand the current product range, particularly from cultivated green 
seaweed as there are no major chlorophyta productions on the market. 
Table 2 List of key seaweed species and major products of the current seaweed industry [28-31, 34]. 
Seaweed species Group Common Name Product 
Saccharina spp. Phaeophyta  Alginate 
Laminaria spp. Phaeophyta Kombu, Japanese kelp Wholefood6, Alginate 
Undaria pinnatifida Phaeophyta Wakame Wholefood, fucoidan  
Ascophyllum spp. Phaeophyta  Alginate, phenolics 
Lessonia spp. Phaeophyta  Alginate 
Porphyra spp. Rhodophyta Nori or laver Wholefood  
Eucheuma spp. Rhodophyta  Carrageenan 
Gracilaria spp. Rhodophyta  Wholefood, Agar 
Chondrus spp. Rhodophyta  Wholefood, Carrageenan 
Kappaphycus spp. Rhodophyta  Carrageenan 
Gelidium spp. Rhodophyta  Agar 
 
 
 
 
 
                                                
6 Wholefoods are foods that are refined as little as possible. Seaweed as a wholefood is often offered to 
consumers as either a fresh, frozen or dried product. 
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Biological Activities of Macroalgae (Inflammation) 
Dietary Bioactives 
One niche market area is functional food products and/or ingredients for optimisation of 
health and disease prevention.  As opposed to simply supplying nutrition, a functional 
food has the ability to modulate in vivo physiological systems, for example immune, 
endocrine, nervous, circulatory and digestive systems [35]. Dietary incorporation of 
these foods and their metabolites has the potential to contribute to disease prevention by 
interacting at a cellular level to modify physiological responses [35]. One particular area 
for potential development is the application of algal-derived bioactives to target 
inflammation. 
In Western societies there is a rise in the number of disorders, collectively referred to as 
chronic, inflammatory, noncommunicable diseases [36, 37], typically characterised by 
slow progression and long duration [38]. Examples include allergies, asthma and 
inflammatory bowel, cardiovascular, metabolic and neurological diseases [36]. These 
afflictions have been linked to underlying low-grade inflammation and oxidative stress 
[36-38]. The immune response of inflammation is a complex and multifactorial network 
of chemical signals [39], wherein an important mediator of inflammation is the enzyme 
nitric oxide synthase (NOS), which regulates nitric oxide (NO) production.  
The enzyme exists in both inducible (iNOS) and constitutive isoforms, which includes 
both endothelial NOS (eNOS) and neuronal NOS (nNOS) and it is important to 
differentiate between the two isoforms. The two constitutive forms of this enzyme 
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(eNOS and nNOS) are under enzymatic control as a result of calcium and calmodulin 
binding and result in small amounts of NO with important physiological roles such as 
acting as a vascular relaxing agent or neurotransmitter [40]. A third iNOS enzyme 
however generates NO as a response to microbes, cytokines, and other activating 
stimuli and can generate very high and toxic levels of NO [40, 41]. It is this elevated 
and sustained NO production from iNOS that is characteristic of prolonged 
inflammatory disorders resulting in tissue injury and subsequently cancer [39-41]. 
Experimental studies have suggested inflammatory cells and their associated mediators 
such as interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-α) and IL-23 combined 
with reactive oxygen species (ROS) form a microenvironment that favours cancer 
development [42-46]. As a result, compounds that exhibit anti-oxidant and anti-
inflammatory biological activities are said to have the ability to confer protection and 
reduce the risk of or aid the healing of disease [47, 48].  
Macroalgae are readily consumed as a whole food, particularly in many coastal 
communities of Asia and have a history of being used in traditional medicines [49]. 
Evidence has shown that a number of bioactive metabolites isolated from macroalgae 
can influence a number of key molecular events that are involved in the inflammation 
pathway [22-24, 50]. For example polysaccharides, phenolics, pigments and terpenoid 
derivatives have all shown the potential to counter-act the immune response to 
inflammation. For example either via the reduction of NO and other pro-inflammatory 
immune mediators [23], reduction of oxidative stress by scavenging of free radicals 
[22], and/or inhibiting cancer via selectively inducing cancer cell death or cell 
proliferation (demonstrated both in vivo and in vitro) [24]. 
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Fatty Acids 
Another important dietary class that has been implicated as regulators and mediators of 
inflammation are fatty acids (FA), specifically the omega-6 arachidonic acid (AA; 
20:4n-6) and eicosapentaenoic acid (EPA; 20:5n-3) and docosahexaenoic acid (DHA; 
22:6n-3) omega-3 polyunsaturated fatty acids (PUFA) [51-54]. Inflammatory cells 
contain both n-6 and n-3 PUFA, which serve as substrates for either pro- or anti-
inflammatory eicosanoids, respectively. In relation to the other PUFA present, AA is far 
more abundant and is the main substrate for the enzymatic synthesis of the pro-
inflammatory eicosanoids [51]. Interestingly, it has been shown that increased dietary 
consumption of either n-3 or n-6 long-chain PUFA (lc-PUFA) can directly modify the 
proportion of their respective FA in these inflammatory cells. This indicates a 
correlation between dietary intake and effect on immune modulation of inflammation 
[51, 55]. This is due to n-3 EPA competing with the n-6 AA as a substrate for 
cyclooxygenase and 5-lipoxygenase enzymes [56]. 
Western diets are characterised by excessively high n-6 PUFA due to the increased 
consumption of meat, cereals (wheat, maize, rice) and seed based oils, which are high in 
n-6 PUFA and low in both n-3 PUFA and anti-oxidants [57, 58]. This change in diet has 
been linked to the increased prevalence of inflammatory and autoimmune diseases, 
along with cardiovascular disease and cancer [57]. Fortunately, patients with pre-
existing inflammatory disorders can reduce their levels of inflammatory cytokines with 
dietary incorporation of EPA and DHA [56]. 
The main dietary source of EPA and DHA is fish and seaweed and the current dietary 
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recommendation for fish is 2-3 serves per week to meet their minimum dietary 
requirements [58]. EPA and DHA can also be obtained by encapsulated fish oil 
supplements. However, to date this demand for fish and fish oil is currently met with 
limited and unsustainable captive based fisheries with low scope for growth to meet 
future demands [29]. Marine algae are primary producers of EPA and DHA that fish 
obtain through trophic bioaccumulation and therefore have the potential to offer an 
alternative dietary source of  these bioactive anti-inflammatory n-3 PUFA [59-61]. 
Target Macroalgal Species  
For the utilisation of algal-derived ingredients as dietary bioactives to counteract 
inflammation, target algal species with desirable and suitable chemistries need to be 
selected. Numerous studies have identified the presence of biological activities across 
the three phyla with the potential to enhance human and animal health by positively 
influencing, modulating and/or eliminating certain risk factors of defined diseases 
(Example Table 4). 
As part of a preliminary screening assessment of algal bioactives and chemistries 
specifically linked to targeting inflammatory disorders, a number or macroalgal species 
were investigated in this thesis. These species consisted of unique native and endemic 
Australian species of marine macroalgae, for which little biochemical and bioactivity 
studies have been reported. These species were from the order Fucales (Hormosira 
banksii and Phyllospora comosa), order Laminariales (Ecklonia radiata), order 
Ectocarpales (Myriogloea sciurus), order Gigartinales (Solieria robusta) and order 
Ulvales (Ulva sp.) (Table 3; Figure 4). 
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Literature reviews of similar non-Australian species belonging to these macroalgal 
orders show potential for these chosen Australian species to benefit health (Table 4 - 
Table 8). 
. 
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Phaeophyta 
A range of reported biological activities from species belonging to the phylum 
Phaeophyta, order Laminariales are summarized in Table 4. Ecklonia is a commonly 
investigated genus with regards to its biological activity. Anti-oxidant, anti-
inflammatory, anti-cancer, neuro-protective and acetyl (AChE) and butyryl-
cholinesterase (BChE) inhibitory activities dominate this phylum and order with many 
of these activities attributed to isolated phlorotannins (Table 4). Acetyl- and butyryl-
cholinesterase inhibitors have the potential to be used as a therapeutic strategy to treat 
and/or slow the progression of Alzheimer’s disease [62]. 
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Table 4 Identified bioactive components and biological activities from species belonging to the Phylum 
Phaeophyta, order Laminariales. 
Bioactive Component Activity Species Ref 
Phloroglucinol  Anti-oxidant 
Neuro-protective 
AChE and BChE inhibitory* 
Ecklonia cava, 
Ecklonia stolonifera 
[63-66] 
Eckol Anti-oxidant 
Neuro-protective 
AChE and BChE inhibitory 
Hepato-protective 
Anti-hypertension, 
Anti-diabetic 
Radio-protective 
Ecklonia cava 
Ecklonia stolonifera 
Eisenia bicyclis  
[63-70] 
Dieckol Anti-oxidant 
Neuro-protective 
AChE and BChE inhibitory 
Anti-hypertension 
Radio-protective 
Melanogenesis inhibiters 
Ecklonia cava 
Ecklonia stolonifera 
Eisenia bicyclis 
[63-66, 68, 
69, 71] 
6,6’-Bieckol Anti-HIV-1 
AChE and BChE inhibitory 
Anti-oxidant 
Anti-allergic 
Anti-inflammatory 
Ecklonia cava 
Ecklonia stolonifera 
Eisenia arborea 
[65, 66, 
72-75] 
6,8’-Bieckol Anti-allergic Eisenia arborea [74, 76] 
8,8’-Bieckol Anti-allergic Eisenia arborea [74, 76] 
Fucodiphlorethol G AChE and BChE inhibitory 
Anti-oxidant 
Ecklonia stolonifera, 
Ecklonia cava 
[65, 66] 
Eckstolonol Neuro-protective Ecklonia cava [64] 
Phlorofucofuroeckol A AChE and BChE inhibitory 
Algicidal 
Anti-oxidant 
Anti-hypertension 
Anti-allergic 
Ecklonia stolonifera, 
Ecklonia kurome 
Ecklonia cava 
Eisenia arborea 
[65, 66, 68, 
74, 77] 
Phlorofucofuroeckol B Anti-allergic Eisenia arborea [74, 78, 
79] 
7-Phloroeckol AChE and BChE inhibitory 
Anti-oxidant 
Melanogenesis inhibitors 
Ecklonia stolonifera, 
Ecklonia cava 
[65, 66, 
80] 
2-Phloroeckol Hepato-protective activity Ecklonia stolonifera [67] 
Triphoroethol-A Anti-oxidant Ecklonia cava [81] 
Dioxinodehydroeckol Anti-cancer Ecklonia cava [82] 
2,7’’-Phloroglucinol-
6,6’-Bieckol 
Anti-oxidant Ecklonia cava [83] 
Triphlorethol A Neuro-protective Ecklonia cava [64] 
Methanol Extract Anti-inflammatory Undaria pinnatifida, [84] 
*Acetyl- (AChE) and butyryl-cholinesterase (BChE) inhibitory 
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The range of reported biologically active components from the phylum Phaeophyta, 
order Fucales is summarized in Table 5. Anti-inflammatory, anti-cancer, anti-oxidant 
and other immuno-modulating activities are commonly reported from the genus 
Sargassum. These activities are often attributed to their unique sulfated polysaccharides, 
known as fucoidan (Table 5). 
Table 5 Identified biological activities from the Phylum Phaeophyta, order Fucales. 
Bioactive Component Activity Species Ref 
Fucotriphlorethol A Anti-oxidant 
Anti-inflammatory 
Anti-cancer 
Fucus vesiculosus [85] 
Trifucodiphlorethol A Anti-oxidant 
Anti-inflammatory 
Anti-cancer 
Fucus vesiculosus [85] 
Fucoxanthin Anti-oxidant 
Anti-inflammatory 
Sargassum siliquastrum, 
Myagropsis myagroides 
[86-88] 
Meroditerpenoids Anti-fouling Halidrys siliquosa [89] 
Diterpene Anti-mitotic  Bifurcaria Bifurcata [90] 
Fucoidan Anti-cancer 
Angiogenesis 
Immuno-modulatory 
Fucus evanescens 
Ascophyllum nodosum 
Fucus vesiculosus 
[91-93] 
Polysaccharides 
(Fucoidan) 
Anti-tumor 
Immuno-modulatory Immuno-
potentiating 
Anti-tumor 
Anti-oxidant 
Sargassum fusiforme 
Sargassum pallidum 
 
[94, 95] [96] 
Polysaccharide 
(Fucoidan) 
Immuno-modulatory 
Anti-inflammatory 
Sargassum fusiforme 
Sargassum hemiphyllum, 
[97-99] 
Methanol Extract Anti-inflammatory Sargassum hemiphyllum, 
Sargassum wightii 
[100, 101] 
Water Extract Anti-cancer Sargassum oligocystum [102] 
 
Species from the order Ectocarpales have been less investigated for their biological 
activity when compared to other Phaeophyta species. Similarly, bioactivities reported 
are attributed to their sulfated polysaccharides (Fucoidan), extracted either from 
Cladosiphon okamuranus or Adenocystis utricularis (Table 6). Fucoidan, the sulfated 
polysaccharide from Phaeophyta species, is a well regarded bioactive. Reported 
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activities include anti-cancer, anti-coagulant, anti-thrombotic, anti-viral, 
immunomodulatory, anti-oxidant and anti-inflammatory activities [103-106]. 
Table 6 Identified biological activities from the Phylum Phaeophyta, order Ectocarpales. 
Bioactive Component Activity Species Ref 
Fucoidan Anti-viral 
Anti-HSV-1, HSV-2* 
Newcastle Disease Virus 
Anti-tumor 
Anti-proliferative 
Cladosiphon okamuranus 
Adenocystis utricularis  
[107-112] 
*Herpes Simplex Virus 1 and 2 
Rhodophyta 
A number of biological activities from the phylum Rhodophyta, order Gigartinales are 
presented in Table 7. The bioactivity is reported from a variety of species and includes 
the commonly reported activities such as anti-oxidant, anti-cancer, anti-fungal, anti-
viral and anti-inflammatory. Interestingly, hypolipidemic activity was represented 
within this phylum and order (Table 7).  Hypolipidemic refers to the ability to modulate 
lipid and lipoprotein levels in blood plasma. Hyperlipidemia is characterised by high 
levels of low-density blood lipoproteins. This is a risk factor for atherosclerosis, an 
inflammatory disorder resulting in the accumulation of lipids within artery walls [113]. 
The identified hypolipidemic activity listed in Table 7 was attributed to an ethanol 
extract and a screen across a number of species indicated that Solieria robusta was the 
most effective in reducing the lipid profile in diet-induced hyperlipidemic rats [114]. 
Ethanol extracts will contain, to an extent, both FA and polyphenols which can 
influence lipid metabolism [115, 116]. 
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Table 7 Identified biological activities from the Phylum Rhodophyta, order Gigartinales. 
Bioactive Component Activity Species Ref 
Methanol, Ethanol, 
Water & other Organic 
Extracts 
Anti-oxidant 
Anti-viral (HSV-1, HSV-2*) 
Hypolipidemic activity 
Anti-cancer 
AChE inhibitory 
Alpha-amylase 
Anti-inflammatory 
Kappaphycus alvarezii 
Hypnea musciformis 
Solieria robusta 
Hypnea musciformis, 
Ochtodes secundiramea 
Eucheuma denticulatum 
[114, 117-
122] 
Polysaccharides 
 
Anti-oxidant 
Anti-viral (HSV-1, HSV-2) 
Anti-inflammatory 
Gigartina skottsbergii 
Sphaerococcus 
coronopifolius 
Hypnea spinella 
Schizymenia binderi 
[123-126] 
Protein (Lectin) Anti-bacterial Kappaphycus striatum [127] 
*Herpes Simplex Virus 1 and 2 
Chlorophyta 
Chlorophyta spp. as a whole have been less represented in the literature when compared 
to Rhodophyta and Phaeophyta. However, the genus Ulva is well represented (Table 1). 
Ulva species of macroalgae can have two different morphologies. For example, Ulva 
can have a highly variable distromatic leafy thallus (Figure 5a) or a monostromatic 
tubular or filamentous thallus (Figure 5b). Filamentous morphologies were once assigned 
as belonging to the genus Enteromorpha [128, 129]. However, it has been defined that 
Enteromorpha and Ulva are not distinct genera and therefore reported bioactives for 
both Ulva and Enteromorpha have been included in this literature review [130, 131]. 
Identified biological activities from the most commonly reported Ulva species of 
macroalgae are presented in Table 8. These species include the leafy distromatic species 
Ulva fasciata, U. pertusa and U. lactuca and the monostromatic filamentous species U. 
intestinalis. Less commonly reported species are represented in Table 9. The defined 
bioactivities have been mainly attributed to extracts, as opposed to isolated compounds 
(Table 4) with anti-oxidant, anti-inflammatory and anti-bacterial activities strongly 
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represented (Table 8 and Table 9). The numerous reported biological activities of Ulva 
and its ability to grow rapidly in culture makes it an attractive target to pursue for 
investigation [132, 133]. 
 
Figure 5 Ulva species of macroalgae (Chlorophyta) can exist as either a (a) distromatic, leafy thallus or 
(b) monostromatic tubular or filamentous thallus. Both morphologies can be found in close proximities to 
one another, as shown above, with leafy morphologies found habiting the exposed intertidal rock pools 
and filamentous morphologies on exposed intertidal rock substrates (Seven Mile Beach, Gerringong, 
NSW, Australia) 
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T
able 8 B
iological activities from
 com
m
only investigated species of U
lva, order U
lvales, phylum
 C
hlorophyta (* including Enterom
orpha intestinalis assigned species). 
Species 
C
om
ponent 
A
ctivity 
R
eference 
U
lva fasciata 
 
 
 
 
G
uaiane Sesquiterpenes 
A
nti-bacterial 
[134] 
 
Labdane D
iterpenoids 
A
nti-bacterial 
[135] 
 
Sesquiterpenoids 
A
nti-oxidant 
[136] 
 
Sulfolipids  
A
nti-viral; A
nti-tum
or; A
nti-m
icrobial 
[137] 
 
G
lycolipids 
A
nti-cancer; A
nti-m
icrobial; A
nti-viral 
[138] 
 
Ethyl A
lcohol Extracts 
A
nti-viral 
[139] 
 
M
ethanol &
 B
utanol Extracts 
A
nti-m
icrobial; H
aem
olytic activity 
[140] 
 
D
ichlorom
ethane Extracts 
A
nti-tum
or 
[141] 
 
Ethanol Extracts 
A
nti-inflam
m
atory; A
nti-oxidant; A
nti-m
icrobial 
[142, 143] 
 
D
ichlorom
ethane &
 M
ethanol Extracts 
A
nti-viral 
[144] 
U
lva intestinalis* 
 
 
 
 
W
ater, A
lcohol &
 O
rganic Extracts 
A
nti-oxidant 
[145] 
 
W
ater Extract 
A
nti-oxidant 
[146] 
 
M
ethanol Extracts 
A
nti-proliferative; A
nti-bacterial and anti-fungal; Phytotoxic; Insecticidal  
[147-149] 
U
lva pertusa 
 
 
 
 
M
ethanol Extracts 
A
nti-bacterial; A
nti-fungal; A
nti-inflam
m
atory 
[84, 148, 150] 
 
C
hloroform
 &
 A
lcohol Extracts 
A
nti-tum
or 
[151] 
 
M
ethanol &
 W
ater  
A
nti-bacterial 
[152] 
 
Polyunsaturated Fatty A
cid (C
16:4 n-3) 
A
nti-Inflam
m
atory 
[153] 
U
lva rigida 
 
 
 
 
M
ethanol Extracts 
A
nti-oxidant 
[154] 
 
C
hloroform
 &
 A
lcohol Extracts 
A
nti-bacterial, A
nti-oxidant, A
nti-A
C
hE 
[155, 156] 
 
Ethanol Extracts 
A
nti-genotoxic; A
nti-hyperglycaem
ic; A
nti-genotoxic 
[157, 158] 
U
lva lactuca 
 
 
 
 
W
ater Extracts 
A
nti-oxidant 
[146] 
 
M
onounsaturated Fatty A
cid D
erivatives 
N
eutralise reactive oxygen species (R
O
S) via N
rf2-A
R
E pathw
ay* 
[159] 
 
M
ethanol Extract 
A
nti-oxidant; A
nti-bacterial 
[160, 161] 
 
W
ater, A
lcohol &
 O
rganic Extracts 
A
nti-bacterial 
[162] 
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 T
able 9 B
iological activities from
 less com
m
only investigated species of U
lva, order U
lvales, phylum
 C
hlorophyta (* including Enterom
orpha prolifera assigned species). 
Species 
C
om
ponent 
A
ctivity 
R
eference 
U
lva prolifera* 
 
 
 
 
Pheophytin 
A
nti-oxidant 
[163] 
 
Enzym
e A
ssisted Extract 
C
holinesterase; A
nti-oxidant; A
nti-inflam
m
atory 
[164] 
 
M
ethanol Extracts 
A
nti-oxidant 
[165] 
U
lva com
pressa 
 
 
 
 
M
ethanol Extracts 
A
nti-inflam
m
atory 
[84] 
 
C
hloroform
 &
 A
lcohol Extracts 
A
nti-bacterial 
[166] 
 
M
ethanol &
 O
rganic Extracts 
A
nti-oxidant 
[167] 
U
lva linza 
 
 
 
 
M
ethanol Extracts 
A
nti-inflam
m
atory; A
nti-proliferative; A
nti-oxidant 
[84, 168] 
 
M
ethanol &
 W
ater Extracts 
A
nti-bacterial 
[152] 
 
Polyunsaturated Fatty A
cids (C
18:4 n-3  &
 C
18:3 n-6) 
A
nti-bacterial 
[169] 
U
lva sp. (not defined) 
 
 
 
 
A
cidic Extract 
A
ntioxidant 
[170] 
 
Peptide SEC
M
A
1 
M
itogenic 
[171] 
 
M
ethanol Extracts 
A
nti-oxidant 
[172] 
U
lva reticulata 
 
 
 
 
C
hloroform
 &
 A
lcohol Extracts 
A
nti-bacterial 
[173] 
 
M
ethanol Extracts 
C
holinesterase inhibitory 
[174] 
O
ther species (Enterom
orpha tubulosa, E. 
flexuosa, E. antenna, U
. clathrata) 
 
 
 
 
M
ethanol &
 O
rganic Extracts 
A
nti-oxidant; Larvicidal 
[167, 175] 
 
M
ethanol Extracts 
A
nti-proliferative; A
nti-oxidant 
[165, 168] 
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Thesis Aims 
Currently, the utilisation of algal-derived dietary bioactives is yet to be realised at any 
level of significance [27]. South Eastern Australia is a diversity hot spot for algal flora 
and species endemism [176, 177]. Thus, there is a unique opportunity in Australia for 
the cultivation of selected Australian seaweed species to deliver quality controlled, 
traceable, high-value dietary bioactives for both human and animal nutrition, 
particularly in the area of inflammation.  
Thus, the aims of this thesis are to: 
1. Screen Australian macroalgal species for metabolites of interest relating to anti-
inflammatory, anti-oxidant and anti-cancer functionalities; 
2. To develop and test robust methods for effective extraction and characterisation 
of the metabolites of interest and; 
3. To test the environmental effects of cultivation on biomass fractions that include 
FA and pigments, and to demonstrate that these fractions have different effects 
on anti-oxidant, anti-inflammatory and anti-cancer potential. 
These aims were addressed across the following five chapters that have resulted in one 
published book chapter, two published manuscripts and two prepared manuscripts for 
submission. Chapter 2 presents two commonly utilised methods in anti-cancer 
screening, one of which is used and referred to throughout this thesis in subsequent 
chapters. Chapter 3 presents the results for the anti-inflammatory and metabolite 
screening of six endemic Australian seaweeds across the three phyla and tests the safety
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and efficacy of these crude extracts. Chapter 4 explores the variability of metabolic 
profiles for FA for Ulva sp. as they can vary to a large extent based on environmental 
stimuli and therefore cultivation conditions. This chapter also explores methods for FA 
profile characterisation. Chapter 5 explores the distribution of these FA for Ulva sp. 
across neutral and phospholipids. In Chapter 6, the pigment, phenolic and flavonoid 
variability across cultivation conditions is similarly explored for Ulva sp. with an 
increased emphasis on the specific fractions to which oxidative functions could be 
linked. Finally a discussion is provided in Chapter 7, which ties together the overall 
assessment of Australian seaweed candidates for the extraction of metabolites and 
development of products that can offset the chronic inflammatory disorders that are 
increasingly prevalent in western societies. 
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FOREWORD TO CHAPTER 2 
This thesis assesses a number of Australian seaweed candidates for potential bioactives 
that can offset chronic inflammatory disorders. Ideally, these bioactives are to be 
incorporated as dietary components for both animal and human nutrition, as a whole 
food, fraction, or concentrated extract. Therefore, the level of toxicity of the sample 
must be determined alongside other biological assays.  
Here, Chapter 2 presents the final accepted version of a published book chapter8 (2013) 
that describes enzyme- and cell-based anti-cancer assays presented in thesis format. The 
title page of the final published version has been provided in Appendix A. The cell-
based assays described are used to determine the level of toxicity as a measure of 
inhibition of cell proliferation and thus cell metabolism. Note, it is not a measure of 
absolute cell death, which must be determined by complementary Trypan blue staining 
(non-viable cells will stain blue) and cell counting if necessary. In addition to evaluation 
of end-point data, cells should be monitored during the assay for morphological 
changes. Photographing cells is also highly recommended and aids enormously when 
revisiting results for discussion at later dates. 
                                                
8McCauley, J., Zivanovic, A., and Skropeta, D., Bioassays for Anticancer Activities, in Metabolomics 
Tools for Natural Product Discovery Methods and Protocols, U. Roessner and D.A. Dias, Editors. 2013, 
Humana Press. p. 191-205. 
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Secondly, it is also important to consider anti-cancer screening against both an 
established cell line and primary cell line. Established cell lines are immortal cancer cell 
lines allowing for an indefinite number of subcultures in vitro. In contrast, a primary 
cell line has finite division potential and is more representative of a normal cell. 
Therefore any determined cytotoxicity for potential anti-cancer agents should ideally be 
selective for an immortal cancer cell line. Nevertheless, it is a useful preliminary screen 
for extract or metabolite toxicity and to determine whether or not the more expensive 
and limited primary cell cultures should be included in future investigations.  
 
McCauley, J., Zivanovic, A., and Skropeta, D., Bioassays for Anticancer Activities, in Metabolomics 
Tools for Natural Product Discovery Methods and Protocols, U. Roessner and D.A. Dias, Editors. 
2013, Humana Press. p. 191-205. 
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Summary 
The MTT/MTS in vitro cell proliferation assay is one of the most widely used assays 
for evaluating preliminary anti-cancer activity of both synthetic derivatives and natural 
products and natural product extracts. The highly reliable, colorimetric based assay is 
readily performed on a wide range of cell lines. This assay gives an indication of whole 
cell cytotoxicity, however to determine the exact molecular target further assays need to 
be performed. Of these, kinase inhibition assays are also one of the most widespread 
enzyme inhibition screening assays performed. Kinases are enzymes that play a key role 
in a number of physiological processes and their inhibitors have been found to exhibit 
anti-cancer activity against various human cancer cell lines. Herein, we describe the 
methods for performing both in vitro MTT/MTS cytotoxicity and kinase enzyme 
inhibition assays. These are two of the most useful anti-cancer screening techniques 
available that are relatively economical and can be easily and routinely performed in the 
laboratory to characterise anti-cancer activity. Both assays are highly versatile and can 
be modified to test against targeted disease processes by using specific kinase enzymes 
or cell lines.  
Key words: MTS/MTT assays, cytotoxicity, anti-cancer activity, human cancer cell 
lines, enzyme inhibition, kinases 
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Introduction 
A goal of many natural product chemistry and organic synthesis laboratories is 
ultimately drug discovery. An important aspect of the drug development process is 
testing both natural products and synthesised compounds for bioactivities that are 
involved in targeted diseases processes. Cancer is a general term to define a number of 
diseases that are characterised by the uncontrolled proliferation of cells resulting from 
the disruption or dysfunction of regulatory signaling pathways that are normally under 
tight control [1, 2]. Cancer can spread rapidly and invade other tissues and organs and 
different cancers are recognized to have unique characteristics or markers [3].  
To assess for preliminary anti-cancer activity in terms of cell viability, the 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and 3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium 
inner salt (MTS) in vitro cytotoxicity assays are considered two of the most economic, 
reliable and convenient methods. This is based on their ease of use, accuracy and rapid 
indication of toxicity [4], as well as their sensitivity and specificity [5]. Both assays are 
in vitro whole cell toxicity assays that employ colorimetric methods for determining the 
number of viable cells based on mitochondrial dehydrogenase activity measurement and 
differ only in the reagent employed. In the MTT assay, 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide is bioreduced by dehydrogenase inside living cells to 
form a coloured formazan dye, while in the MTS assay, a similar bioconversion takes 
places utilising 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazo-lium, inner salt and an electron coupling reagent (phenazine 
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ethosulfate) PES (Figure 6).  
The MTT assay requires the addition of solubilising agents to dissolve the insoluble 
formazan product formed, while the MTS assay generates a water-soluble formazan 
product, thus simplifying the assay. The number of viable cells is measured through 
colorimetry and works on the principle that the mitochondrial dehydrogenase enzymes 
which produces NADH or NADHP, reduces the colourless tetrazolium salt into a 
coloured aqueous soluble formazan product by the mitochondrial activity of viable cells 
at 37°C (Figure 6). The quantity of the coloured product is directly proportional to the 
number of live cells in the culture since the MTT/MTS reagent can only be reduced to 
formazan by metabolically active cells.  
 
Figure 6 The reduction of the MTS tetrazolium salt to the red formazan product by viable cells. 
This is a useful assay to characterise potential anti-cancer agents and can be performed 
routinely and easily in the laboratory without the need to forego intellectual property. 
The MTT and MTS assays assess for toxicity to the particular cell under investigation 
(not anti-cancer activity per se). Therefore, most researchers screen for cytotoxicity 
against either murine or human cancer cell lines, as well as against a normal cell line 
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such as peripheral blood lymphocytes. A selectivity index of the compound for cancer 
cells over normal cells can then be determined. It is also advisable to confirm 
MTS/MTT results with qualitative observations under the microscope of the cell 
morphology both before and after the assay. This can often assist in identifying 
potential modes of actions and deciding which further assays should be performed such 
as caspase activation, assessing stage of cell cycle arrest and microtubule stabilisation or 
destabilisation [6]. In addition to performing MTT or MTS assays against specific cell 
types, many researchers worldwide also submit their compounds to screening by the 
National Cancer Institute (NCI, http://www.cancer.gov), which is part of the US 
Government National Institutes of Health (NIH). The NCI offers a rapid in vitro 
primary anti-cancer drug screen to support cancer researchers worldwide [7]. The 
screen, which is performed at no cost to the researcher other than shipping of their 
sample, consists of a panel of 60 different human tumour cell lines from several cancer 
types including leukaemia, melanoma and cancers of the lung, colon, brain, ovary, 
breast, prostate and kidney. The NCI60 screen tests the degree of growth, inhibition or 
cytotoxicity of a compound against each cell line over a range of concentrations to 
generate a characteristic profile or fingerprint of cellular response [8]. A computer 
program (COMPARE) is used to assess the pattern of response across the cell lines, 
which can point towards a likely mechanism of action or identify compounds with 
unique modes of activity and/or selectivity’s for specific cell types. Operational details 
are provided by the NCI Developmental Therapeutics Program (DTP) and can be found 
at http://dtp.nci.nih.gov and for information regarding the submission of compounds for 
testing in the NCI screens see 
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http://dtp.nci.nih.gov/docs/misc/common_files/submit_compounds.html [9]. Only pure 
compounds are screened in the assay and the supplier of the sample is required to 
provide the molecular structure of any compounds submitted, which are then reviewed 
and considered for testing.  
The above assays are whole cell assays, however, often a researcher will want to 
determine activity against a specific molecular or cellular target in order to confirm the 
mechanism of action and to assess for selectivity towards different targets and any off-
target effects. This can be achieved using in vitro inhibition assays against either 
purified enzymes or cell-free extracts enriched in the enzyme target of interest. One 
such anti-cancer screening method that can be easily and routinely performed in the 
laboratory in low-, medium- or high-throughput format is protein kinase inhibition [10]. 
After G protein-coupled receptors (GPCRs), protein kinases are the second most 
important anti-cancer drug target being pursued today.   
Unlike MTS-type assays, which are cell based, these assays are based on detecting the 
degree to which the potential drug compound can inhibit an enzyme’s activity. Most 
drugs used today demonstrate their bioactivity by acting as either receptor antagonists 
or as enzyme inhibitors. Enzymes are popular drug targets as they play a significant role 
in a number of disease processes and are susceptible to inhibition by small drug-like 
molecules [11]. 
Protein kinases are an abundant group of enzymes in the human body with 
approximately 518 different protein kinases encoded in the human genome [12]. 
Kinases catalyse the chemical transfer of a phosphate group from a high-energy 
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molecule such as adenine triphosphate (ATP) to a hydroxyl-containing substrate such as 
serine, threonine and tyrosine, and are divided into different families based on their 
selectivity for these amino acids.  
As one of the most abundant groups of enzymes in the human body, protein kinases are 
important in almost every major pathway in eukaryotic cells. They play a central role in 
the regulation of cellular activities and in signal transduction in signal transmission 
pathways. Moreover, kinases have important roles in metabolism, cell growth, 
apoptosis, immune response, gene expression, oncogenesis, cell differentiation and 
proliferation, metabolism, DNA damage repair and cell motility [2]. As a result, the 
deregulation of kinases has been identified to be the main cause in an increasing list of 
diseases [13]. An estimated one-third of pharma drug discovery programs now focus on 
targeting cancer-related kinases with the aim of developing potent and selective 
inhibitors with lower side effects than treatments that traditionally focus on DNA and 
chromosome regulation [14-17]. An example of a kinase inhibitor that has successfully 
proceeded onto the pharmaceutical market is Imitinib (Gleevec, Novartis), which is a 
tyrosine kinase inhibitor that has dramatically improved the prognosis for sufferers of 
chronic myeloid leukaemia after being the first small-molecule kinase inhibitor to be 
approved for human use [13].  
c-AMP Dependent protein kinase A (protein kinase A, PKA) is an enzyme involved in 
the phosphorylation of a wide range of proteins, ion channels and transcription factors 
[18]. It has been demonstrated to regulate a number of physiological processes 
including cardiovascular function, steroid biosynthesis, reproductive function, 
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myogenesis, adipocyte metabolism, exocytotic processes and immune function [19, 20]. 
PKA was also found to play a key role in memory processes [21]. The cAMP-PKA 
pathway has been linked to the promotion of malignant phenotypes of head and neck 
squamous cell carcinoma [22] and demonstrated to be activated in a range of tumours 
[23]. Conversely, PKA inhibitors have been found to display both in vitro and in vivo 
anti-tumour activity against various human cancer cell lines and to enhance monocyte 
function in HIV-infected patients [24]. Thus, it is becoming increasingly apparent that 
the ability to selectively inhibit PKA provides a new way of potentially modulating 
cancer, immune function, and memory disorders such as Alzheimer’s disease, 
Parkinson’s disease and schizophrenia [19, 21, 25].  
Herein, we describe methods for performing both the MTT/MTS cell proliferation 
cytotoxicity assay and for screening against the enzyme PKA. Both methods are widely 
used in our laboratory [6, 26, 27].  
Materials 
Carry out all procedures at room temperature unless otherwise specified. 
Protein kinase assay  
This protocol is for the analysis of 14 samples per plate – each sample is run twice at 
100 µg/mL and in triplicate. This gives six data points per % inhibition reading. 
Alternatively, 14 samples can be run once at two different concentrations (100 µg/mL, 1 
µg/mL) in triplicate. This will give three data points per % inhibition reading (adjust 
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protocol accordingly). The volumes provided in this protocol are intended for a 96-well 
plate. The actual volumes used can be adjusted as needed. 
1. Prepare sample solutions: Prepare a 5 mg/mL stock solution of sample in 100% 
dimethyl sulfoxide (DMSO). 
2. Sample dilution: Make 1 mL of a 1 mg/mL secondary stock solution (in 20% 
DMSO) of the sample by taking 200 µL of the above 5 mg/mL stock and adding 
800 µL of Milli Q water. During the assay, this will be diluted by 1:10 to give a 
final concentration of 100 µg/mL in 2% DMSO [see Notes 1 & 2]. 
3. Prepare kinase reaction buffer: Dissolve 48.5 mg of 
tris(hydroxymethyl)aminomethane (Tris), 19.0 mg of magnesium chloride 
(MgCl2) and 1.0 mg of bovine serum albumin (BSA) in 2 mL of ultra-pure H2O 
and then make up to 10 mL in a falcon tube. Adjust the pH to 7.5 using aqueous 
hydrochloric acid (HCl) if required. This will make 10 mL of reaction buffer 
that is sufficient for 1 x 96-well plate (i.e. 45 µL x 96 wells = 4.3 mL, plus 5 mL 
for adenosine triphosphate (ATP) stock) [see Note 3]. 
4. Enzyme preparation: The PKA enzyme (Promega) used herein is supplied in 
buffer as 2500 units at 114 units/µL. Dissolve whole contents of tube containing 
enzyme in a total of 2 mL of kinase reaction buffer (see step 3 above). Aliquot 
out 10 x 200 µL of this solution into labeled Eppendorf tubes and store at -70 
°C, to give 250 units of activity per tube. The assay described herein utilises 
2.50 units per well, i.e. 2.50 units x 96 wells = 240 units in total. Thus the 
supplied enzyme will enable testing of 10 x 96-well plates [see Note 4]. 
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5. Kemptide (PKA) specific substrate (Promega, Australia) (10 mg/mL). The 
substrate is used as supplied and stored at -20 ºC [see Note 5]. 
6. Prepare ATP solution: Label 3 tubes: ATP stock 1, ATP stock 2 and ATP stock 
3 (the last one is used in the assay). Weigh 5.51 mg of ATP and make up to 500 
µL with kinase reaction buffer to give a 20 mM solution of ATP (stock 1). Take 
100 µL of ATP stock 1 and dilute to 500 µL in kinase reaction buffer to give a 4 
mM solution. Take 15 µL of the ATP stock 2 and dilute to 3000 µL in kinase 
reaction buffer to give a 20 µM solution. This last solution is used in the assay to 
give a final concentration of 10 µM [see Note 6]. 
7. 96-well opaque white (non-sterile) plates  (Corning #3912). 
8. Micropipettes. 
9. Luminometer compatible for 96-well plates. 
10. 20% DMSO solution: Add 800 µL of distilled water to 200 µL of pure DMSO. 
11. A known kinase inhibitor standard reference for positive control, e.g.  
staurosporine, H-9 or H-89 (Sigma-Aldrich) [see Note 7]. 
12. Kinase-Glo® Reagents:  Kinase-Glo® Buffer and Kinase-Glo® Substrate 
(Promega Corporation, Australia). Store at -20°C. 
MTS assay  
Plates containing compound dilutions should be discarded in cytotoxic waste bins. All 
pipette tips that came into contact with the test compounds should also be disposed of in 
cytotoxic waste bins  
1. Sample preparation: Prepare a 4 mg/mL stock solution of sample in DMSO. 
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2. MTS reagent: Should be stored at -20 ºC for long-term storage and protected 
from light. Reagent should be warmed up to room temperature before use in the 
assay. 
3. RPMI tissue culture medium containing 5% fetal bovine serum (FBS) [see Note 
8].  
4. Stock cultures of cells should be maintained in RPMI medium containing 5% 
FBS (fetal bovine serum).  
5. Clear, sterile 96-well microplates. 
6. Trypan blue solution (0.4%, liquid, sterile-filtered, suitable for cell culture). 
7. Dimethyl sulfoxide (DMSO). 
8. Human, leukemic, monocyte-like, histolytic lymphoma (U937) and human, 
metastatic breast adenocarcinoma (MDA-MB-231) cancer cell lines, or other 
cell lines as required [see Note 9] 
9. Haemocytometer. 
10. Centrifuge. 
11. Sterile incubator. 
12. UV spectrophotometer compatible for 96-well plate. 
Methods 
The kinase assay described here utilises the Kinase-Glo® Luminsecent Kinase Assay 
Platform from Promega and is performed according to the manufacturer’s instructions 
[28] with minor modifications as used in our laboratory. The method below is relevant 
to screening against PKA, however a wide range of kinases can be used in this assay 
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including GSK-3β, PI3K, Src and MAPK [28, 29]. In theory, potentially any kinase 
could be used, provided the appropriate substrate is also utilised. 
Kinase Assay  
1. To wells A/F1-12 of a 96-well plate, add 5 µL of the 1 mg/mL stock solution of 
the test compounds, which will give a final concentration of 100 µg/mL sample 
in 2% DMSO (Table 10). To the positive control wells (G1-6) and the negative 
control wells (H1-6), add 5 µL of the 20% DMSO solution.  
Table 10 Kinase assay plate preparation: wells A-F[1-12] are the test compounds; wells G1-6 are positive 
controls; wells H1-6 are negative controls; and H7-12 and G7-12 are internal reference standards (Std). 
The plate below shows the set-up for 12 test compounds run twice (samples a and b) in triplicate. This 
gives six data points per % inhibition reading. 
 1 2 3 4 5 6 7 8 9 10 11 12 
A 1a 1b 2a 2b 3a 3b 4a 4b 5a 5b 6a 6b 
B 1a 1b 2a 2b 3a 3b 4a 4b 5a 5b 6a 6b 
C 1a 1b 2a 2b 3a 3b 4a 4b 5a 5b 6a 6b 
D 7a 7b 8a 8b 9a 9b 10a 10b 11a 11b 12a 12b 
E 7a 7b 8a 8b 9a 9b 10a 10b 11a 11b 12a 12b 
F 7a 7b 8a 8b 9a 9b 10a 10b 11a 11b 12a 12b 
G Positive Control (100% Luminescence) Std1a Std1a Std1a Std2a Std2a Std2a 
H Negative Control (0% Luminescence) Std1b Std1b Std1b Std2b Std2b Std2b 
2. To wells G/H7-12, add 5 µL of the internal standard (e.g. staurosporine). 
3. Thaw a single tube of the enzyme (250 units per tube) and make up to 2 mL with 
the kinase reaction buffer to give a concentration of 125 units/mL. This will give 
a final concentration of 50 units/mL (or 2.50 units/well). 
4. To six of the positive control wells (G1-6), add 20 µL of the reaction mixture 
containing 2.5 X the optimal concentration of kinase in kinase reaction buffer. 
The positive control should provide 100% luminescence. There will be 1880 µL 
of this reaction mixture remaining.  
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5. Add 20 µL of the kemptide (PKA peptide substrate, 10 mg/mL) to the remaining 
1880 µL of kinase mixture. This will provide 200 µg of the kinase substrate in 
1900 mL to give a 140 µM substrate/enzyme solution in buffer. This amount is 
sufficient for 1 x 96-well plate, giving a final concentration of 56 µM in each 
well per 50 µL reaction. 
6. To all remaining wells, add 20 µL of the above reaction mixture (step 5) 
containing 2.5 X the optimal concentration of kinase and kinase substrate in 1X 
kinase reaction buffer. (Negative controls, 0% luminescence). 
7. To all wells, add 25 µL of the ATP solution (20 µM, stock 3 ATP solution). This 
will give a final concentration of 10 µM in each well per 50 µL reaction. See 
Table 11 for a summary of the reagent volumes added to the 96-well plate.  
8. Using a plate shaker, gently shake the plate and incubate at room temperature for 
the optimal amount of time [see Note 10].  
9. Prepare Kinase-Glo® reagent: The kinase buffer should be stored in the freezer 
and thawed at room temperature. Add the Kinase-Glo® Substrate to the Kinase-
Glo® Buffer and add 50 µL of this mixture to each well [see Note 11]. 
10. Mix the plate and incubate for 10 minutes at room temperature. Due to the long 
half-life of the Kinase-Glo® signal, the plates may be left longer before reading, 
if desired. Record luminescence, which will be directly proportional to percent 
inhibition of the controls [see Notes 12-14]. 
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Table 11 Kinase assay summary of reagent concentrations and volumes added to plate. 
 Initial 
Stock 
Conc. 
Standard 
Wells 
(µL) 
Positive 
Control  
(µL) 
Negative 
Control  
(µL) 
Final 
Conc. 
(in 50 µL) 
Sample  1 mg/mL - - - 100 
µg/mL 
DMSO solution 20 % - 5 5 2 % 
Enzyme/no substrate 
(2.5X) 
125 
units/mL 
- 20 - 50 
units/mL 
Enzyme/substrate 
(2.5X) 
140 µM 20 - 20 56 µM 
ATP solution (2X) 20 µM 25 25 25 10 µM 
Total reaction volume  50 50 50  
Kinase-Glo® reagent  50 50 50  
MTS Assay  
The MTS assay described here utilises Promega’s MTS CellTiter 96® AQueous One 
Solution Cell Proliferation assay and is performed according to the manufacturer’s 
instructions [30, 31].  
1. Determination of cell number and viability: Place 20 µL cells + 20 µL Trypan 
blue on parafilm and place 20 µL of this mixture under a cover-slip on the 
haemocytometer. Count the number of cells using the equation provided [see 
Note 15] to determine the volume required to get a cell concentration of 111,000 
cells/mL. 
2. Day 1 - Setting Up the Plate: Pipette 610 µL of cells (as determined in Step 1 of 
the procedure) into a new Falcon tube and centrifuge at 1600 rpm for five min. 
(For four plates, pipette 2.44 mL of cells). 
3. Drain off supernatant and resuspend the pellet into 2.5 mL of media. This will 
give you 2.5 mL of cell solution at 111,000 cells/mL. (For four plates, you 
would resuspend in 10 mL of media). 
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4. Pipette 100 µL of media into wells A1-A12, H1-H12, B1-G1, B11-G11, B12-
G12, B5-B7, E5-E7, F5-F7 and G5-G7 as per Figure 7. These wells are used as 
blanks to stop any interference that may occur when the spectrophotometer reads 
the absorbance values for the test wells.  
 
Figure 7 96-Well microplate set-up for the MTS assay. 
5. Pipette 90 µL of media into wells B8-G8, B9-G9, B10-G10. These wells will 
form the sample background controls. 
6. Pipette 90 µL of cell solution into wells B2-G2, B3-G3, B4-G4. These wells will 
form the sample wells. 
7. Pipette 90 µL of cell solution into wells D5-D7. These wells will form the 2.5%  
DMSO controls.  
8. Pipette 100 µL of cell solution into wells C5-C7. These wells will form the cell 
controls. 
9. Incubate plates for 24 hours at 37 ºC with 5% carbon dioxide (CO2). 
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10.  Day Two - Diluting Test Compounds: Prepare a microtitre plate for serial 
dilutions of the test compounds as shown in Figure 8 for each compound to be 
tested. Wells A3-G3 should all contain a final volume of 100 µL. 
 
Figure 8 Preparation of microtitre plate for 1:2 serial dilutions. Add 100 µL of DMSO and 100 µL of 
the test compound (4 mg/mL in DMSO) to well A1. Next, add 100 µL of DMSO to wells B1 to G1. 
Then, 100 µL is transferred from A1 to B1; B1 to C1 and so forth until F1, where 100 µL is removed 
and discarded. G1 should contain just 100 µL of 100% DMSO. Next 50 µL of media is added to 
wells A2-G2 and A3-G3 and 50 µL transferred from A1 to A2 and then from A2 to A3 to give 100 
µL of the sample at a concentration of 500 µg/mL in 25% DMSO in media. This is repeated for wells 
B2-B3, C2-C3, etc to give a series of 1:2 dilutions of the sample. 
11. Adding serial dilutions of samples to cells: Using the plate of cells prepared on 
Day 1, pipette 10 µL of each sample dilution of the test compound in 25% 
DMSO (i.e. A3-F3, step 11) in triplicate into the 18 wells containing 90 µL of 
cell solution (i.e. 10 µL of the sample at 500 ug/mL in triplicate into wells B2-
B4, 250 ug/mL sample into C2-C4 etc. (Figure 7), down to the 15.5 µg/mL 
sample into G2-4). Repeat this step, by adding 10 µL of the serial dilutions of 
the sample in triplicate to the 18 wells containing 90 µL of media (e.g. wells B8-
G8, B9-G9, B10-G10). The test compounds will now have a final concentration 
of 2.5% DMSO in all wells.  
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12. Pipette 10 µL of the 0 µg/mL in 25% DMSO (i.e. G3 from step 11) into the 
three remaining wells containing 90 µL cells (wells D5-D7). This will be the 
2.5% DMSO control. 
13. Incubate plate for 24 hours at 37 ºC and 5% CO2 [see Note 16]. 
14. Day Three - Adding MTS Reagent and Plate Reading: Thaw MTS reagent 
before use (~1 mL MTS reagent required per plate). 
15. Pipette 20 µL of the MTS reagent into all sample wells (e.g. B2-G2, B3-G3, B4-
G4, B5-D5, B6-D6, B7-G7, B8-G8, B9-G9, B10-G10) [see Note 17].  
16. Incubate for three hours at 37 ºC and 5% CO2. 
17. Wrap the plates in aluminium foil and take to the spectrophotometer. Read the 
absorbance of the whole plate at 490 nm [see Note 18]. 
Notes 
1. A final concentration of 2% DMSO was used for the sample and was found not 
to interfere with results at this concentration. Standards and controls used in the 
assay were also dissolved in a final concentration of 2% DMSO. Other solvents 
such as 2% ethanol can be used, provided all standards/controls are also 
prepared in this solvent. 
2. We found that a starting stock solution of 1 mg/mL of sample (diluted to 100 
µg/mL in the assay) was appropriate to identify kinase inhibitory activity. 
Samples can be tested at lower concentrations or over a range of different 
concentrations to determine IC50 values. 
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3. We found that it is best to prepare the buffer solution fresh each time and to 
store the buffer at room temperature. 
4. For kinases other than PKA, the optimum amount of kinase enzyme will need to 
be determined and the quantity of other reagents adjusted accordingly [28].  
5. Kemptide (PKA Peptide Substrate) is a synthetic peptide substrate for PKA 
derived from the PKA phosphorylation site in liver pyruvate kinase.  
6. This assay can be used to identify whether the kinase inhibitor is ATP 
competitive or non-competitive, by utilising various ratios of ATP (e.g. <10 µM 
ATP for ATP-competitive inhibitors and >100 µM for ATP non-competitive 
inhibitors). In general, we found it is best to prepare ATP solutions fresh, while 
the ATP reagent itself should be stored in the freezer. 
7. We include an internal reference of a known kinase inhibitor such as 
staurosporine in our assays (IC50 = 7 nM vs PKA; IC50 = 0.7 nM vs PKC ) by 
adding 5 µL of a 1 mg/mL solution of the inhibitor (in 20% DMSO) to six of the 
wells in place of a sample set. Staurosporine is a potent inhibitor of PKC and 
can induce apoptosis in Jurkat cells. Other PKA inhibitors include the 
isoquinoline sulfonamides H-9 (IC50 = 2 µM) and H-89 (IC50 = 48 nM). 
8. RPMI-1640 was developed by Moore et al. [32, 33] at Roswell Park Memorial 
Institute. 
9. Human, leukemic, monocyte-like, histolytic lymphoma (U937) and human, 
metastatic breast adenocarcinoma (MDA-MB-231) cancer cells were obtained 
from American Type Culture Collection (ATCC, VA, USA) distributed by 
Cryosite, NSW, Australia. Cells were regularly cultured in vitro in culture 
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medium consisting of RPMI-1640 medium, along with 2 mM L-glutamine, 
5.6% (2 g/L) NaHCO3 and 5% foetal calf serum. The cells were maintained in a 
Huracell incubator (Kendro Laboratory Products, Langenselbold, Germany) at 
37 °C with a humidified atmosphere containing 5% CO2. However, a wide range 
of both normal and cancer cell lines can be used in this assay.  
10. We found that thawing the Kinase-Glo® reagents (Kinase-Glo® substrate and 
Kinase-Glo® buffer) generally took one hour and we also allowed an hour for 
the incubation time. We strongly advise optimizing the kinase reaction 
conditions so that the reaction can be run at room temperature to avoid 
formation of temperature gradients. Information regarding optimization of 
kinase reaction conditions can be found in the manufacturer’s Technical Bulletin 
[28]. 
11. The choice of Kinase-Glo® reagent will depend on the desired ATP 
concentration to be used in the assay. This information can be found in the 
manufacturer’s protocol, Promega Corporation, Australia [28, 34]. 
12. We find that it is best to read the plate within 15 mins after the addition of the 
Kinase-Glo® reaction mixture. 
13. Instrument settings depend on the manufacturer. An integration time of 0.25–1 
second per well should serve as a guideline. We found that the best plate reading 
is immediately after adding the Kinase-Glo® Buffer and when the incubation is 
performed at room temperature. 
14. The most common assay detection methods are colorimetric or fluorescence-
based. However, luminescent-based detection is particularly desirable for 
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coloured products such as natural products, as coloured extracts and compounds 
can lead to false results when using absorbance as the end point. Utilization of 
luminescence can be more beneficial for biological screening  by identifying hits 
with a lower number of false positives [35]. 
15. An example calculation of cell concentration of which the values obtained will 
be used in the method protocol described herein:  
!". !" !"##$ =  (# !" !"##$ !" 4 !"#$%)4  × 2   × 10000 
For example if we count 91* cells: 
!".  !" !"##$ =   91 ∗4  × 2 × 10000 =  455000 !"##$ 
Therefore, to get a cell concentration of 111,000 cells/mL, you will need: 
111000 !"##$/!"
455000!"##$  =  0.244 !" =  244 µ! 
For the preparation of one plate the cells will be resuspended in 2.5 mL media 
therefore the volume of cells required would be: 
244 µ! × 2.5 =   610 µ! 
Adjust accordingly if more plates are required.  
For example, the preparation of 4 plates will require: 
244 !" ! 10 !" (2.5 !" !"# !"#$% ! 4 !"#$%&)  =  2.44 !" 
16.  Longer incubation times of 48 – 72 hours are also routinely employed in this 
assay. 
17. The MTS reagent is light sensitive so this step should be performed with the 
lights off in the cytotoxic cabinet. 
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18. As this is a colorimetric assay, it should be kept in mind that both coloured 
compounds and natural product extracts may interfere with the absorbance 
reading, and appropriate background controls should always be performed. 
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FOREWORD TO CHAPTER 3 
The previous Chapter 2 explored an anti-cancer cell based method that can be used as a 
preliminary assessment of a sample’s toxicity. This assay was first established in order 
to proceed with the following work (Chapter 3), which involved screening wild 
collections of macroalgae, including one cultivated species of Australian macroalgae for 
anti-inflammatory and anti-cancer activities and determination of their fatty acid 
profiles. An anti-inflammatory assay was also established in house to measure the 
amount of nitric oxide produced in cell supernatants in bacterial lipopolysaccharide 
stimulated inflammatory cells. A thorough explanation of the methods for this anti-
inflammatory cell-based assay is provided in Appendix B. 
This chapter presents the final accepted version (in thesis format) of a published 
manuscript9 (2015) within the Journal of Applied of Phycology (Impact factor 2.372). 
The title page of the article, as it appears in the printed journal can be found in 
Appendix C. 
 
                                                
9McCauley, J.I., et al., Selecting Australian marine macroalgae based on the fatty acid composition and 
anti-inflammatory activity. Journal of Applied Phycology, 2015. 27: p. 2111-2121. 
 
Permissions regarding copyrights have been obtained 
 
 
 67 
 
McCauley, J.I., et al., Selecting Australian marine macroalgae based on the fatty acid composition 
and anti-inflammatory activity. Journal of Applied Phycology, 2015. 27: p. 2111-2121. 
68 
CHAPTER 3 SELECTING AUSTRALIAN MARINE 
MACROALGAE BASED ON THE FATTY ACID COMPOSITION 
AND ANTI-INFLAMMATORY ACTIVITY 
Janice I. McCauley,1 Barbara J. Meyer,2 Pia C. Winberg,2,3 Marie Ranson,4,5,6 and 
Danielle Skropeta1,6* 
 
1School of Chemistry, Faculty of Science, Medicine, and Health (SMAH), University of 
Wollongong (UOW), NSW, 2522, Australia 
2School of Medicine, SMAH, UOW, Wollongong, NSW, 2522, Australia  
3Venus Shell Systems, Narrawallee, NSW, 2539, Australia  
4Illawarra Health and Medical Research Institute, UOW, Wollongong, NSW, 2522, 
Australia 
5School of Biological Sciences, SMAH, UOW, NSW, 2522, Australia 
6Centre for Medical and Molecular Bioscience, UOW, Wollongong, NSW, 2522, 
Australia  
 
Corresponding Author*  
Danielle Skropeta 
Phone: +61-2-42214360 
Fax: +61-2-42214287 
Email: skropeta@uow.edu.au  
Reads 119  
Citations 4  
Downloads 10 
 
Contributions 
 
60% Janice McCauley  Performed the work and prepared/edited and submitted the paper 
10% Barbara Meyer Provided GC access, training and supervision 
10% Pia Winberg   Editing and input on project design 
5% Marie Ranson  Guidance for molecular and cell biology techniques 
15% Danielle Skropeta  Oversight of project, editing and proof-reading 
 
As agreed by supervisor A/Prof. Danielle Skropeta 
Chapter 3 Metabolite and Bioactivity Screening 
 69 
Abstract  
Increasingly macroalgae are being recognized as a growth opportunity for functional 
foods and nutritional security in the future. Dominating traits of interest are metabolites 
that function as anti-inflammatories and are anti-proliferative. However seaweeds 
cultivated in the northern hemisphere dominate this field of research. Australia has a 
unique flora of macroalgae and it is poorly understood which species should be targeted 
for cultivation towards food and health markets. Herein, six Australian marine 
macroalgae were selected for screening of one anti-inflammatory group; n-3 
polyunsaturated fatty acids (PUFA). PUFA profiles were determined using gas 
chromatography - mass spectrometry and multivariate analysis. Thirty-one fatty acids 
(FA) were identified across the six macroalgal species with C16:0 the dominant FA in 
all samples with variations across taxa in the saturated FA C10:0, C14:0, C16:0, C18:0 
and C20:0 and variations in monounsaturated FA attributed to C16:1 n-7 and C18:1 n-9. 
For PUFA profiles, all six species had significantly different n-6/n-3 ratios, while the 
green seaweed Ulva sp. possessed the lowest n-6/n-3 ratio of 0.4, along with a 2-fold 
higher C18:3 n-3 to C18:2 n-6 content. Ulva sp. was the only species that contained 
docosahexaenoic acid. Extracts of both the Ulva sp. and H. banksii showed selective 
cytotoxicity towards a human pancreatic cancer cell line, while the non-polar extracts of 
all six algal species strongly inhibited production of the inflammatory-mediator nitric 
oxide. 
Keywords Seaweeds, Fatty acid profiles, PUFA, Omega-3, Inflammation, Functional 
foods 
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Introduction 
Macroalgae are a large and growing multi-billion dollar food and biotechnology 
industry [1, 2]. Increasingly they are being recognised as a rich source of biologically 
active metabolites for utilisation in functional foods, nutritional supplements and/or 
pharmaceuticals [3]. This is due to important functional roles of these metabolites in a 
range of biological processes including cell mediation and immune responses [4-9]. 
Research in medical and health applications of seaweed metabolites now dominate the 
publication of phycology related scientific literature [10]. There is particular promise 
for chronic inflammatory diseases and cancers of the digestive system [11, 12] (Figure 
9). Metabolites that contribute to anti-inflammatory function include essential 
polyunsaturated fatty acids (PUFA) such as alpha-linolenic acid (ALA, C18:3 n-3) that 
cannot be synthesised by humans and therefore must be obtained from dietary sources, 
as well as the essential n-3 long-chain PUFA such as eicosapentaenoic acid (EPA, 
C20:5 n-3), docosapentaenoic acid (DPA, C22:5 n-3), and docosahexaenoic acid (DHA, 
C22:6 n-3) [13]. These PUFA function as competitors to the pro-inflammatory 
metabolism of linoleic acid (LA, C18:2 n-6) as the parent fatty acids (FA) for the pro-
inflammatory metabolism of the n-6 PUFA arachidonic acid (AA). n-6 AA is a 
biosynthetic precursor to prostaglandin E2 (PGE2) and leukotriene B4 (LTB4) 
inflammation pathways and inflammatory eicosanoids such as prostaglandins and 
leukotrienes [13]. Conversely, n-3 PUFA can be enzymatically converted to bioactive 
autacoids with inflammatory-resolving properties that compete with and offset 
inflammation status [14, 15]. Thus, a reduced ratio of n-6/n-3 PUFA is considered 
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important to suppress chronic inflammatory disease triggered by a higher intake of n-6 
PUFA in modern diets [16, 17]. The pathogenesis of diseases includes cardiovascular 
disease, cancer and other inflammatory disorders [17, 18]. Thus, a greater consumption 
of long chain n-3 FA may offer protective effects by suppressing proinflammatory 
activity [18, 19].  
 
Figure 9 The distribution of published research effort in terms of reference to macroalgae and each of the 
health application terminologies (e.g. anti-inflammatory) as found in Google Scholar database of 
scientific literature. 
Of the n-3 PUFA, ALA is predominately found in vegetable oils and nuts, and EPA and 
DHA in marine fish and fish oils [16]. Conversion of ALA to EPA and DHA is limited 
and therefore dietary consumption of these two long-chain PUFA is highly 
recommended [20, 21]. The proposed health benefits of n-3 PUFA have led to increased 
demand for their use as animal feed additives to promote bioaccumulation, and for 
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direct human consumption [22, 23]. Because of increasing costs and availability of fish 
derived PUFA from fish oil, there is a need to develop alternative sources. 
Marine algae are primary producers of PUFA that fish obtain through trophic 
bioaccumulation and represent a promising new PUFA source. This presents an 
opportunity to target whole seaweed as a food and animal feed, not only for trace 
elements like iron and iodine, but also for lipids that are deficient in the Western diet 
[16, 24]. However, a challenge remains to understand which species contain optimal 
PUFA profiles that could balance current dietary practice and the profile variablility 
between taxa.  
Inflammation is a complex and multifactorial network of chemical signals [25]. Nitric 
oxide (NO), an important biological mediator, is one chemical molecule that is 
generated by the enzyme inducible nitric oxide synthase (iNOS) during immune and 
inflammatory responses [26]. Elevated and chronic NO production, as seen in persistent 
inflammatory disorders is associated with dysregulation of signaling events and immune 
response resulting in cell and tissue injury [27] and subsequently cancer [25]. 
Suppression of NO production has been observed with n-3 PUFA via inhibition of 
iNOS [28]. Further anti-inflammatory compounds are diverse across fractions of 
metabolites and function in different inflammation pathways including iNOS, 
cyclooxygenase (COX) and reactive oxygen species (ROS) metabolism [11]. For algae, 
these fractions include both non-polar and polar extracts and have been shown to 
function differently across assays for these different inflammatory processes. For 
example non-polar algal extracts include phlorotannins that have been shown to reduce 
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the production of NO and reduce edema, along with anti-inflammatory PUFA, 
carotenoids, terpenoids and xanthophylls [15]. 
The metabolic profiles and biological activity of extracts from northern hemisphere 
macroalgal species have been well described including both genetic and 
spatial/temporal variations [29, 30]. However in Australia, which is a macroalgal 
biodiversity hotspot [31] with high species richness and endemism of benthic flora [32], 
a legacy of little use in food has resulted in a paucity of knowledge of Australian 
species with the potential for applications in health. Australia has been seeking to grow 
its aquatic production industries, and macroalgae have been selected based on existing 
market (colloid) or bioremediation potential, but little has been done to select species 
based on the potential applications in targeted health markets. Herein, six Australian 
macroalgal species were screened for their FA profiles and organic extracts of varying 
polarity from each species were evaluated for both anti-inflammatory activity and 
selective cytotoxicity for prioritising candidates from a human health context.  
Materials and Methods  
Collection  
Macroalgal species for biological assessment and FA profiling were collected 
seasonally from a number of locations along the South East coast of New South Wales 
(NSW) Australia. For biological assessment, the algal species: Hormosira banksii 
(Turner) Decaisne, Phyllospora comosa (Labillardière) C.Agardh and Ecklonia radiata 
(C.Agardh) J.Agardh were collected from Gerringong, Solieria robusta (Greville) Kylin 
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was collected from Callala Beach and Myriogloea sciurus (Harvey) Kuckuck ex 
Oltmanns was collected from Manyana. Samples were cleaned from epiphytes and sand 
and dried (70 °C), pulverized and vacuumed sealed until analysis. For FA profiling 
fresh samples were collected, cleaned and freeze-dried immediately prior to analysis. 
The Ulva sp. used herein was obtained from culture, kept and maintained for several 
months (Table 12). 
Table 12 Summary of samples collected seasonally from various locations along the South East cost of 
NSW Australia, including species, phylum, order, collection site (latitude & longitude) and/or date of 
harvest or collection. 
Species  Phylum Order Location Latitude Longitude Date 
Ecklonia radiata Ochrophyta Laminariales Jervis Bay 150.7347 35.0653 10/4/14 
Hormosira banksii Ochrophyta Fucales Jervis Bay 150.7347 35.0653 10/4/14 
Phyllospora comosa Ochrophyta Fucales Jervis Bay 150.7347 35.0653 10/4/14 
Solieria robusta Rhodophyta Gigartinales Jervis Bay 150.7347 35.0653 10/4/14 
Ecklonia radiata Ochrophyta Laminariales Gerringong 150.8271 34.7423 04/4/12 
Hormosira banksia Ochrophyta Fucales Gerringong 150.8271 34.7423 04/412 
Phyllospora comosa Ochrophyta Fucales Gerringong 150.8271 34.7423 04/4/12 
Solieria robusta Rhodophyta Gigartinales Callala Beach 150.6899 35.0086 29/4/12 
Myriogloea sciurus Ochrophyta Ectocarpales Manyana 150.5167 35.2500 01/11/12 
Ulva sp. ♯ Chlorophyta Ulvales Cultivated# - - - 
♮Fresh samples collected and immediately freeze-dried for species fatty acid profiling; ♭Freeze-dried 
sample prepared from frozen voucher sample; #Species name withheld; species maintained in culture. 
Extraction and Transesterification of Fatty Acids  
Lipids were extracted using the method of Folch et al. [33] with modifications by 
Kumari et al. [34]. In brief, 250 mg dry weight was extracted with 3x3 mL of 
chloroform/methanol (2/1, v/v) with 0.001% butylated hydroxytoluene (BHT) by 
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vortexing (~1 min) and centrifugation (3000 rpm, RT, 15 mins). Combined supernatants 
were washed with 2 mL of Milli-Q water (3000 rpm, RT, 5 mins). The extract was 
evaporated to dryness in pre-weighed 9 mL Teflon lined screw top glass culture tubes 
under a stream of nitrogen. Crude lipid extracts were transesterified according to the 
method of Lepage and Roy [35] with added BHT (0.01% w/v). Extractions performed 
in triplicate using homogenized powder of the whole algae sample. 
FA Analysis 
FA were analysed by flame-ionization GC (model GC-17A; Shimadzu, Rydalmere, 
NSW, Australia) using a 50 m x 0.25 mm internal diameter capillary column. One 
microliter of the transesterified sample was auto-injected into the column, and 
individual FA were quantified using the Shimadzu analysis software (Class-VP 7.2.1 
SP1). FA were identified by comparison with known standards (Nu-chek or Sigma, 
Sydney, Australia). Heneicosanoic acid (0.2 mg.mL-1 in toluene) was used as an 
internal standard for quantification and samples were analysed in triplicate. Relative 
compositional data is represented as molar % composition of total FA taking into 
account the molecular weight of the identified FA. Quantified data is represented as 
mg.g-1 dry weight (d.w.). 
Biological Assays  
For biological assays samples were dried at 70 °C for 48 h, pulverised to a fine powder 
and extracted in a 1:1 dichloromethane (DCM): methanol solution using a modified 
version of Ebada et al. [36]. The crude extract was partitioned into DCM, ethyl acetate 
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(EtOAc) and butanol (BuOH) and organic phases evaporated to dryness. Stock solutions 
were dissolved in 100% dimethyl sulfoxide (DMSO) (10 mg.mL-1) and diluted with 
culture medium to obtain testing concentrations of 100 ug.mL-1 in 1% DMSO.  
Extracts were assessed for cytotoxicity at 100 µg.mL-1 on human pancreatic carcinoma 
(MIA-PaCa-2) cell line, Abelson murine leukemia virus-induced tumor macrophage 
(RAW 264.7) and wild-type murine embryo fibroblasts cell lines (WT-MEF). 
Cytotoxicity was determined as % inhibition of cell proliferation, measured by 
colorimetric markers (MTS Reagent) of dehydrogenase enzyme activity, relative to 
controls (24-48 hr incubations) [37]. RAW 264.7 macrophage cells were either pre- or 
co–incubated with lipopolysaccharides (LPS) (1 µg.mL-1) and the extracts (100 µg.mL-1) 
for 24 hrs (37 ºC, 5% CO2), including controls.  
The quantity of nitrite (NO2-) accumulated in the supernatant, as a measure of positive 
inflammation response (NO production), was measured by mixing equal volumes of 
supernatant with Griess reagent (1% sulphanilamide and 1% N-(1-
Naphthyl)ethylenediamine dihydrochloride solution). After 10 mins incubation at rt 
absorbance was measured. NO2- concentrations were calculated using a standard curve. 
NO inhibition was determined as % of LPS induced inflammatory controls [38]. 
Statistical Analysis  
Multivariate FA profiles across macroalgal taxa were visualised in multidimensional 
scaling (MDS) plots using Euclidean distances due to a large number of zeros in the 
data. Apparent groupings were tested using Analysis of Similarity (ANOSIM) with 
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PRIMER-E V6 software (Plymouth Marine Laboratories [39]. Data was analysed in 
both untransformed raw format, to compare the relative abundance of different FA to 
chemical profiles differences, as well as presence/absence transformation (either a 1 or a 
0 value) to compare the overall FA composition. This is a rapid method to objectively 
identify key groups of or specific FA that differ across taxa, which could then be tested 
in univariate analyses. Identification of the FA or groups of FA that contributed most to 
differences between taxa was done using the PRIMER-E Similarity Percentages 
Analysis (SIMPER) tool in PRIMER-E.  One-way Anova, Tukey’s multiple 
comparisons test, and Students t-Test were used to determine significantly different 
means for individual fatty acids of interest using GraphPad Prism version 6.00, 
GraphPad Software, La Jolla California USA, www.graphpad.com. 
Results 
Key differences in FA composition across species  
A total of 31 FA were identified across the six algal species (Table 13). The highest 
number of FA (26) were identified in the both the brown algae Hormosira banksii and 
the green algae Ulva sp.; followed by the three brown algal species with 18 FA 
identified in both Myriogloea sciurus and Phyllospora comosa, 15 in Ecklonia radiata; 
and the lowest number (14 FA) in the lipid extract of the red algae Solieria robusta.  
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Table 13 FA composition of six Australian macroalgal species. Data presented as % molar area of total 
FA. Means with different letters are significantly different (p < 0.05). 
Fatty Acid Ochrophyta Rhodophyta Chlorophyta 
% Molar Area E. radiata M. sciurus. H. banksii P. comosa S. robusta Ulva sp. 
10:0 8.5b 4.3ad 3.6a 5.3ad 17.1c 5.6d 
11:0 0.0 0.0 0.0 0.0 0.0 0.1 
12:0 0.0 0.0 0.0 0.0 0.0 0.7 
14:0 10.7a 9.4a 4.8b 7.5d 1.0c 3.1b 
14:1 n-7 0.0a 0.0a 0.0a 0.0a 0.0a 2.5b 
15:0 0.6 0.6 0.6 0.5 0.0 0.6 
15:1 0.2 0.3 0.1 0.9 0.0 0.5 
16:0 27.9b 46.3a 27.5b 25.4c 26.4bc 20.5d 
16:1 n-7 11.4a 6.5cd 3.7b 6.1cd 9.9ae 9.1e 
17:0 0.0 0.2 0.2 0.1 0.0 1.2 
17:1 n-7 0.0a < 0.1a 0.1a 0.2a 3.5b 0.6a 
18:0 1.8a 3.8b 1.5a 1.7a 16.7c 6.6d 
18:1 n-9  20.2a 19.7a 18.7a 13.7b 1.5c 10.6d 
18:1 n-7 0.0a 0.0a 0.3ac 0.0a 2.3b 1.9bc 
18:2 n-6 (LA) 3.0a 3.7ab 5.5bc 7.0c 0.2d 5.4b 
18:3 n-6 0.5 < 0.1 0.1 0.6 0.0 0.6 
18:3 n-3 (ALA) 1.8a 1.9a 7.4b 3.9d 0.1a 12.2c 
20:0 2.4b 1.2b 1.5b 1.8b 2.6b 5.8a 
20:1 n-9 0.0 0.1 0.1 0.0 0.0 0.0 
20:2 n-6 0.0 0.0 0.8 0.0 0.0 0.0 
20:3 n-6 0.0 0.0 1.3 0.7 0.1 0.1 
20:4 n-6 (AA) 8.7d 1.3b 13.2 c 21.1a 20.6a 0.8b 
20:3 n-3 (ETA) 0.0 0.0 0.7 0.0 0.0 0.0 
20:5 n-3 (EPA) 2.3acd 0.9a 5.8b 3.9de 0.9a 5.3be 
22:0 0.0 0.3 1.3 0.1 0.0 0.3 
22:1 n-9 1.2 0.0 1.7 0.0 0.0 0.3 
22:2 n-6 0.0 0.0 0.1 0.0 0.0 0.0 
22:5 n-6 0.0 0.0 < 0.1 0.0 0.0 0.1 
24:0 0.0 0.0 0.1 0.0 0.0 0.0 
22:6 n-3 (DHA) 0.0 0.0 0.0 0.0 0.0 0.5 
24:1 n-9 0.0 0.0 0.0 0.0 0.0 0.6 
Σ SFA 50.7a 65.5b 40.6c 42.0c 60.8b 47.4a 
Σ MUFA 33.0b 26.7ac 24.6cd 20.8def 17.2e 26.0f 
Σ PUFA 16.3d 7.8c 34.8a 37.2a 22.0b 26.5b 
n-6/n-3 3.0a 1.8b 1.5c 3.8d 15.7e 0.4f 
LA/ALA 1.7 1.94 0.74 1.8 2 0.44 
AA: arachidonic acid; ALA: alpha-linolenic acid; DHA: docosahexaenoic acid; EPA: eicosapentaenoic 
acid; ETA: eicosatrienoic acid; LA: linoleic acid 
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Key differences in abundance across species  
Analysis of the quantified FA data (mg.g-1 d.w. whole biomass) showed significant 
differences were observed between phyla (analysis of similarity, R < 0.9, p < 0.01) and 
between species within the Ochrophyta (analysis of similarity R < 0.9, p < 0.02) (Figure 
10). Transformation of the data to reduce the effect of abundance indicated that phyla 
differences are significantly distinct in terms of the composition of FA profiles (analysis 
of similarity R < 0.9, p < 0.01). However, species differences were not significant 
within the Ochrophyta (p = 0.10) despite some evident clustering (data not shown).  
 
Figure 10 Multivariate Dimentional Scaling plot comparing similarities of species FA profiles (mg.g-1 
d.w.). Samples are from triplicate lipid extracts of six Australian native and endemic macroalgae. Data is 
untransformed. 
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SIMPER analysis revealed that C18:0, C20:0 and C22:0 were the three main SFA that 
determined species variation in terms of both composition and abundance (Figure 10). 
C18:0 is most abundant in S. robusta followed by Ulva sp. along with higher C20:0 
content for the latter species. C22:0 was not present in E. radiata or S. robusta and was 
most abundant in H. banksii. In regards to PUFA, SIMPER analysis showed that species 
variations were primarily due to C18:2 n-6 (LA), C18:3 n-3 (ALA), C20:4 n-6 (AA), 
C20:3 n-3 (ETA) and C20:5 n-3 (EPA). Oleic acid (C18:1 n-9) was most abundant in H. 
banksii and M. sciurus with trace amounts in S. robusta. Ulva sp. showed the highest 
abundance of essential ALA (C18:3 n-3) as a proportion of total significantly identified 
PUFA. This was followed by H. banksii, which had the second highest ALA content 
along with a significantly higher proportion of AA (C20:4 n-6) and EPA (C20:5 n-3). 
On a molar % basis, palmitic acid (C16:0) was the predominant FA in all six samples 
ranging from 20.5% in the Ulva sp. to more than double that amount (46.3%) in M. 
sciurus. The second most dominant FA was oleic acid (C18:1 n-9) for E. radiata, M. 
sciurus and H. banskii (20.2, 19.7 and 18.7% resp.); AA (C20:4 n-6) for P. comosa and 
S. robusta (21.2 and 20.6% resp.); and ALA (18:3 n-3) for Ulva sp (12.2%). The third 
most abundant FA ranging from 9.4-17.1% differed for each species from saturated FA 
for M. sciurus and S. robusta (myrisitic acid (C14:0) and capric acid (C10:0) resp.); to 
MUFA for E. radiata (C16:1 n-7), P. comosa and Ulva sp. (C18:1 n-9) and AA 
(C20:4 n-6) for H. banksii. The latter species also had a relatively high abundance of 
other desirable FA such as ALA, LA and EPA (7.4%, 5.5% and 5.8% resp.), identifying 
this as a key species to pursue further. 
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Along with high C16:0, S. robusta was characterised by a high C18:0 and C10:0 SFA, 
the latter 2 to 5-fold greater than for all other species, coupled with low oleic acid 
(C18:1 n-9) levels (Figure 11). Ulva sp. was characterised by a high proportion of C16:0, 
oleic acid (C18:1 n-9) and C20:0 SFA, and moderate, essentially equivalent palmitoleic 
(C16:1 n-7) levels (Figure 11). Conversely, all four Ochrophyta species were 
characterised by moderate C14:0 and low C18:0 SFA content, instead dominated by a 
high proportion of oleic acid (C18:1 n-9), 10-fold greater than S. robusta and 2 to 3-fold 
greater than Ulva sp.  
The predominant PUFA across all six species were the n-3 FA, ALA (C18:3 n-3) and 
EPA (C20:5 n-3) and the n-6 FA LA (C18:2 n-6) and AA (C20:4  n-6) (Figure 11). The 
most desirable ALA to LA ratio was observed for the Ulva sp. with a 2-fold higher 
ALA content compared to LA; followed by H. banksii with 1.3-fold higher ALA than 
LA; and then conversely P. comosa showing a 2-fold higher LA to ALA content. AA 
(C20:4 n-6) was the second most abundant FA for S. robusta and P. comosa, and third 
most abundant for H. banksii, and lowest in the Ulva sp. The DHA precursor, EPA 
(C20:5 n-3) was highest in H. banksii (5.8%), followed by Ulva sp. (5.3%) and P. 
comosa (3.9%). H. banksii also showed traces of eicosatrienoic acid (ETA; C20:3 n-3), 
while the long-chain n-3 DHA (C22:6 n-3) was only detected in the green macroalgae 
Ulva sp., albeit in trace amounts (0.5%).  
The lowest ratio of n-6/n-3 PUFA was observed for the Ulva sp. (0.4), with the ratio 
ranging from 1.5-3.8 for the four brown species, and 5-fold higher for the red seaweed 
S. robusta (15.7). 
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Figure 11 Key differences in FA content (mg.g-1 d.w.) across the six Australian marine macroalgae of 
both total and individual SFA, MUFA and PUFA. 
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was greatest in the non-polar, lipid-rich dichloromethane (DCM) extracts (>76% 
activity for all species), followed by the intermediate polarity ethyl acetate (EtOAc) 
extracts (>50% activity for all species except H. banksii), with the lowest activity 
observed in the polar butanol (BuOH) extracts (Table 14). Although the non-polar DCM 
extracts were the most active, those of P. comosa and S. robusta also exhibited high 
cytotoxicity towards all three cell lines investigated, including the normal (WT-MEF) 
cell line. In general, the EtOAc extracts, in particular P. comosa, M. sciurus and Ulva 
sp. showed promising NO reducing activity, coupled with low toxicity towards the 
normal cell line, with the exception of M. sciurus. 
Cytotoxicity  
A qualitative summary of 24 and 48 hr cytotoxicity data for three cell lines is presented 
in Table 14. The non-polar DCM extracts of P. comosa and S. robusta showed high 
cytotoxicity (>76%) across all cell lines investigated (i.e. macrophage RAW 264.7, 
wild-type murine embryonic fibroblast WT-MEF and human pancreatic carcinoma 
MIA-PaCa-2 cell lines). In addition to strongly reduced NO production, the DCM and 
EtOAc extracts of Ulva sp. showed preferential cytotoxicity towards the MIA-PaCa-2 
human pancreatic carcinoma cell line. The EtOAc extract of H. banksii showed the 
greatest selectivity towards the pancreatic cancer cell line, along with a moderate 
reduction in NO production.  
  
Chapter 3 Metabolite and Bioactivity Screening 
 84 
Table 14 Cytotoxicity and anti-inflammatory activity (via inhibition of nitric oxide (NO)) of 18 algal 
extracts from six macroalgae. Data are presented as % activity at 100 µg.mL-1 from two independent trials 
done in duplicate. 
Species Extract RAW 
264.7 
WT MEF MIA 
PaCa-2 
% ↓ NO 
E. radiata DCM + - - +++ 
 EtOAc - - - ++ 
 BuOH + - - - 
M. sciurus DCM - - - +++ 
 EtOAc - + - +++ 
 BuOH - - - ++ 
H. banksii DCM - + - +++ 
 EtOAc - - +++ + 
 BuOH + - - - 
P. comosa DCM +++ +++ +++ +++ 
 EtOAc - - - +++ 
 BuOH - - - - 
S. robusta DCM +++ +++ +++ +++ 
 EtOAc nt nt +++ ++ 
 BuOH + - - + 
Ulva sp. DCM + + +++ +++ 
 EtOAc + - +++ +++ 
 BuOH - - - + 
Key: (-) 0 - 24% activity; (+) 25 - 50%; (++) 51 - 75%; (+++) 76 - 100% activity; (nt); not tested, no 
available extract. Investigated cell lines include human pancreatic carcinoma (MIA-PaCa-2), Abelson 
murine leukemia virus-induced tumor macrophage (RAW 264.7) and wild-type murine embryo 
fibroblasts cell lines (WT-MEF) 
Discussion  
Herein this study presents key differences from the screening process of six taxa of 
Australian macroalgae for prioritizing future work towards anti-inflammatory 
applications. To this end, consistent anti-inflammatory activity was observed for all taxa 
in terms of decreased NO production, predominantly in the DCM and EtOAc extracts. 
However, the species were highly diverse in the abundance of FA, with approximately 
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30% more types of FA in Ulva sp. and H. banksii than in the other taxa. The highest 
abundance of PUFA was in H. banksii and the 4th lowest in Ulva, while the more 
preferable n-6/n-3 ratio and LA/ALA ratio was found for Ulva. In addition, the selective 
cancer cell toxicity was greatest for Ulva and H. banksii (Table 15). 
Table 15 Summary of key differences from the screening process of six taxa of Australian macroalgae for 
prioritizing future work towards anti-inflammatory applications with a focus on PUFA content. 
 PUFA 
content 
Abundance Low n-
6/n-3 
ratios 
LA/ALA  
< 1 
Selective 
cancer cell 
toxicity 
iNOS 
inflammatory 
response 
Ecklonia radiata  YES    YES 
Myriogloea sciurus      YES 
Hormosira banksii HIGH    YES YES 
Phyllospora 
comosa 
MED     YES 
Solieria robusta      YES 
Ulva sp.#  YES YES YES YES YES 
# Species name withheld. 
With the exception of the well-studied green macroalgae genus Ulva [40-42] the five 
other macroalgal species described herein have been studied in other contexts such as 
their protein, trace element and carbohydrate content [43], but rarely in terms of their 
FA profiles and anti-inflammatory activity. Investigation of a different sample of P. 
comosa from South Eastern Australia has been reported by us previously with an 
analogous profile to that described here [44]. The FA profile of a red seaweed belonging 
to the genus Solieria has been described as dominated by C16:0 and C20:5 n-3, with the 
EPA content differing from our results [45].  
Apart from palmitic acid (C16:0), which was the dominant FA in all six species and is 
consistent with other macroalgae [29, 30, 44] the remainder of the FA profiles were 
significantly different for the three phyla investigated herein. This is consistent with 
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previous reports where FA signatures have been used to distinguish taxonomic groups 
up to the family level but not at the level of species [46, 47].  
From the four Ochrophyta species, the two fucales species showed comparable total 
SFA, MUFA and PUFA levels [47, 48]. M. sciurus (order Ectocarpales) and E. radiata 
(order Laminariales) reported herein however showed reduced levels of total PUFA 
when compared to similar species previously reported from the same order [47, 48]. 
Overall, the four Ochrophyta species were characterised by high C16:0, moderate C14:0 
and low C18:0 SFA; the highest levels of oleic acid, particularly for E. radiata, M. 
sciurus and H. banksii; but varying PUFA profiles and abundance with H. banksii and 
P. comosa containing amongst the highest amounts of the long-chain PUFA AA 
(C20:4 n-6) and EPA (C20:5 n-3) and M. sciurus and E. radiata containing the lowest 
abundance of PUFA of all the six species. The dominant C18:1 n-9, C20:4 n-6 and 
C20:5 n-3 is consistent with average abundances reported for the Class Phaeophyceae 
[49].  
The red seaweed S. robusta (order Gigartinales) was characterized by the highest 
amount of capric acid (C10:0), along with other SFA in high amounts (C16:0 and 
C18:0); the lowest abundance of MUFA; and a PUFA profile comprised almost entirely 
of AA, consistent with other reports that Rhodophyta are dominated by the presence of 
C20 PUFA [49, 50]. EPA (C20:5 n-3) levels herein were comparable to results reported 
for a number of species belonging to the order Gigartinales from the Senegalese coast  
by Aknin et al [51]. However, EPA has been reported in higher amounts in other red 
algae (order Gigartinales) from the Pacific coast of North California [48]. In terms of 
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total SFA, MUFA, PUFA, the results obtained were comparable to reported values for 
Rhodophyta species [47]. On the other hand, the green seaweed Ulva sp. was 
characterized by a high proportion of longer chain SFA such as C20:0; higher amounts 
of oleic (C18:1 n-9) (cf. to C18:0) and equivalent amounts of palmitoleic acid (C16:1 n-
7), both dominant MUFA; and a PUFA profile rich in ALA (C18:3 n-3), the highest 
proportion of all species, LA (C18:2 n-6) and EPA (C20:5 n-3), with the LA and ALA 
content a defining feature of Chlorophyta species [49]. 
The species differences in PUFA composition contributed to significantly different n-
6/n-3 ratios for each of the six species investigated. With the exception of S. robusta, 
the n-6/n-3 ratios were between 0 and 4, which is consistent with previous reports for 
the FA profiles of diverse species of macroalgae [30, 52, 53]. As a desirable ratio for 
human health is around 1 [16, 17], this further highlights the potential health benefits 
available from large-scale cultivation of macroalgae such as Ulva sp. as a source of 
beneficial PUFA with n-6/n-3 < 1 along with a ratio of LA/ALA <1. 
It is important to note that chemical composition, including FA profiles can exhibit 
clear seasonal and within plant variation, particularly in regards to total lipid content 
rather than the lipid profile [3, 54, 55]. Thus any future algal cultivation would need to 
consider cultivation conditions that best enhance PUFA profiles for target algal species 
and total lipid content, along with rigorous measures to ensure quality control. 
Biological evaluation of the organic extracts generated from oven dried biomass of all 
six species was also performed. All 18 extracts exhibited a degree of inhibition of 
production of the inflammatory mediator NO, whereby the activity followed the order: 
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non-polar extracts > intermediate polarity extracts > polar extracts. Non-polar (DCM) 
extracts are the FA-rich fraction and also known to contain phenolic compounds as well 
as pigments; all of which have unique functions in inflammatory metabolism [15, 56]. 
Interestingly, n-3 PUFA have been reported as modulators of the activity of nitric oxide 
synthase (NOS) [57], one of the primary enzymes involved in NO production. MUFA 
derivatives have also been isolated from Ulva lactuca which act as activators of the 
cytoprotective Nrf2 –ARE pathway [58], linked to suppression of inflammatory 
responses [59]. Furthermore, the brown alga Eisenia bicyclis (order Laminariales) was 
evaluated for anti-inflammatory activity via inhibition against LPS-induced NO and 
other inflammatory mediators in RAW 264.7 cells, as in this study. Similar to our 
findings, the activity was found to be greatest in the non-polar DCM extract [60]. In 
their case the activity was attributed to fucosterol, which has also been shown to 
suppress production of NO and the inflammatory cytokines TNF-α and IL-6 in the 
brown alga Undaria pinnatifida (order Laminariales) [61]. 
Anti-inflammatory activity has been reported for a range of other algal metabolites 
isolated from non-polar and DCM extracts including the chromene sargachromanol G 
from the Korean brown alga Sargassum siliquastrum (order Fucales) [62]; halogenated 
compounds from the Malaysian red alga Laurencia snackeyi [63] and the porphyrin 
derivatives, pheophorbide a and pheophytin a, along with the xanthophyll fucoxanthin, 
from the edible brown alga Saccharina japonica (order Laminariales) [64]. Other 
bioactive algal metabolites isolated from non-polar extracts include cytotoxic, 
antibacterial linear sesquiterpenoids from the green alga Penicillus capitatus (class 
Ulvophyceae, order Bryopsidales) [65]; antibacterial labdane diterpenoids from Ulva 
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fasciata  [66]; and antiatherosclerotic phytosterols from the brown alga Sargassum 
fusiforme (order Fucules) [67].  
Most extracts displayed minimal toxicity to the cell lines investigated. However, six 
algal extracts showed high cytotoxicity towards a human pancreatic cancer cell line, 
with the EtOAc extracts of Ulva sp. and H. banksii showing the greatest selectivity with 
no toxicity towards a normal murine cell line. Marine algae are well known as rich 
sources of unique, structurally diverse, biologically active natural products with a range 
of reported activities including anti-cancer, anti-viral, anti-bacterial, anti-fungal and 
immunomodulating activities [8, 68, 69]. In particular, a number of promising anti-
cancer compounds have been isolated from algae including the anti-mitotic stypoldione 
from the brown alga Stypodium zonale and the cytotoxic dehydrothysiferol from the red 
alga Laurencia viridis (Brown et al. 2014). Thus, further investigation to identify the 
active component of the selectively cytotoxic extracts is needed. 
In summary, six Australian macroalgal species were evaluated for their FA composition 
and anti-inflammatory activity. From these studies, the green seaweed Ulva sp. emerged 
with one of the highest number of different FA identified and exhibited a favourable n-
6/n-3 ratio of 0.4, as well as a 2-fold higher ALA (C18:3n-3) to LA (C18:2n-6) content. 
Ulva was also the only species to contain the desirable long-chain n-3 DHA with the 
lowest amounts of AA. The brown seaweed H. banksii was also of interest in terms of 
its rich FA profile with the highest EPA and ETA content of all six species, the latter 
known to have anti-inflammatory properties [70], the second lowest n-6/n-3 ratio of 1.5, 
the second best ALA to LA ratio of 1.3:1, although accompanied by the highest 
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abundance of AA. These results have implications in product development by 
highlighting target species such as Ulva sp. and H. banksii with both desirable n-3 
PUFA and biological activity profiles. 
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FOREWORD TO CHAPTER 4 
The metabolite and bioactivity screening of wild and cultivated macroalgal species 
presented in the previous Chapter 3 established a number of key species of interest for 
future investigations (Figure 12). 
 
 
Figure 12 A summary of the major findings and most interesting macroalgal candidates presented in 
Chapter 2, as a result of preliminary metabolite and bioactivity screening of five macroalgal species 
obtained from wild collection and one cultivated Ulva sp. (provided by Venus Shell Systems Pty. Ltd.10) 
Myriogloea sciurus and Hormosira banksii 
Myriogloea sciurus showed anti-inflammatory activity at a consistently high level 
across all extracts with little toxicity. Interestingly, Hormosira banksii showed selective
                                                
10 Venus Shell Systems, Narrawallee, NSW, 2539, Australia  
P. comosa H. banksii E. radiata M. sciurus S. robusta Ulva sp. 
•  Selective anti-cancer 
•  High anti-inflammatory 
    activity 
•  Desirable omega-6/omega-3 
•  Diverse fatty acid profile 
•  Low levels of pro-
inflammatory substrate 
arachidonic acid 
•  Desirable linoleic acid/α-
linolenic acid 
  
•  Selective anti-cancer 
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anti-cancer activity against pancreatic cancer. Whilst cancer and natural product 
isolation for potential anti-cancer drug compounds is beyond the scope of this thesis, 
this finding was subsequently explored and the active extract was purified into 24 
fractions using column chromatography (Supplementary Methods Appendix D) (Figure 
13). 
 
Figure 13 The % cytotoxicity on pancreatic cancer (MIAPaCa-2) cells (as a measure of inhibition of cell 
proliferation) of 24 fractions generated by silica-gel chromatography purification of the active Hormosira 
banksia extract which was identified by bioactivity screening work presented in Chapter 2. High anti-
cancer activity was retained in 4 fractions (F9, F10, F11 and F22). 
As fraction 10 had one of the highest yields (mg) of product it was chosen for further 
analysis by analytical high-pressure liquid chromatography (HPLC), which revealed 9 
minor and 2 major peaks (Supplementary Results Appendix E). This indicates the 
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presence of 12 compounds. Further preparative HPLC revealed the most dominant peak 
to be two compounds indicating the presence of 13 compounds in fraction 10, in which 
one or all may be responsible for selectively inhibiting pancreatic cancer 
(Supplementary Results Appendix E) However, poor yields (< 1 mg) of the final 
isolated compound(s) limited further structural characterisation via mass spectrometry 
and nuclear magnetic resonance spectroscopy (NMR). However, these preliminary 
investigations of Hormosira banksia highlight this macroalgae as a novel and unique 
Australian species to pursue, particular as part of a future natural product focused 
project. Myriogloea sciurus also warrants further investigations as species from the 
order Ectocarpales have mainly been investigated with regards to their water-soluble 
polysaccharides or Fucoidan (as outlined in Chapter 1) and herein we demonstrate high 
anti-inflammatory potential across three organic extracts of differing polarities with 
limited to zero toxicity against both established and primary cells lines.   
Ulva sp. 
Of greater interest herein were the positive results obtained for the cultivated Ulva 
sample, which not only showed high anti-inflammatory functionalities across all three 
organic extracts, but also a diverse fatty acid profile. The nonpolar dichloromethane 
extract and the more polar ethyl acetate extract showed the strongest anti-inflammatory 
activities and it was hypothesised that that this could be due to the presence of anti-
inflammatory fatty acids and pigments. As the metabolism of macroalgae responds 
readily to their environment it is important to determine the cultivations conditions that 
enhance that metabolite and bioactivity profile of interest, particular in regard to their 
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fatty acids. Fatty acids are one of the most variable compositional categories that differ 
across taxa but they also readily change within taxa in response to the environment. The 
analysis of fatty acids and pigments were undertaken to determine if variability due to 
cultivation of different biomass fractions was significant and quantifiable.  
Furthermore, due to the variability found in the reporting of fatty acids for Ulva sp. in 
the literature, along with first-hand experience with fatty acid variability across different 
protocols in-house, it was considered necessary to consider the extraction protocols and 
analytical methods and their affect on the fatty acid profile. 
Therefore work was undertaken to determine the effect of cultivation conditions and 
extraction method on the fatty acid profiles of a cultivated Ulva sp. This work presented 
in Chapter 4, is the final accepted version in thesis format of a published manuscript11 
(2016) within the journal Food Chemistry (Impact factor 3.391). The title page of the 
article as it appears in the printed journal can be found in Appendix F. 
 
 
                                                
11 McCauley, J.I., et al., Parameters affecting the analytical profile of fatty acids in the macroalgal genus 
Ulva. Food Chemistry, 2016. 209: p. 332-340. 
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Abstract  
The fatty acids (FA) of Ulva have potential to contribute to nutrition. However the 
large variability of FA profiles of Ulva species; thus the quality and quantity of 
FA in relation to nutrition is poorly defined. Herein we investigate the FA profile 
of 74 cultured Ulva samples crossing five culture regimes, six extraction regimes 
and four post-harvesting processes. This is compared alongside a comprehensive 
review of FA profiles of Ulva spp. With regard to the literature, Ulva is 
characterised by C16:0 (30.5 ± 11.5 %), C18:3 n-3 (14.5 ± 6.3 %), C18:4 n-3 
(12.5 ± 5.4 %), C16:4 n-3 (8.9 ± 4.8 %) and C18:1 n-7 (10.1 ± 4.0 %). The 
investigated Ulva fell within the reported range of specific FA. High nutrient 
conditions showed the most desirable FA profile for health, along with the highest 
total FA content (56 mg.g-1 dry weight equivalent) when extracted with an 
optimised protocol.   
Key words: PUFA, desiccation, extraction, cultivation, environment, nutrition, 
health 
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Introduction 
The marine macroalgal genus Ulva (Chlorophyta) is a source of valuable long-chain 
polyunsaturated fatty acid (LC-PUFA) profiles, in particular the biologically important 
eicosapentaenoic acid (C20:5 n-3, EPA) [1]. Ulva spp. also show the presence of trace 
amounts of docosahexaenoic acid (C22:6 n-3, DHA), however more abundant LC-
PUFA include the DHA precursor, docosapentaenoic acid (C22:5 n-3, DPA), along with 
the more unique C18:4 n-3 and C16:4 n-3 PUFA [1]. Ulva grows abundantly in waters 
enriched by nutrients and is frequently involved in green tides in eutrophicated coastal 
areas producing a high quantity of biomass [2]. This characteristic of Ulva means that it 
is well suited for cultivation. Therefore as whole biomass or as part of a sequential 
biorefinery system of production, cultivated Ulva biomass has the potential to offer a 
sustainable source of essential FA for human and animal consumption and nutrition.  
The feasibility of cultivating marine macroalgae, as a sustainable source of high value 
products is largely dependent on the cost-effectiveness and scalability of cultivation to 
deliver high yields of quality controlled biomass. Ulva is a cosmopolitan genus (Figure 
14) and can readily adjust its metabolism under specific environmental conditions, 
wherein the lipids and FA play an important role in this adaptation [3]. As such, the 
profiles of reported FA for Ulva show a wide degree of natural variation. For example 
U. intestinalis has demonstrated an increase in unsaturation with increasing 
mineralisation in a study of a number of abiotic factors [3]. 
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Figure 14 World map indicating the various world locations where samples from the genus Ulva were 
collected and subsequently analysed for FA content as reported in the literature.  
Seasonal comparison of U. lactuca samples collected in Western Ireland showed a 
notable decrease in the n-6/n-3 ratio when collected in November (cf. June) [4]. 
Furthermore, the range of reported n-6/n-3 values were also more favourable when 
compared to an U. lactuca specimen collected from Northern Chile [5]. However, one 
of the appeals of Ulva in particular as a target genus, is its ability to be grown 
effectively and rapidly in culture, while tailoring PUFA profiles through nutrient replete 
conditions, which have been demonstrated on the laboratory scale [6]. It has also been 
shown that culture conditions including temperature [7], pH [8] and nutrient availability 
along with the presence of organic carbon [6], will also influence the lipid profile of 
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many algae including Ulva spp. Despite this, there are species-specific patterns within 
that variability that can be determined with experimental means and comprehensive 
review of the data. Yet little has been done beyond the laboratory scale in developing 
controlled commercial production systems. Therefore it is important to demonstrate the 
degree to which scaled cultivation conditions can be controlled to deliver the desired 
compositional profiles. A second consideration that could drive the variability of 
reported FA content and profiles is whether or not there are effects on the FA 
composition due to post-harvest processing, and in particular the drying process, along 
with effects due to variations in analysis methods on the quantification of these desired 
traits. This is important in delivering, from the farm to the consumer, a high quality 
health food product and/or ingredient with well-established processing and/or quality 
controlled testing criteria.  
For example a number of studies have demonstrated that the choice of analytical 
method and any deviations of the method can significantly influence the FA yield and 
profile. For example, comparisons across standard extraction and transesterification 
techniques such as the International Organization for Standardization (ISO) method, the 
Association of Official Analytical Chemists (AOAC) method and the Folch method [9] 
found no significant differences in regards to total FA recoveries of flaxseed oil [10]. 
However, monounsaturated fatty acids (MUFA) and PUFA were found to be 
underestimated after extraction with the ISO method when compared with AOAC and 
Folch methods [10].  
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In terms of the effects from extraction methods on FA yields, the comparison of 
extraction-transesterification techniques versus direct transesterification showed 
significantly increased FA yields in lipid-producing microheterotrophs for direct 
transesterification methods [11]. Various solvents and solvent combinations have also 
been explored with higher FA recoveries found with either the Folch or Bligh and Dyer 
extractions protocols [12]. These protocols both use a ratio of the nonpolar solvent 
chloroform with the more polar methanol [12].  In macroalgae specifically, Kumari et al 
(2011) did a comparative evaluation of Bligh and Dyer, Folch and Cequier-Sánchez 
methods for the quantitative determination of total lipids and FA, along with 
investigating the effect of sonication and addition of a buffer in the solvent system. For 
U. fasciata no added benefit was observed for a buffered solvent system with high lipid 
and FA yields obtained for the traditional Folch extraction. Therefore, for the 
development of a nutritionally valuable, high yielding algal-derived oil, it is important 
to investigate both environmental effects of cultivation and effects due to post-harvest 
processing and analysis methods. 
Herein we present the FA profile of a medium-scaled production of a genetically 
identified strain of one sp. of Ulva as a model to test the effects of environment and 
processing. The FA profile is presented and compared against a comprehensive 
literature review for the FA profile of the genus Ulva. The effects of environmental 
conditions were compared across five different medium-scale (5 m3) culture conditions; 
low nutrients, high nutrients, shaded, added glucose and acetic acid boost. Thirdly, this 
research explores the effects of post-harvesting processes and analysis methods on the 
FA composition and total content of the cultured algae. The findings presented have 
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important implications for the application of Ulva spp. in nutrition. This includes the 
development of diverse techniques to establish the best practices for analysis of FA in 
Ulva spp. as well as understanding the scale and type of effects from the environment.  
Materials and Methods 
Analysis of the literature 
A literature review of the reported FA profiles for the genus Ulva was conducted. The 
search was conduced using Web of Science with “Ulva” and “fatty acids” as key search 
terms. The review was comprised of 40 FA profiles from 23 references. Only papers 
reporting profiles as a percentage of total FA were considered. Due to large variations in 
the level of reporting of Ulva FA profiles, data was modified for analysis. All structural 
variations of identified C14, C16, C17 and C20 MUFA were grouped and identified at 
the level of C14:1, C16:1, C17:1 and C20:1 respectively. Similarly, this was applied to 
all identified C16:2 and C20:2 PUFA. Identified cis and trans isomers of the C18:1 n-9 
were also analysed collectively as C18:1 n-9. Furthermore, a number of identified FA 
were excluded due to (1) the bond position not being specified for a commonly reported 
FA and/or  (2) FA is uncommon and/or appears less than 3 times out of the 40 profiles 
reviewed. Data was aligned and visualised using GraphPad Prism version 6.00, 
GraphPad Software. 
Experimental Samples 
A total of 74 Ulva samples were analysed over the course of two yearly cultivation 
periods. The Ulva samples were from scaled, cultivated stock, provided by Venus Shell 
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Systems Pty. Ltd. Samples were from controlled cultivation conditions of high nutrient 
(natural sunlight with nutrient-rich media); low nutrient (natural sunlight with reduced 
nutrients); low light (reduced natural sunlight with nutrient-rich media), added acetic 
acid (natural sunlight with nutrient-rich media supplemented with acetic acid) and 
added glucose (natural sunlight with nutrient-rich media supplemented with glucose). 
For investigations into desiccation effects, samples were oven-dried (70 °C, 48 hrs), 
freeze-dried (liquid nitrogen followed by lyophilisation for 48 hrs), fresh (stored -4 °C, 
48 hrs) or frozen (-18 °C). Samples were extracted directly, or milled using a mortar 
and pestle (5 mins, continuously), sonicated (15 mins, rt) or co-incubated with enzyme 
(Onozuka R10, 2% w/v, rt, 15 mins) to test for effects of processing techniques. 
Extraction and Transesterification 
Lipids were extracted based on a standard method (referred to as extraction regime E1) 
of Folch et al. [9], with modifications based on Kumari, Reddy [13]. In brief, two grams 
of non-homogenized fresh sample was extracted with 3 x 6 mL of chloroform/methanol 
(2/1, v/v) with 0.001% butylated hydroxytoluene (BHT) by vortexing (~1 min) and 
centrifugation (3000 rpm, rt, 15 mins), with two extracts left overnight. The extract was 
evaporated to a consistent weight (dryness) in pre-weighed 9 mL Teflon lined screw top 
glass tubes under a stream of nitrogen. Crude lipid extracts were transesterified 
according to the method of Lepage and Roy [14] with added BHT (0.01% w/v).  
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Extraction Regimes 
Further modifications to the standard method (E1) were also investigated and involved 
alterations to the solvent and mass ratio, extraction time and number of extractions, as 
well as the inclusion of a pre-treatment step. Specific modifications to the method (E1) 
involved pre-homogenization of the biomass with a mortar and pestle (5 mins, 
continuously) and the removal of one overnight incubation (E2); pre-treatment of the 
biomass with an enzyme (Onozuka R10, 2% w/v, rt, 15 mins) before extraction (E3); 
pre-treatment of the biomass with sonication (15 mins, rt) before extraction (E4); pre-
homogenization of the biomass with a mortar and pestle (5 mins, continuously) and an 
increase in the number of consecutive reactions from 3 to 6 (limit observed where no 
more colour could be extracted) (E5) and; increase in the solvent to mass ratio from 3:1 
to 6:1 with the removal of two overnight incubations (E6). 
 FA Analysis 
FA were analysed by flame-ionization gas chromatography (GC-FID) (model GC-17A; 
Shimadzu, Rydalmere, NSW, Australia) using a 50 m x 0.25 mm internal diameter 
capillary column. One microlitre of the transesterified sample was auto-injected into the 
column, and individual FA were quantified using the Shimadzu analysis software 
(Class-VP 7.2.1 SP1). Samples were also analysed by GC mass spectrometry (GC-MS), 
performed on a Shimadzu QP-5050A GC-MS system equipped with a BP-5 fused silica 
Rxi-5ms capillary column (5% phenyl/95% polysiloxane, 30 m x 0.25 mm, 0.25 um 
film thickness, Restek), using helium carrier gas (1.0 mL.min-1) and samples of one 
microlitre over the temperature range of 80 - 300 °C. FA were identified by comparison 
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with known standards (Nu-chek or Sigma, Sydney, Australia) and comparison with 
mass spectral database library. Heneicosanoic acid (0.2 mg.mL-1 in toluene) was used 
as an internal standard for quantification and samples were analysed in triplicate. 
Relative compositional data is represented as molar % composition of total FA taking 
into account the molecular weight of the identified FA. Quantified data is represented as 
mg.g-1 dry weight equivalent (d.w. equiv.). 
Statistical Analysis 
The relative compositional profiles and content of FA across the five cultivation 
conditions, six extraction regimes and four post-harvesting processes were assessed 
using Two-way ANOVA and Tukey’s multiple comparisons to determine significantly 
different means using GraphPad Prism version 6.00, GraphPad Software. 
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Results and Discussion 
FA Profile of the genus Ulva 
A review of 40 reported FA profiles from 23 references of the genus Ulva was used to 
establish a generic FA profile for the genus Ulva and to determine the degree of 
variability that can occur if spp., environment and/or processing variables are viewed 
collectively. Furthermore, it provides a reference upon which to base our comparisons. 
Figure 14 shows the diverse locations of the collected Ulva samples that were reviewed 
and analysed.  The number of FA reported varied between 7 and 31, with an average of 
16. From the 12 spp. of Ulva that were reported, U. lactuca and U. pertusa were heavily 
represented (33 % and 25 % respectively). Furthermore, the most commonly used 
extraction method was the traditional extraction protocol of Bligh and Dyer (55 %) 
followed by the Folch method (23 %). Analyses were more commonly conducted on 
fresh samples (30 %), followed by dried and frozen samples (both 23 %), with 
extraction on freeze-dried biomass representing 20 %. A number of publications 
reported a pre-treatment step of boiling in water or isopropyl alcohol to inactivate 
enzymes or for de-proteinisation of the sample (Table 16). 
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Consolidation of the literature, shown in Figure 15, shows the FA profile of Ulva 
macroalgae being comprised of 35.3 ± 13.7 % saturated fatty acids 
(average ± standard deviation, SFA), 15.9 ± 6.6 % MUFA and 41.8 ± 15.6 % PUFA. 
The lowest degree of variation occurs within the MUFA. Notably larger increases in 
total SFA with reduced PUFA content has been reported. For example samples 
collected from Tunisia [23], the Egyptian Mediterranean [28], Persian gulf of Iran [26] 
and the Algarve coast, Portugal [34] report SFA between 59 - 72 % of total FA with 
PUFA between 6 - 24%.  In contrast, FA profiles of Ulva collected from the sea of 
Japan [18, 19] and the Chinese Bohai sea [25] showed a reported range of SFA between 
21 - 33 % and PUFA between 49 - 61 %. Herein, analysis of the FA composition of 74 
samples of one cultured Ulva sp. over the course of two years fell well within the ranges 
of the reported literature (SFA 32.8 ± 5.8 %, MUFA 16.5 ± 4.3 % and 
PUFA 51.0 ± 7.3 %) (Figure 15). 
The most commonly reported SFA for Ulva spp. were found to be C14:0 (1.8 % ± 2.1), 
C16:0 (30.5 % ± 11.5), C18:0 (1.5 % ± 1.8) and C22:0 (1.7 % ± 1.5) with C16:0 being 
the most dominant FA, a main characteristic of all macroalga in general [34]. 
The cultured Ulva sample reported similar values: C14:0 (1.1 ± 0.7 %), C16:0 (26.5 ± 
5.2 %), C18:0 (0.8  ± 0.7 %) and C22:0 (0.5 ± 0.2 %) (Figure 15). In general, C16:0 was 
also the most variable FA, with the lowest content (14 %) reported in an Ulva sample 
from Chile [5] and the highest content (59.4 %) reported from a Tunisian sample [23].  
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Figure 15 Sum
m
ary of the characteristic FA
 and their representative abundance (as a percentage of total FA
) for the genus U
lva as reported in the literature (review
 of 40 
profiles from
 23 references as outlined in Table 1). G
raph represents reported values alongside literature average ± standard deviation. This is further com
pared w
ith a 
cultured filam
entous U
lva sp. (*) as reported herein and represents the average of 74 analysed sam
ples w
hich included five different culture regim
es, six extraction regim
es 
and four post-harvesting processes. 
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Commonly reported MUFA from least abundant to most abundant were 
C14:1 (1.5 ± 1.2 %), C18:1 n-9 (4.1 ± 4.1 %), C16:1 (4.4 ± 3.2 %) and C18:1 n-7 
(10.1 ± 4.0 %), with comparable findings for our cultured Ulva sp. (Figure 15). There 
was little variability in the literature in regards to MUFA content, although some 
discrepancy in regards to the reporting and level of identification of C18:1 was 
apparent. For example, in some cases bond position is not specified [3, 23]. In other 
cases, only C18:1 n-7 [30] or C18:1 n-9 is reported [26]. In these cases the abundance 
of the respective C18:1 showed variation between 4.9 and 15.9 % of total FA. In 
instances where both FA were identified [19, 20, 25], the abundance of C18:1 n-7 to 
C18:1 n-9 was often greater than 1-fold and reflects the literature trend as shown in 
Figure 15. Notably, papers identifying only C18:1 n-9, show it to be more abundant than 
the literature average. For example Rohani-Ghadikolaei and Abdulalian [26] reported an 
abundance of C18:1 n-9 of 11.5 % representing a 2-fold increase when compared to the 
literature average. This raises the question as to whether or not the bond position of the 
C18:1 MUFA is being correctly identified or is simply a matter of intra-species 
variation that is known to occur [4, 24, 30]. Indeed we found that comparison of our 
sample with a standard FA methyl ester mixture lacking C18:1 n-7, C18:1 n-9 can be 
easily assigned to the more dominant C18 MUFA due to similar retention times.  Only 
upon running an additional C18:1 n-7 standard were we able to assign both C18:1 n-9 
and C18:1 n-7. 
Ulva was further characterised by abundant C16 and C18 PUFA comprising about 45 % 
and 40 % of total FA respectively. Of note C18:4 n-3, a characteristic FA of marine 
algae and C16:4 n-3 a distinguishing characteristic FA for green algae, along with high 
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levels of C18:2 n-3 and C18:3 n-3 [1]. The FA in order of increasing abundance were 
C18:2 n-6 (5.3 ± 3.6 %), C16:4 n-3 (8.9 ± 4.8 %), C18:4 n-3 (12.5 ± 5.4 %) and C18:3 
n-3 (14.5 ± 6.3 %). The FA C18:2 n-6 (8.3 ± 3.5 %) and C18:3 n-3 (19.5 ± 3.4 %) for 
the investigated cultured Ulva were marginally above the literature average. However, 
C18:2 n-6 and C18:3 n-3 have been reported to be as high as 21 % of total FA for C18:2 
n-6 [15] and 28.8 % for C18:3 n-3 [21].  
LC-PUFA combined, as reported in the literature for Ulva comprised approximately 
6.0 % of total FA. Most commonly reported LC-PUFA from least abundant to most 
abundant are C20:4 n-6 (0.9 ± 0.6), C22:6 n-3 (1.1 ± 2.3), C20:5 n-3 (1.6 ± 1.2) and 
C22:5 n-3 (2.2 ± 1.0). The cultivated Ulva sample fell well within the reported range of 
the literature (Figure 15). It was found that DHA content (C22:6 n-3) is often reported to 
be present in trace amounts, on average < 2 %, however DHA content has been reported 
to be as high as 9 % [28] from the only reported FA profile for U. linza.  
Effect of environmental conditions on FA profile (% total FA) 
Over the course of two years the FA profile of a cultured filamentous sp. of Ulva was 
analysed to investigate the effect of different medium-scale open pool outdoor 
cultivation conditions. The 74 samples investigated included five different culture 
regimes; high nutrients, low nutrients, low light, added acetic acid and added glucose 
and also included samples prepared by six different extraction regimes and four 
different post-harvesting processes. FA profiles from the respective culture conditions 
are presented in Table 17. The most notable shifts occurred between the low nutrient and 
high nutrient treatments. Multiple comparisons indicated a significant increase in the 
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proportion of total SFA (41 %) and decrease in PUFA (25 %) for the low nutrient group 
when compared to the high nutrient group (P < 0.005). This is due to changes in C16:0 
content (Table 17). 
Table 17 The FA profile of a filamentous Ulva sp. from five different culture treatments. Data is 
expressed as the % of total FA. Data represents the average ± se of 74 Ulva samples investigated over a 
two-year period. Means with different letters are significantly different (Tukey’s multiple comparisons, p 
< 0.05). 
 
High Nutrients 
(n = 35) 
Low Nutrients 
(n = 9) 
Low Light 
 (n = 12) 
+Acetic Acid 
 (n = 12) 
+Glucose 
(n = 6) 
C8:0 0.11 ± 0.05 0.15 ± 0.12 - - 0.72 ± 0.12 - - 
C10:0 1.41 ± 0.31 0.79 ± 0.35 1.76 ± 0.33 0.46 ± 0.09 1.68 ± 0.37 
C11:0 0.27 ± 0.04 2.20 ± 0.03 0.44 ± 0.13 0.97 ± 0.32 0.29 ±  0.05 
C12:0 0.74 ± 0.06 0.45 ± 0.09 0.75 ± 0.07 0.55 ± 0.09 0.88 ± 0.12 
C14:0 1.19 ± 0.14 1.27 ± 0.13 1.15 ± 0.18 0.81 0.02 1.05 ± 0.17 
C14:1 n-7 0.41 ± 0.12 0.27 ± 0.24 0.46 ± 0.09 0.03 ± 0.02 0.76 ± 0.19 
C15:0 0.26 ± 0.03 0.25 ± 0.07 0.34 ± 0.02 0.20 ± 0.03 0.38 ± 0.02 
C15:1 0.47 ± 0.06 0.47 ± 0.09 0.50 ± 0.09 0.42 ± 0.07 0.26 ± 0.06 
C16:0 24.46 ± 0.67a 35.22 ± 0.11b 25.33 ± 0.83a 28.22 ± 1.01c 24.75 ± 1.27a 
C16:1 n-7 5.25 ± 0.53 4.30 ± 0.26 5.22 ± 0.64 4.22 ± 0.29 4.56 ± 0.79 
C17:0 0.70 ± 0.09 0.63 ± 0.12 1.56 ± 0.12 0.25 ± 0.05 1.25 ± 0.23 
C17:1 n-7 0.35 ± 0.05 0.34 ± 0.08 0.69 ± 0.08 0.18 ± 0.04 0.41 ± 0.14 
C16:4 n-3 12.11 ± 0.40a 4.79 ± 0.19b 10.92 ± 0.57ac 10.37 ± 0.44ac 8.49 ± 0.66c 
C18:0 0.61 ± 0.07 1.36 ± 0.06 0.99 ± 0.21 0.34 ± 0.01 1.71 ± 0.27 
C18:1 n-9 0.83 ± 0.11 2.09 ± 0.08 0.78 ± 0.09 0.42 ± 0.04 1.23 ± 0.08 
C18:1 n-7 8.62 ± 0.76a 9.70 ± 0.24ab 7.16 ± 0.75a 12.30 ± 0.08b 10.79 ± 1.20b 
C18:2 n-6 6.61 ± 0.30a 12.90 ± 0.08b 9.51 ± 0.86c 6.90 ± 0.15a 11.62 ± 1.71b 
C18:3 n-6 0.84 ± 0.06 0.90 ± 0.06 0.97 ± 0.15 0.42 ± 0.02 1.32 ± 0.11 
C18:3 n-3 20.95 ± 0.60a 14.17 ± 0.16b 19.65 ± 0.35a 20.09 ± 0.31a 17.81 ± 0.62c 
C18:4 n-3 9.02 ± 0.27a 4.13 ± 0.13b 7.35 ± 0.40a 7.80 ± 0.35a 5.68 ± 0.26b 
C20:1 n-9 0.04 ± 0.01 0.14 ± 0.03 0.03  ± 0.01 0.08 ± 0.02 0.16 ± 0.03 
C20:4 n-6 0.74 ± 0.08 0.86 ± 0.09 1.19 ± 0.19 0.31 ± 0.01 1.53 ± 0.15 
C20:3 n-6 0.19 ± 0.03 0.36 ± 0.05 0.36 ± 0.06 0.10 ± 0.02 0.53 ± 0.01 
C20:5 n-3 1.49 ± 0.24 1.28 ± 0.21 1.44 ± 0.23 1.30 ± 0.06 1.10 ± 0.06 
C22:0 0.56 ± 0.05 0.49 ± 0.07 0.42 ± 0.04 0.55 ± 0.05 0.38 ± 0.02 
C22:1 n-9 0.05 ± 0.03 0.31 ± 0.05 0.29 ± 0.23 0.06 ± 0.01 0.17 ± 0.10 
C22:5 n-3 1.81 ± 0.13a 1.03 ± 0.13b 1.09 ± 0.06 b 2.20 ± 0.22c 1.01 ± 0.10 b 
C22:6 n-3 0.09 ± 0.03 0.01 ± 0.27 0.03 ± 0.02 0.15 ± 0.15 0.01 ± 0.00 
% SFA 30.30 ± 0.75a 42.83 ± 0.11b 32.74 ± 0.56c 33.08 ± 1.43c 32.36 ± 0.96a 
% MUFA 16.03 ± 0.89 17.61 ± 0.21 15.14 ± 0.84 17.73 ± 0.29 18.33 ± 2.13 
% PUFA 53.90 ± 1.22a 40.63 ± 0.19b 52.66 ± 1.42a 49.72 ± 1.33c 49.32 ± 0.94c 
n-6/n-3 0.23 ± 0.01a 0.74 ± 0.01b 0.37 ± 0.05c 0.23 ± 0.01a 0.55 ± 0.08bc 
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It is regarded that nitrogen is an important factor in algal lipid metabolism and that 
nitrogen starvation can contribute to the formation and accumulation of 
triacylglycerides, comprising of predominantly SFA [35]. This is often considered in a 
positive context with applications such as biodiesel production. Results here suggest 
that for the development of an algal-derived oil for human and animal nutrition, 
nitrogen-deplete conditions are unfavourable due to this shift of PUFA to SFA. Also 
unfavourable was a significant shift in C18:3 n-3 to C18:2 n-6, with the low nutrient 
group showing a reduction in C18:3 n-3 of 32 % and an increase in C18:2 n-6 of 95 % 
when compared to the high nutrient group. The relative abundance of C16:4 n-3 and 
C18:4 n-3 PUFA were also shown to be affected by environmental conditions. 
Stearidonic acid (C18:4 n-3) showed a lower relative abundance for the added glucose 
and low nutrient groups. For example, low nutrients showed a reduction in C18:4 n-3 of 
54 % compared to the high nutrient treatment. Similarly C16:4 n-3 showed a decrease 
of 60 % for the low nutrient group when compared to the high nutrient group. These 
results suggest that the high nutrient treatment has the most desirable FA profile and 
importantly, a lower n-6/n-3 ratio, for human and animal health applications. We found 
no added benefit with regard to the FA profile of Ulva with either glucose 
supplementation or acetic acid supplementation, except for a slight increase in n-3 DPA 
content with acetic acid supplementation when compared to the high nutrient group. 
Effect of freezing, drying and homogenisation on the FA profile (% total FA) and total 
FA content (mg.g-1 d.w. equiv.) 
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Freeze-drying is a drying process in which the solvent (usually water) is crystallized at 
low temperature and thereafter sublimated from the solid state directly into the vapor 
phase [36]. Freeze-drying is a common technique to preserve diverse sources of fresh 
material before analysis and extraction of bioactives. Reviews of the effects of freeze-
drying on extraction efficiencies of plant phytochemicals reveal highly variable results 
[37].  
From the analysis of 74 samples, including five cultivation regimes; four different 
extraction regimes and four different post-harvesting processes, no significant effects of 
drying (freeze-dried or oven-dried) were found on the relative FA composition, (F (3, 
210) = 0.041, P = 0.99). There is an underlying assumption that freeze-drying, as 
opposed to oven or air-drying, best preserves the bioactive chemical constituents of 
plant biomass [37]. Our results suggest that both oven and freeze-drying are effective 
for FA preservation and do not alter the relative FA composition of the Ulva 
macroalgae. This is in agreement with Molina Grima et al. [38] who showed that freeze-
drying did not affect the FA profiles of microalgal samples.  
Effects were seen with homogenisation in regards to FA total content (mg.g-1 d.w. 
equiv.). As expected, the FA yields increased by 2- and 19-fold for both freeze-dried 
and oven-dried homogenised samples respectively when compared to non-homogenised 
samples (Figure 16a). However, no benefit from homogenisation was observed for 
extracted fresh biomass and even showed a slight decrease (Figure 16a).  The highest 
yield was obtained from the extraction of non-homogenised fresh biomass, which 
achieved a total FA content of 51 mg.g-1 d.w. equiv. Our results suggest that non-
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homogenised fresh biomass for the filamentous Ulva sp. investigated herein is the most 
efficient method for determination of total FA content, as it eliminates both a drying 
and processing step. We found that by using fresh non-homogenised Ulva, we were able 
to significantly double the extraction yields from 3.1 to 6.6 mg.g-1 fresh weight when 
compared to the extraction of homogenised pre-frozen biomass, Figure 16b. Furthermore 
it is more convenient, particularly for high throughput analysis, as it removes a 
processing step. If the biomass is to be dried and stored, homogenisation before analysis 
is necessary to maximise yields and avoid underestimation of total content. We found  
milled oven-dried biomass preferable, as it showed an increase in yield of 49.9 % when 
compared to milled lyophilised biomass (Figure 16a).  
 
Figure 16 (a) Comparison of total FA content of non-homogenised freeze-dried, fresh and oven-dried 
samples versus homogenised samples and (b) comparison of the total FA content of non-homogenised 
fresh samples compared to homogenised frozen samples when extracted with the same protocol. Dotted 
line represents reported literature value for frozen, homogenised equivalent extracted under a similar 
protocol [13]. 
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In contrast, Ryckebosch et al. [39] reported no significant difference in FA yields for 
freeze-dried algae when compared to fresh. However it is important to consider that 
different extraction protocols were employed and extractions were performed on 
microalgae, as opposed to macroalgae with an extensive extracellular matrix [13]. 
Martins et al (2012) also noted the presence of significant matrix effects between 
macroalgal species and suggest that the analysis method for different organisms should 
be selected carefully. This highlights that the pre-treatment of Ulva biomass, or other 
samples of interest, is an important consideration when quantifying algal FA from the 
macroalgal genus Ulva. 
 Effect of extraction regimes and environmental conditioning on total FA content 
(mg.g-1 d.w. equiv.)  
From the analysis of 36 fresh-only samples significant differences in the extraction 
efficiency of different protocols were observed. As shown in Figure 17a, extraction 
protocols E1, E3 and E6 exhibited significantly higher yields than E2, E4 and E5 
(F (5,120) = 37.17, P < 0.0001). Compared to a standard regime (E1), which involved 
three consecutive extractions of a 3:1 solvent to mass ratio with two over-night 
incubations, the removal of one over-night incubation (E2) reduced the yield by 59%. 
The addition of a membrane disruption step using either an enzyme (E3) or sonication 
(E4) did not have any benefit when compared to the control (E1). Similarly, Lewis, 
Nichols [11] found no significant effect of sonication on extracted FA. Furthermore, 
increasing the number of consecutive extracts per sample from three (E1) to six (E5) did 
not significantly increase yields. The most efficient extraction method was found to be 
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E6, which involved extraction of three immediate consecutive extractions with a higher 
solvent to mass ratio (6:1), providing yields comparable to both the standard (E1) and 
extended extraction (E5) regimes.  As a result, E6 is the method of choice for high 
throughput analysis as extraction can be complete in under an hour. The variations in 
total FA contents observed highlight the importance of method optimisation for the 
sample of interest. This is potentially due to cellular matrix effects [11, 40]. Extraction 
methods have also been highlighted as another key element in the quantification of 
lipids and FA [13]. 
 
Figure 17 (a) The total FA yields (mg.g-1 d.w. equiv) from fresh Ulva samples from six different 
extraction protocols.  Extraction 1 (E1) represents the standard extraction involving 3 extractions with a 
3:1 solvent to mass ratio with 2 over-night incubations; E2 involves the removal of one over-night 
incubation; E3 involves a pre-treatment step with an enzyme; E4 involves a pre-treatment step with 
sonication; E5 shows an extended extraction involving 6 extractions with a 3:1 solvent to mass ration 
with 2 over-night incubations and E6 represents three immediate consecutive extractions with a 6:1 
solvent to mass ratio; (b) total FA yields (mg.g-1 d.w. equiv.) of samples from four different culture 
treatments extracted with E6 protocol. Means with different letters are significantly different (Tukey’s 
multiple comparisons, p < 0.05).  
As a result, cultured samples that were extracted using the E6 protocol were compared 
to determine the effect of culture on total content (Figure 17b). High nutrients showed 
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significantly higher total FA content with an increase of 23 mg.g-1 d.w. equiv. when 
compared to the low nutrient treatment (F (3, 32) = 78.74, P = < 0.0001). High nutrient 
levels have been shown to increase crude lipid content [30]. Furthermore a study by Ak, 
Öztaşkent [6] showed no effect of low sodium nitrate (NaNO3) concentrations (0.02 - 
0.11 g/L) on lipid content with increased lipid content observed for control regimes 
which had a much higher concentration of NaNO3 (1.5 g/L). Our results indicate that 
the high nutrient regime, at this scale of cultivation, in terms of total FA content, 
desirable PUFA profile and n-6/n-3 ratios, is the optimal growth environment for 
potential biomass biorefinery of an algal-oil for human and/or animal nutrition.  
Monitoring of FA profile consistency of treatments and time. 
The potential utilisation of cultured algal biomass for higher value products, such as an 
algal-derived oil for human and animal nutrition, is ensuring batch-to-batch 
reproducibility between harvests. The tests for reproducibility of results using two 
variables with similar SFA and PUFA ratios showed no significant change in the overall 
FA profile in terms of total SFA, MUFA and PUFA as a percentage of total extract 
composition (F (3,33)= 0.05 P = 0.98) (Figure 18).  
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Figure 18 The relative FA profile of Ulva sp. as a percentage of total extract composition of two harvest 
dates for two culture conditions to test for reproducibility of results. 
Conclusion 
Production controlled Ulva biomass through cultivation has future potential to generate 
an algal-based oil for human and/or animal nutrition, as part of a biorefinery process for 
high value products. Here we demonstrate that despite inconsistencies in the analysis of 
FA of Ulva in the literature, there is a key profile of abundant and some unique FA for 
the genus, which is high in unsaturated FA (about 60%) compared to SFA. These 
include C16:4 n-3, C18:4 n-3, C18:2 n-6 and C18:3 n-3 FA which are thought to 
contribute to the algicidal and competitive strategy of Ulva spp. [15]. We found that the 
literature was not consistent in reporting all potential FA in Ulva spp. and that it is 
important to include standards, or other identification techniques such as GC-MS, for 
feature FA such as C16:4 n-3 and C18:4 n-3 as well as C18:1 n-7, the latter likely to 
have been under reported in the literature. Despite some clear characteristics of the FA 
profiles of Ulva spp. there is a range of variation in the relative amounts of different FA. 
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One reason for this could be the environment as our work here demonstrated. We found 
C16:0, C16:4 n-3, C18:1 n-7, C18:2 n-6, C18:3 n-3 and C18:4 n-3 FA to be most 
affected by the environment. Notably, Ulva cultivated under low nutrient conditions 
showed accumulation of specific fatty acids, in particular C16:0 and C18:2 n-6 at the 
detriment of n-3 PUFA. However, this did not translate into greater total FA content. 
Future research may consider conditioning the low nutrient treated algae to the point of 
suspended growth, often accompanied with significant loss of pigments to see if a boost 
in content can be observed. However, from a commercial production point of view, any 
stressed condition is unfavourable as it dramatically reduces cell division. High nutrient 
conditions on the other hand showed the most desirable FA profile for health 
applications. This environmental condition also displayed the highest total FA content 
achieving 56 mg per gram of dry weight, 30 mg of which is comprised of PUFA. From 
a nutritional perspective, the appeal of this FA profile from the high nutrient condition 
lies in the low n-6/n-3 ratio. It is rich in C18:3 n-3, in contrast to plant derived oils 
which are high in C18:2 n-6. Ulva is also unique from plant and fish derived oils due to 
high levels of C18:4 n-3, as well as offering essential dietary EPA and DHA, which are 
generally absent in land plants. From a commercial production point of view, high 
nutrient conditions are more favourable for achieving a higher turnover and such 
biomass could have considerable future value for FA supplementation in the diet of 
animals or humans. 
We have demonstrated that post-harvest processing and extraction methods are 
important considerations in FA quantification and should be selected carefully to avoid 
underestimation of total content. Future work should consider the scalability and 
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logistics of post-harvest treatments and processing, along with exploration of safer and 
less toxic extraction alternatives, such as supercritical CO2 extraction. 
Acknowledgments 
This work was supported financially by the Centre for Medical and Molecular 
Bioscience, University of Wollongong (UOW) and an Australian Postgraduate Award 
(JM). We further thank the Rural Industries Research and Development Corporation 
(RIRDC) who funded the FA standards. 
Conflicts of Interest 
The authors declare no conflict of interest 
  
Chapter 4 Ulva Fatty Acids 
 128 
References 
1. Holdt, S.L. and Kraan, S., Bioactive compounds in seaweed: functional food applications and 
legislation. Journal of Applied Phycology, 2011. 23: p. 543-597. 
2. Leliaert, F., et al., Identity of the Qingdao algal bloom. Phycological Research, 2009. 57: p. 147-
151. 
3. Nesterov, V.N., Rozentsvet, O.A., and Bogdanova, E.S., Influence of abiotic factors on the 
content of fatty acids of Ulva Intestinalis. Contemporary Problems of Ecology, 2013. 6(4): p. 
441-447. 
4. Schmid, M., Guihéneuf, F., and Stengel, D.B., Fatty acid contents and profiles of 16 macroalgae 
collected from the Irish Coast at two seasons. Journal of Applied Phycology, 2014. 26: p. 451-
463. 
5. Ortiz, J., et al., Dietary Fiber, amino acid, fatty acid and tocopherol contents of the edible 
seaweeds Ulva lactuca and Durvillaea antarctica. food Chemistry, 2006. 99: p. 89-104. 
6. Ak, I., et al., Effect of sodium acetate and sodium nitrate on biochemical composition of green 
algae Ulva rigida. Aquaculture International, 2015. 23: p. 1-11. 
7. An, M., et al., Temperature regulates the fatty acid desaturases at a transcriptional level and 
modulates the fatty acid profile in the Antarctic microalga Chlamydomonas sp. ICE-L. 
Bioresource Technology, 2013. 134: p. 151-157. 
8. Spilling, K., et al., The effect of high pH on structural lipids in diatoms. Journal of Applied 
Phycology, 2013. 25: p. 1435-1439. 
9. Folch, J., Lees, M., and Sloane Stanley, G.H., A simple method for the isolation and purification 
of total lipids from animal tissues. Journal of Biological Chemistry, 1957(226): p. 497-509. 
10. Taha, A.Y., Metherel, A.H., and Stark, K.D., Comparative analysis of standardised and common 
modifications of methods for lipid extraction for the determination of fatty acids. Food 
Chemistry, 2012. 134: p. 427-433. 
11. Lewis, T., Nichols, P.D., and McMeekin, T.A., Evaluation of extraction methods for recovery of 
fatty acids from lipid-producing microheterotrophs. Journal of Microbiological Methods, 2000. 
43: p. 107-116. 
Chapter 4 Ulva Fatty Acids 
 129 
12. Sheng, J., Vannela, R., and Rittmann, B.E., Evaluation of methods to extract and quantify lipids 
from Synechocytis PCC 6803. Bioresource Technology, 2011. 102: p. 1697-1703. 
13. Kumari, P., Reddy, C.R.K., and Jha, B., Comparative evaluation and selection of a method for 
lipid and fatty acid extraction from macroalgae. Analytical Biochemistry, 2011. 415: p. 134-144. 
14. Lepage, G. and Roy, C.C., Direct transesterification of all classes of lipids in a one-step reaction. 
Journal of Lipid Research, 1986. 27: p. 114-120. 
15. Alamsjah, M.A., et al., Algicidal activity of polyunsaturated fatty acids derived from Ulva 
fasciata and U. pertusa (Ulvaceae, Chlorophyta) on phytoplankton. Journal of Applied 
Phycology, 2008. 20(5): p. 713-720. 
16. Kendel, M., et al., Lipid composition, fatty acids and sterols in the seaweeds Ulva armoricana 
and Solieria chordalis from Brittany (France): an analysis from nutritional, chemotaxonomic, 
and antiproliferative activity perspectives. Marine Drugs, 2015. 13: p. 5606-5628. 
17. Colombo, M.L., et al., Marine macroalgae as sources of polyunsaturated fatty acids. Plant Foods 
For Human Nutrition, 2006. 61: p. 67-72. 
18. Khotimchenko, S.V., Fatty acids of green macrophytic algae from the sea of Japan. 
Phytochemistry, 1993. 32(5): p. 1203-1207. 
19. Hotimchenko, S.V., Fatty acid composition of algae from habitats with varying amounts of 
illumination. Russian Journal of Marine Biology, 2002. 28(3): p. 218-220. 
20. Gubelit, Y.I., et al., Fatty acid and elemental composition of littoral "green tide" algae from the 
Gulf of Finland, the Baltic Sea. Journal of Applied Phycology, 2015. 27: p. 375-386. 
21. Rozentsvet, O.A. and Nesterov, V.N., Lipids and fatty acids from Ulva intestinalis from 
estuaries of the Caspian basin (Elton Region). Chemistry of Natural Compounds, 2012. 48(4): p. 
544-547. 
22. Horincar, V.B., et al., Extraction and characterization of volatile compounds and fatty acids from 
red and green macroalgae from the Romanian Black Sea in order to obtain valuable bioadditives 
and biopreservatives. Journal of Applied Phycology, 2014. 26: p. 551-559. 
23. Yaich, H., et al., Chemical composition and functional properties of Ulva lactuca seaweed 
collected in Tunisia. Food Chemistry, 2011. 128: p. 895-901. 
Chapter 4 Ulva Fatty Acids 
 130 
24. Serviere-Zaragoza, E., et al., Seasonal and interannual variation of fatty acids in macrophytes 
from the Pacific coast of Baja California Peninsula (Mexico). Journal of Applied Phycology, 
2015. 27: p. 1297-1306. 
25. Li, X., et al., Fatty acids of some algae from the Bohai Sea. Phytochemistry, 2002. 59: p. 157-
161. 
26. Rohani-Ghadikolaei, K. and Abdulalian, E.N., W-K., Evaluation of the proximate, fatty acid and 
mineral composition of representative green, brown and red seaweeds from the Persian Gulf of 
Iran as potential food and feed resources. Journal of Food Science and Technology, 2012. 49(6): 
p. 774-780. 
27. Khotimchenko, S.V., Vaskovsky, V.E., and Titlyanova, T.V., Fatty acids of marine algae from 
the  Pacific Coast of North California. Botanica Marina, 2002. 45: p. 17-22. 
28. El Maghraby, D.M. and Fakhry, E.M., Lipid content and fatty acid composition of 
Mediterranean macro-algae as dynamic factors for biodiesel production. Oceanologia, 2015. 57: 
p. 86-92. 
29. Nelson, M.M., Phleger, C.F., and Nichols, P.D., Seasonal lipid composition in macroalgae of the 
Northeastern Pacific Ocean. Botanica marina, 2002. 45: p. 58-65. 
30. Floreto, E.A.T., Teshima, S., and Ishikawa, M., Effects of nitrogen and phosphorus on the 
growth and fatty acid composition of Ulva pertusa Kjellman (Chlorophyta). Botanica Marina, 
1996. 49: p. 69-74. 
31. Floreto, E.A.T., et al., Influence of light intensity on the fatty acid composition of Ulva pertusa 
Kjellman (Chlorophyta). Botanica Marina, 1994. 37: p. 143-149. 
32. Floreto, E.A.T., et al., Fatty Acid Composition of Ulva pertusa Kjellman (Chlorophyta) and 
Gracilaria incurvata Okamura (Rhodophyta) in Japanese Coastal Waters. Botanica Marina, 
1993. 36(3): p. 217-222. 
33. McCauley, J.I., et al., Selecting Australian marine macroalgae based on the fatty acid 
composition and anti-inflammatory activity. Journal of Applied Phycology, 2015. 27: p. 2111-
2121. 
34. Pereira, H., et al., Polyunsaturated fatty acids of marine macroalgae: potential for nutritional and 
pharmaceutical applications. Marine Drugs, 2012. 10: p. 1920-1935. 
Chapter 4 Ulva Fatty Acids 
 131 
35. Sharma, K.K., Schuhmann, H., and Schenk, P.M., High lipid induction in microaglae for 
biodiesel production. Energies, 2012. 5: p. 1532-1533. 
36. Liu, Y., Zhao, Y., and Feng, X., Exergy analysis for a freeze-drying process. Applied Thermal 
Engineering, 2008. 28: p. 675-690. 
37. Abascal, K., Ganora, L., and Yarnell, E., The effect of freeze-drying and its implications for 
botanical medicine: a review. Phytotherapy Research, 2005. 18: p. 655-660. 
38. Molina Grima, E., et al., Preservation of the marine microalga, Isochrysis galbana: influence on 
the fatty acid profile. Aquaculture, 1994. 123: p. 377-385. 
39. Ryckebosch, E., Muylaert, K., and Foubert, I., Optimization of an analytical procedure for 
extraction of lipids from microalgae. Journal of the American Oil Chemists' Society, 2012. 89: p. 
189-198. 
40. Martins, A.P., Yokoya, N.S., and Colepicolo, P., Comparison of extraction and 
transesterification methods on the determination of the fatty acid contents of three Brazilian 
seaweed species. Brazilian Journal of Pharmacology, 2012. 22(4): p. 854-860. 
 
 
 132 
FOREWORD TO CHAPTER 5 
The previous Chapter 4 explored the fatty acid profiles of cultivated Ulva to determine 
the optimal growth conditions to achieve high quality fatty acids that are optimal for 
human and animal nutrition. In particular, emphasis was placed on the effect of the 
methods on the fatty acid profiles and yields as a dominant theme of the previous 
chapter and manuscript. 
The fresh cultivation experiments that were investigated as part of Chapter 4 were 
harvested and the biomass stored as a finely milled powder. These dried samples were 
subsequently analysed for all the following investigations herein. Interestingly, at the 
time of harvesting, the biomass from nutrient starved treatment showed a dramatic loss 
of pigments, differing from the nutrient starved biomass analysed previously in 
Chapter 4. This had a dramatic affect on total lipid yields and this is explored in the 
following Chapter 5, along with investigating the effect of cultivation on the 
distribution of fatty acids across both neutral and phospholipid fractions. In particular, 
emphasis is placed on the potential health benefits an algal-derived oil may offer human 
and animal nutrition. The chapter is presented as a prepared short communication for 
submission.12 In addition, results of further investigations that were not incorporated 
                                                
12McCauley, J.I., et al., Fatty acid composition of neutral and phospholipids of an emerging 
algal-based and sustainable omega-3 oil alternative, Prepared Short Communication for Submission 
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in the short communication are presented at the end of the chapter 
 
Prepared Short Communication for Submission 
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Abstract  
Ulva has a high quality omega-3 fatty acid (n-3 FA) profile that can respond to the 
environment yet it is poorly understood which lipids are affected. This has implications 
for FA bioavailability and processing. Here nutrient-rich conditions resulted in 61-69% 
of total FA (2.6-3.4 mg.g-1) bound within neutral lipids, characterised by 16:0 (18-
26%), 18:3n-3 (24-25%), 16:4n-3 (13-17%), 18:2n-6 (11-15%), 18:1n-7 (6-9%) and 
18:4n-3 (4-6%). Low-pigment (nutrient-starved) conditions increased neutral lipids (10 
mg.g-1) with increased 16:0, 18:1n-7, 18:2n-6, 18:3n-3 and reduced 16:4n-3 and 18:4n-3 
(p<0.0001). Despite the increased yield of 18:3n-3, it represented a lower percentage 
(10%) of total extract leading to an unfavourable n-6/n-3 ratio (1.6 c.f. 0.3 for the 
nutrient-rich, high-pigment culture). All phospholipid fractions were characterised by 
the presence of 16:0, 16:1n-7, 18:1n-7, 18:2n-6 and 18:3n-3. However, the low-pigment 
(nutrient-starved) biomass showed reduced phospholipids (12%) as a percentage of total 
lipids (c.f. nutrient-rich conditions 31-38%). In summary, the n-6/n-3 ratio, 
phospholipid fraction and relative amounts of unique n-3 FA (18:4n-3) are significantly 
higher in nutrient-rich conditioned biomass and are potentially more optimal for health. 
Thus it may be important to optimise the high quality rather than the quantity of fatty 
acids for nutritional applications through the cultivation of Ulva. 
Key words: Ulva, chlorophyta, PUFA, health, nutrition, cultivation 
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Introduction 
Fish oil is a highly priced commodity. The recommendation for the consumption of 2-3 
serves of fish per week has led to increased awareness of the health benefits of omega-3 
fatty acids (n-3 FA) [1]. These recommendations can be obtained through diet, however 
this is not always practical and has created the demand for encapsulated fish oil 
supplements [2]. Fish oils are also sought for aquaculture, along with high protein 
fishmeal. To date, this demand is currently met with limited captive based fisheries [3] 
but has low scope for growth to meet future demands. Typical fish oil preparations are 
high in n-3 long chain (≥ 20 carbons) polyunsaturated fatty acids (LC n-3 PUFA) 
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (Table 18).  
Whilst EPA and DHA are high in certain microalgae, it is typically low in the green 
macroalgae Ulva (Table 18). However, Ulva spp. have a unique fatty acid profile 
characterised by high levels of alpha-linolenic acid (18:3n-3, ALA) and stearidonic acid 
(18:4n-3, SDA) [4]. SDA is the first metabolite of ALA in the metabolic pathway 
leading to EPA and DHA and has been identified as an efficient precursor of EPA 
synthesis (Figure 19) [3]. The metabolic conversion of ALA represents approximately 
6% for EPA and 3.8% for DHA with a further loss in efficiency up to 50% with a high 
n-6 diet [5]. Adequate dietary provision of EPA and DHA can be obtained through 
direct supplementation [5]. However, studies have indicated that dietary 
supplementation with SDA can increase human tissue EPA levels much more 
effectively than ALA [2]. As a result, it has been proposed that SDA oils could offer an 
attractive alternative to EPA-containing fish oils [6]. 
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Figure 19 Biosynthesis pathways of n-6 and n-3 polyunsaturated fatty acids. Adapted from Pereira, 
Barreira [12]. AA: arachidonic acid; ALA: alpha-linolenic acid; DHA: docosahexaenoic acid; DPA: 
docosapentaenoic acid; EPA: eicosapentaenoic acid; GLA: gamma-linolenic acid; LA: linoleic acid; 
SDA: stearidonic acid 
Ulva is readily cultivated at scale for commercialisation and together with its unique 
and relatively abundant n-3 content offers an attractive source of quality controlled and 
traceable biomass for nutritional applications [11]. Furthermore, green algae are 
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naturally rich in neutral polar glycolipids (up to 50%) with various levels of charged 
polar phospholipids (typically between 10-20%) [13] (Figure 20) differing from 
traditional fish oils.  
 
Figure 20 Typical lipid composition (%) of neutral polar glycolipids and highly polar charged 
phospholipids of green algae of whole cells, chloroplast envelopes and thylakoids. Representative 
glycolipids: monogalactosyldiacylglycerol (MGDG); digalactosyldiacylglycerol (DGDG). Adapted from 
Harwood (1998). 
This has implications for FA bioavailability as marine derived PUFA from fish oil are 
commonly bound within triacylglycerides, which are bioavailable, however they may 
not be as efficient as other lipids classes [14]. For example, Krill oil is unique in that as 
it has a substantial proportion of EPA and DHA in abundant phospholipids and there is 
evidence to suggest that polar lipids have a higher bioavailability than nonpolar 
triacylglycerides [15]. More recently it was shown that tissue uptake of LC n-3 PUFA 
from an algal oil containing EPA partly conjugated to 15% phospholipids, as well as 
glycolipids was found to be equivalent to krill oil containing EPA partly conjugated to 
40% phospholipids, demonstrating a promising bioavailability for algal derived oils 
[14]. 
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Limited studies have explored the fatty acid composition of Ulva phospholipids [16], as 
the characterisation of major glycolipids is more common [17-19]. Previously we 
demonstrated that PUFA and n-6/n-3 ratios can be optimised through cultivation, 
influencing these profiles by up to 2-fold [11]. However it is unclear what lipid classes 
comprise these fatty acid shifts and this has implications for the bioavailability and 
extraction optimisation of these lipid classes. Therefore in scoping the potential of an 
Ulva-derived n-3 alternative, this communication further develops the understanding of 
the composition of fatty acids across the phospholipid and neutral fractions from a 
cultivated Australian Ulva species. 
Materials and Methods 
Samples 
The samples (dried, milled) were provided by Venus Shell Systems Pty. Ltd and 
represented four culture regimes (5m2): (1) control (natural sunlight with nutrient-rich 
media); (2) nitrogen starved, low pigment (natural sunlight with reduced nutrients); (3) 
shaded (reduced natural sunlight with nutrient-rich media) and; (4) acetic acid nutrient 
boost (natural sunlight with nutrient-rich media supplemented with acetic acid).  
Extractions and Transesterification 
The lipids were extracted twice in triplicate as described by Kumari et al. 2011 with 
modifications [20]. In brief, samples (250 mg) were extracted with 
chloroform/methanol (3 x 3 mL; 2/1, v/v) with butylated hydroxytoluene (0.001%) by 
brief vortexing and centrifugation (3000 rpm, rt, 15 mins). The phospholipids were 
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isolated from the crude extract by the addition of cold acetone (2 x 3 mL) with added 
magnesium chloride (4 % in ethanol) and centrifugation (3000 rpm, 4 ºC, 15 mins). The 
decanted acetone soluble (neutral) lipids and the insoluble residue (phospholipids) were 
dried under nitrogen and transesterified as per Lepage and Roy [21]. Extract 
compositions were qualitatively assessed by thin layer chromatography to confirm 
isolation of phospholipids. 
Pigments 
The pigments (250mg) were extracted with methanol (3 x 3 mL) by brief vortexing and 
centrifugation (3000 rpm, rt, 15 mins) and quantified as per Lichtenthaler [22].  
Fatty acid analysis 
The samples (1µL) were analysed by flame-ionization gas chromatography (GC-FID) 
(GC-17A; Shimadzu) using a 50m x 0.25mm internal diameter capillary column and 
analysis performed using Shimadzu software (Class-VP 7.2.1 SP1). Fatty acids were 
identified with known standards (Sigma) and an internal standard (heneicosanoic acid) 
was used for quantification. The data are represented as molar % extract composition ± 
standard deviation Quantified fatty acid data are represented as mg.g-1 dry weight (d.w.) 
± standard error. 
Statistical Analysis 
The data were assessed using Two-way ANOVA and Tukey’s multiple comparisons 
using GraphPad Prism version 6.00. 
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Results and Discussion 
Previously we have shown that Ulva is characterised by abundant C16:0, C18:3n-3, 
C18:4n-3, C16:4n-3 and C18:1n-7 fatty acids with high nutrient conditions delivering 
biomass with the most desirable fatty acid profile for health and nutritional applications 
[11]. Here we determine the effect of these cultivation conditions on the distribution of 
fatty acids across the neutral and phospholipid fractions (Table 19). The low nutrient 
treated algae showed a significant loss of pigments both visually and 
spectrophotometrically (Figure 21). 
 
Figure 21 Chlorophyll a/b and total carotenoid content (ug.mL-1) of methanol extracts for control (high-
nutrient) versus nutrient-starved cultivated Ulva samples (F (1,12) = 625.0, P < 0.0001). 
Total Content (mg.g-1 d.w.) 
The combined neutral and phospholipids in this experiment yielded an average of 3.03 
mg.g-1 d.w total fatty acids across the nutrient-rich conditions which included the 
control, shaded and acetic acid cultures (Figure 22), although we have previously 
reported that we can obtain 56 mg.g-1 d.w. equivalent using an optimised extraction for 
fresh biomass cultivated under nutrient-rich conditions [11]. The low pigment (nutrient-
starved) samples showed a significant 3-fold increase in total content (12.01 mg.g-1 
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d.w.) when compared to the other samples (Figure 22) (p < 0.0001). This increase in 
content occurred within the neutral fraction, which represented 88% of the total lipids, 
suggesting accumulation of triacylglycerols. The major contributing fatty acids to this 
increase in total content within the neutral fraction of low-pigment (nutrient-starved) 
biomass were 16:0 (4.02 ± 0.15 mg.g-1 d.w.), 18:1n-7 (1.79 ± 0.06 mg.g-1 d.w.), 18:2n-6 
(2.30 ± 0.08 mg.g-1 d.w.) and 18:3n-3 (1.09 ± 0.03 mg.g-1 d.w). Although 18:3n-3 
increased in yield it represented a lower percentage of total extract composition (10.0%) 
when compared to the nutrient-rich conditions (24.3 - 24.7%) (Table 2) resulting in a 
higher and unfavourable n6/n3 ratio (Figure 22). Due to the increase in neutral lipids in 
the low-pigment (nutrient-starved) biomass, phospholipids represented only 12% of 
total lipids, a 65% reduction in phospholipids when compared to remaining nutrient-rich 
samples (31 - 38%), which contained between 61-69% neutral lipids. Elsewhere Ulva 
neutral lipids have been shown to represent up to 76% with phospholipids constituting 
24% [16], however phospholipid content in Ulva sp. has been reported to be as high as 
50% [23].  
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Figure 22 Total content (mg.g-1 d.w.) of saturated fatty acid (SFA), monounsaturated fatty acids (MUFA) 
and polyunsaturated fatty acids (PUFA) of neutral and phospholipid fractions for the average yield (± 
standard error) of nutrient-rich cultivation conditions (control, shaded, acetic acid cultivations) versus the 
yield for low pigment (nutrient-starved) conditions. *Significantly different (p < 0.0001) 
Phospholipid Fractions 
The acetone insoluble Ulva phospholipid extract (highly charged polar lipids) was 
characterised by high levels of saturated FA (SFA) (51.2 - 59.5%) with lower PUFA 
(21.3 - 29.7%) when compared with the corresponding neutral fractions (Table 19). 
Samples showed abundant 16:0 (49.6 - 58.8%), 16:1n-7 (1.4 - 5.8%), 18:1n-7 (11.8 - 
17.5%), 18:2n-6 (8.6 - 13.1%) and 18:3n-3 (7.9 - 13.9%), in agreement with similar 
findings for Ulva [16]. The n-3 PUFA 16:4n-3 and 18:4n-3 were present in trace 
amounts (< 2.2%) but have been reported as high as 2.2% and 3.3% respectively [16]. 
The low pigment (nutrient-starved) samples showed reduced 16:1n-7 (1.4%) when 
compared to the other samples (3.3 - 5.8%). Low pigment and acetic acid samples also 
showed higher 16:0 (56.9% and 58.8 respectively) compared to the control (nutrient-
rich) and shaded cultures (49.6 and 52.8% respectively). Low pigment samples were 
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significantly higher in 18:1n-7 (17.5%) with a significant reduction in 18:3n-3 (7.9%) 
when compared to the other nutrient-rich samples (13.3 - 13.9%). No significant 
differences were observed in the LC PUFA across the different cultures for the 
phospholipid fractions (F (3,102) = 1.841, P = 0.1444). The PUFA 20:4n-6 was present 
in trace amounts (≤ 0.6%) across control, low pigment and shaded culture regimes 
whilst 20:5n-3 was slightly more abundant in the control and low pigment cultures 
(1.1% and 1.5% respectively) (Table 19). 
Neutral Lipid Fractions 
The neutral lipid fraction (acetone soluble), which represented between 61-88% of total 
lipid yield comprised between 37.3 - 66.1% of total PUFA across samples, indicating 
that most PUFA reside within the neutral lipid fraction (Table 19). Ulva commonly 
exhibits high PUFA due to abundant 18:3n-3 [24] and herein represents approximately 
25% of the neutral fraction for nutrient-rich conditions which include the control, 
shaded and acetic acid cultivations. An increase in total content in the neutral fraction 
under starved conditions (Figure 22) suggests an accumulation of triacylglycerols for 
energy storage, although neutral glycolipids are also present in this fraction.  In low-
pigment (nutrient-starved) conditions the relative amount of 18:3n-3 is significantly 
lower (10%), although the absolute amount in dried biomass is higher, contributing to 
an increase in PUFA content (Figure 22). Higher relative abundance of 18:4n-3 (4.4 - 
5.8%) and 16:4n-3 (13.1 - 16.6%) were evident across the remaining samples and 
represent two characteristic fatty acids of Ulva [4]. High 18:4n-3 in neutral glycolipids 
has also been reported by Sanina et al. [17].  
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5.8 ± 0.8
a 
1.4 ± 0.9
b 
3.7 ± 0.5
ab 
3.3 ± 0.3
b 
17:0 
2.2 ± 0.2
a 
0.4 ± 0.1
b 
2.4 ± 0.2
a 
0.7 ± 0.5b 
0.5 ± 0.7 
0.1 ± 0.3 
2 ± 0.3 
- 
17:1n-7 
0.6 ± 0.6 
0.4 ± 0.1 
0.1 ± 0.3 
- 
- 
- 
- 
- 
16:4n3 
16.6 ± 1
a 
2.1 ± 0.1
b 
17.1 ± 0.9
a 
13.1 ± 0.8
c 
1.8 ± 0.1 
0.2 ± 0.5 
2.2 ± 0.1 
1.6 ± 1.4 
18:0 
0.9 ± 0.3 
0.7 ± 0.1 
0.7 ± 0.4 
1.1 ± 0.1 
- 
0.1 ± 0.3 
- 
0.3 ± 0.7 
18:1n-9 
1.1 ± 0.2 
1.6 ± 0.1 
0.8 ± 0.4 
1.0 ± 0.1 
- 
0.2 ± 0.5 
- 
- 
18:1n-7 
7.9 ± 0.3
a 
16.2 ± 0.2
b 
6.0 ± 0.4
c 
8.5 ± 0.1
a 
14.6 ± 0.3
a 
17.5 ± 0.8
b 
11.8 ± 0.8
c 
13.5 ± 0.4
ac 
18:2n-6 
11.5 ± 0.3
a 
21 ± 0.2
b 
15.1 ± 0.2
c 
12.2 ± 0.5
a 
11 ± 0.5
a 
12.8 ± 2
a 
13.1 ± 0.9
a 
8.6 ± 0.6
b 
18:3n-6 
0.7 ± 0.1 
0.4 ± 0.1 
0.7 ± 0.5 
0.3 ± 0.4 
- 
- 
- 
- 
18:3n-3 
24.5 ± 0.9
a 
10 ± 0.2
b 
24.3 ± 0.3
a 
24.7 ± 0.8
a 
13.6 ± 0.4
a 
7.9 ± 0.7
b 
13.9 ± 0.9
a 
13.3 ± 1.4
a 
18:4n-3 
5.8 ± 0.3
a 
1.1 ± 0.1
b 
4.6 ± 0.3
ac 
4.4 ± 0.3
c 
1.3 ± 0.1 
0.1 ± 0.2 
0.2 ± 0.5 
0.3 ± 0.7 
20:3n-6 
0.8 ± 0.1
a 
0.7 ± 0.1
a 
0.5 ± 0.4
ab 
0.1 ± 0.3
b 
- 
0.1 ± 0.2 
- 
- 
20:4n-6 
2.2 ± 0.2
a 
1.1 ± 0
b 
2.4 ± 0.1
a 
2.2 ± 0.2
a 
0.6 ± 0.6
 
0.2 ± 0.4
 
0.2 ± 0.5
 
-  
20:5n-3 
1.4 ± 0.1
a 
0.7 ± 0
b 
1.2 ± 0.1
a 
1.6 ± 0.2
a 
- 
- 
- 
- 
22:0 
0.2 ± 0.3 
0.3 ± 0 
- 
0.3 ± 0.4 
1.1 ± 0.1
a 
1.5 ± 0.4
a 
-  
0.5 ± 0.7
b 
22:4n-6 
- 
- 
- 
0.1 ± 0.3 
- 
- 
- 
- 
22:5n-3 
0.7 ± 0.1
ab 
0.3 ± 0.1
bc 
0.1 ± 0.3
c 
0.8 ± 0.1
a 
- 
- 
- 
- 
SFA
 
24 ± 1.3
a 
42.1 ± 0.5
b 
24.9 ± 0.6
a 
28.9 ± 1.8
c 
51.2 ± 1.3
a 
58.8 ± 3.7
b 
54.8 ± 1.8
c 
59.5 ± 1.6
bd 
M
U
FA
 
11.8 ± 1.1
a 
20.6 ± 0.5
b 
9.0 ± 0.4
c 
11.5 ± 0.4
a 
20.4 ± 0.9
a 
19.9 ± 1.6
a 
15.5 ± 0.7
b 
16.8 ± 0.4
b 
PU
FA
 
64.2 ± 2.2
a 
37.3 ± 0.6
b 
66.1 ± 0.9
c 
59.6 ± 2
d 
28.3 ± 0.6
a 
21.3 ± 3.3
b 
29.7 ± 1.8
a 
23.7 ± 1.9
c 
n-6/n-3 
0.3 ± 0.1
a 
1.6 ± 0.1
b 
0.4 ± 0.1
a 
0.3 ± 0.1
a 
0.7 ± 0.1
a 
1.6 ± 0.3
b 
0.8 ± 0.1
a 
0.6 ± 0.1
a 
Chapter 5 Ulva Lipids 
 147 
The marked relative and absolute reduction of 16:4n-3 (2.1%) and 18:4n-3 (1.1%) in the 
low-pigment (nutrient-starved) samples indicate that PUFA can be shifted by the 
environment, consistent with our previous report [11]. Herein we show that this occurs 
primarily in the neutral lipid fraction and only for these specific PUFA. Indeed most of 
the other PUFA increased in content per gram of dry weight in nutrient-starved 
material. Green macroalgae do not naturally accumulate significant amounts of 
triacylglycerols [25]. Ulva is one of the few species that can be pushed to accumulate 
triacylglycerols with a subsequent relative increase in SFA and relatively lower PUFA 
content as a percentage of total extract composition [26]. This is evident in Table 19, 
although we also show that there is an absolute increase in PUFA content per gram of 
seaweed dry weight (Figure 22). The low pigment nutrient-starved samples showed 
significantly higher 16:0 (40.1%) and 18:1n-7 (16.2%) when compared to the other 
samples along with a 7-fold increase in the absolute amount of 18:2n-6 subsequently 
increasing the n-6/n3 ratio (Table 19; Figure 22). This is consistent with nitrogen 
starvation effects reported for Ulva [23, 27]. Significant effects of culture were 
observed on the extract composition of LC PUFA within the neutral fractions (F (3,114) 
= 46.61, P < 0.0001) with the control (nutrient-rich) culture having significantly higher 
relative abundance of 20:4n-6, 20:5n-3 and 22:5n-3 when compared to the low pigment 
(nutrient-starved) biomass. 
Conclusion 
High nutrient cultivation (control regime) provided biomass with desirable n-6/n-3 (0.3) 
and 18:2n-6/18:3n-3 (0.5) ratios, along with higher relative levels of 18:4n-3, 20:5n-3, 
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22:5n-3 (Table 20). This fatty acid profile was predominant in the more abundant neutral 
lipid fraction, which comprised 62% of the total lipid extracted (3.4 mg.g-1 d.w.). In 
contrast the phospholipid fraction had a higher ratio of SFA, although the n-6/n-3 ratio 
was still reasonable (0.7), and comprised 38% of the biomass for the high nutrient 
cultivation. The low pigment (nutrient-starved) Ulva provided for a 3-fold increase in 
overall lipid yields (12.0 mg.g-1 d.w.) and included both increased SFA, 
monounsaturated FA (MUFA) and PUFA per gram of seaweed dry weight, as has been 
found for other algae and we demonstrate that this increase is primarily in the neutral 
lipid fraction. This increase however was at a detriment to the oil’s profile with 
increases in SFA content being far greater than increases in MUFA and PUFA. This 
also resulted in less desirable n-6/n-3 ratios, as well as a lower ratio of phospholipids 
(12%).  
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Table 20 A qualitative summary of the neutral and phospholipid fractions of Ulva from four cultivation 
regimes 
Neutral Fraction Control Low pigment Shaded Acetic Acid 
Low n-6/n-3 Yes  Yes Yes 
Low 18:2n-6/18:3n-3 Yes  Yes Yes 
LC-PUFA Content ++++ + +++ ++++ 
n-3 Content ++++ + ++++ +++ 
18:4n-3 Content ++++ ++ +++ +++ 
Total Content +++ ++++ ++ ++ 
Phospholipid Fraction     
Low n-6/n-3 Yes  Yes Yes 
Low 18:2n-6/18:3n-3 Yes  Yes Yes 
LC-PUFA Content ++++ ++++ + ++ 
n-3 Content +++ + ++++ ++ 
18:4n-3 Content ++ + + + 
Total Content ++ ++ ++ + 
Key Neutral: LC-PUFA (++++) > 5 % total extract; (+++) 4 - 5 %; (++) 2 - 3 %; (+) < 2 % and n-3 
content: (++++) > 40 % total extract; (+++) 30-40 %; (++) 20 - 29 %:  (+) < 20 % 
Key Phospholipid: LC-PUFA: (++++) 1.5 - 2 % total extract; (+++) 1 - 1.5 %; (++) 0.5 - 1 %; (+) < 0.5 
% and n-3 content: (++++) >15 %; (+++) 14-15%; (++) 12 - 13 %; (+) < 12 % 
Key 18:4n-3: (++++) > 5% total extract; (+++) 3 - 5 %; (++) 1 - 2 %; (+) < 1 % 
Key Total Content: (++++) > 5 mg.g-1 d.w.; (+++) > 2 mg.g-1 d.w; (++) 1 - 2 mg.g-1 d.w; (+) < 1 mg.g-1 
d.w 
These results highlight that Ulva cultivated under high nutrient conditions offers a 
unique and sustainable source of biomass rich in n-3 PUFA (Table 20). The neutral lipid 
fraction is highlighted as the richest fraction and target for a nutritionally potent PUFA 
extract and could direct the future choice of extraction protocol, although it is not yet 
understood how these are distributed across the different neutral lipid classes such as 
glycolipids and triacylglycerols. For example a one-step neat super-critical carbon 
dioxide (SC-CO2) extraction without ethanol supplementation could optimise a 
sequential biorefinery process that concentrates the neutral lipids fractions, such as 
glycolipids, to deliver a nutritionally valuable high-end product [28]. However 
increased content of PUFA can also be achieved with nutrient starvations but with a 
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consequence of less desirable n-6/n-3 ratios and these would have to be altered through 
a selective biorefinery process. 
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Method Optimisation 
The optimisation of the fatty acid extraction of fresh filamentous Ulva was a key 
finding presented in Chapter 4 (p. 101-130). Key aspects of this optimisation for fresh 
biomass involved:  
1. Removal of the homogenisation step  
2. Increasing the solvent to mass ratio from 3:1 (2 g fresh in 6 ml solvent) to 6:1 
(0.5 g fresh in 3 mL solvent) 
3. Removing two overnight incubations from three sequential extractions thereby 
reducing extraction time from 3 days to 1 day. 
Chapter 5 then employed this optimised extraction protocol for the extraction of the 
harvested, and subsequently oven-dried and milled biomass from these same four 
different cultivation regimes: 
1. High nutrients with natural sunlight; 
2. Low nutrients with natural sunlight; 
3. High nutrients with reduced natural sunlight (low light) and; 
4. High nutrients plus acetic acid supplementation with natural sunlight 
The extraction is quick and convenient and involved extracting 250 mg of oven-dried, 
milled biomass in 3 mL of solvent, thus differing only in the solvent to mass ratio (12:1 
as opposed to 6:1 for fresh). As the solvent ratio was shown to be an influential variable 
in the extraction of fresh biomass, this increase in solvent ratio for the extraction of 
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dried biomass was determined to be appropriate at the time. Whilst a variation in yield 
was expected, it was not anticipated that this optimized extraction method for fresh 
would result in such dramatic reduction in yield for dried biomass (from 56 mg.g-1 dry 
weight equivalent to 3 mg.g-1 dry weight) (Figure 23). Therefore, further investigations 
were carried out to see if this loss in yield could be recovered. It was found that the 
optimised method for the extraction of fatty acids from dried biomass was the 3-Day13 
extraction protocol that involved 2 over-night incubations and a solvent to mass ratio of 
24:1 (250 mg in 6 mL extraction solvent) (Figure 23) 
 
Figure 23 Comparison of the 3-Day extraction protocol for fresh (non-homogenised) and dried (milled) 
biomass which involved either 2 g fresh or 250 mg dried biomass in 3 x 6 mL extraction solvent with 2 
overnight incubations versus the 1-Day extraction protocol involving either 500 mg fresh or 250 mg dried 
biomass in 3 x 3 ml consecutive extractions.  
                                                
13 3-Day Protocol - Lipids extracted based on a standard method of Folch et al. 1957 [1] with 
modifications based on Kumari et al. 2011 [2] In brief, either two grams of non-homogenized fresh 
sample or 250 mg of dried biomass was extracted with 3 x 6 mL of chloroform/methanol (2/1, v/v) with 
0.001% butylated hydroxytoluene (BHT) by vortexing (~1 min) and centrifugation (3000 rpm, rt, 15 
mins), with two extractions left overnight. The extract was evaporated to a consistent weight (dryness) in 
pre-weighed 9 mL Teflon lined screw top glass tubes under a stream of nitrogen. Crude lipid extracts 
were transesterified according to the method of Lepage and Roy 1986 [3] with added BHT (0.01% w/v). 
 
1-Day Protocol Involved either 500 mg of non-homogenized fresh sample or 250 mg of dried biomass 
was extracted with 3 x 3 mL consecutive extractions of chloroform/methanol (2/1, v/v) with 0.001% 
butylated hydroxytoluene (BHT) by vortexing (~1 min) and centrifugation (3000 rpm, rt, 15 mins).  
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Whilst the there were no significant effects of the two extraction protocols on the total 
fatty acid content recovery of fresh biomass, a significant increase and complete 
recovery of total fatty acid yields is observed with the 3-Day extraction protocol (P < 
0.0001) for dried biomass. This indicates that the extraction of dried milled powder 
benefits positively from longer extraction times. It is possible that the solvent requires 
more time to penetrate the matrix of dried biomass and dissolve the lipids compared to 
fresh biomass. Future investigations of dried biomass should consider the addition of a 
magnetic stirring bar during the extraction process and/or further increase the solvent 
ratio to try and reduce the extraction time and thus increasing sample through-put. 
Non-toxic Solvent Extraction 
The results presented in Chapters 4 and 5 propose the idea that cultivated Ulva has the 
potential to be formulated as an algal-derived oil supplement to complement human and 
animal nutrition. However, the traditionally utilised lipid extraction protocol, which 
uses a fixed ratio of chloroform to methanol is toxic and unsuitable for up-scaling at any 
significant level beyond the laboratory due to its toxicity and lack of food grade 
compatibility. Thus whilst it is an effective solvent extraction for initial characterisation, 
safer non-toxic extraction techniques need to be considered and different solvents have 
been found to effect both yield and composition of lipid extracts [4]. Therefore, 
additional fresh samples cultured under optimal conditions for fatty acid output 
(provided by Venus Shell Systems14) were analysed on a separate occasion to determine 
                                                
14Venus Shell Systems, Narrawallee, NSW, 2539, Australia  
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if extraction with 100% ethanol can achieve comparable fatty acid yields and 
composition as previously demonstrated in Chapter 4 and 5 (Figure 24). 
 
 
Figure 24 The total fatty acid yields (TFA), saturated fatty acids (SFA), monounsaturated fatty acids 
(MUFA) and polyunsaturated fatty acids (PUFA) (mg.g-1 d.w. equivalent) for fresh Ulva biomass, which 
was conditioned under optimal conditions (high nutrients) for desired fatty acid output and extracted with 
two different solvents (ethanol and chloroform: methanol 2/1 v/v) as per the optimised protocol outlined 
in Chapter 4 (P < 0.0001).  
In terms of yields, ethanol compared very favourable to the tradition chloroform and 
methanol extraction. Performing the lipid extraction with 100% ethanol yielded 
significantly higher total fatty acids and total polyunsaturated fatty acids when 
compared to the traditional chloroform and methanol solvent mixture. Furthermore 
there was no significant effect of solvent on the fatty acid composition (% extract) F 
(1,100) = 3.898, P = 0.0511. This result is in contrast to the findings reported by Schmid 
et al. 2016 [4] in which ethanol was found to be the second most efficient solvent after 
chloroform and methanol. However their analyses were conducted on freeze-dried 
powders of Laminaria digitata (Phaeophyta) and Palmaria palmata (Rhodophyta) 
differing in our analysis of fresh filamentous Ulva (Chlorophyta). However, in support 
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of our finding Schmid et al. 2016 [4] did find that ethanol delivered the highest levels of 
PUFA. 
Thus ethanol is deemed as a suitable alternative to the traditional chloroform and 
methanol solvent system for the extraction of lipids from fresh filamentous Ulva with 
total fatty acids representing 4.1 % dry weight (d.w.). This is one of the higher yields 
reported in the literature. For example Kumar et al. 2011 [5] reported total lipid contents 
of 1.83, 2.03 and 2.00 % d.w. for wild collections of Ulva fasciata, U. reticulata and U. 
rigida respectively. Recently, Trivedi et al. 2016 [6] further reported up to 2.7 % d.w. 
for wild collections of Ulva fasciata using a sequential extraction process of multiple 
algal components. With regards to cultivated Ulva, Mata et al. 2016 [7] reported a total 
fatty acid yield of 2.0 % d.w. for cultivated U. ohnoi whilst Carl et al. 2016 [8] reported 
a lipid yield of 3 % d.w. for cultivated U. tepida. 
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FOREWORD TO CHAPTER 6 
After the biological screening of a number of Australian macroalgal taxa (Chapter 3), 
attention was directed towards the cultivation candidate Ulva. Due to the strong anti-
inflammatory activity identified in Ulva extracts in Chapter 3, it was hypothesised that 
two major metabolite classes may be responsible for this activity. These two metabolite 
classes were fatty acids and phytochemicals (pigments and phenolics). Thus Chapter 4 
was dedicated to exploring the fatty acid profiles of Ulva. It offered a comprehensive 
review of the literature and presented the fatty acid profiles for cultivated Ulva from 
five different treatments conditions, along with method optimisation. Chapter 5 then 
explored the distribution of these fatty acids across the neutral and phospholipids, along 
with further highlighting considerations for the extraction method. As a result of the 
work presented in Chapters 4 and 5, the nutritionally value of the proposed algal-
derived oil from cultivated Ulva from Venus Shell Systems15 was clearly defined. The 
four samples, from four different treatment regimes, that were analysed in Chapter 5 
were a dried commercially milled powder, provided by Venus Shell Systems. The 
following Chapter 6 now presents the phytochemical analysis of these same four 
samples to offer characterisation and quantification of pigments, phenolics and 
flavonoid content and correlation of this content to anti-oxidant and anti-inflammatory 
activity. It is presented as a prepared full research manuscript for submission.16. 
                                                
15 Venus Shell Systems, Narrawallee, NSW, 2539, Australia 
16  McCauley, J.I., et al., Anti-oxidant activity and anti-inflammatory activities of pigment extracts of 
cultivated Ulva, Prepared Full Research Manuscript for Submission 
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Abstract 
Macroalgae are rich in photosynthetic pigments and phenolics. The biomass from 
cultivated Ulva sp. (Chlorophyta) is a potentially sustainable and alternative source of 
these nutritionally important metabolites. Algae can readily adjust their metabolism and 
thus the production of these pigments and anti-oxidant molecules as a response to their 
environment. Therefore, cultivation conditions can be engineered to optimise these 
metabolite yields. However, in contrast to microalgal research, this has not been 
explored as extensively for cultivated macroalgae. Thus, herein we determine the effect 
of both cultivation and extraction processes on the yield and bioactivity, including both 
anti-inflammatory and anti-oxidant functionalities, of pigments, phenolics and 
flavonoids of a cultivated Ulva sp. It was found that ethanol (95%) extracts of high 
nutrient cultures with natural sunlight were optimal to maximise levels of total 
chlorophyll (1.48 mg.g-1 dry weight (d.w)), phenolics (1.58 mg.g-1 d.w.) and 
corresponding anti-oxidant activity (18.8 % inhibition 1,1-diphenyl-2-picryl-hydrazyl 
(DPPH) free radical). In contrast, acetone extracts of high nutrient cultures under 
natural sunlight showed the highest carotenoid content (0.1 mg.g-1 d.w.) and anti-
inflammatory activity (97% inhibition of nitric oxide (NO) in lipopolysaccharide (LPS) 
stimulated macrophages). Low nutrient conditions under natural sunlight however was 
found to substantially increase flavonoid content (1.27 mg.g-1 d.w). No cell toxicity 
(100 µg.mL-1) was observed in any extracts. In contrast, results indicate that ethanol 
(95%) extracts, which contain the highest level of pigments and phenolics, promoted 
cell proliferation at twice the rate when compared to controls. These results establish a 
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foundation upon which to further optimise macroalgal culture for the production of 
desired metabolites, such as pigments and phenolics, for functional food products.  
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Introduction 
Phytochemicals from plants have been increasingly highlighted as metabolites of 
importance with a range of health benefits [1], These phytochemicals are abundant 
within fruits and vegetables and include polyphenol compounds such as phenolic acids 
and flavonoids, terpenoid derived compounds such as carotenoids, lutein, lycopene and 
β-carotene, and substituted tetrapyrrole chlorophylls [2, 3]. Specific phytochemicals 
have strong anti-oxidant and anti-inflammatory activities that have the ability to confer 
protection and reduce the risk or aid the healing of disease [4, 5].  
For example, the phenolic oleuropein has been shown to reduce damaging lipid 
peroxidation caused by free radicals as well as suppress nitric oxide (NO) production 
via inducible nitric oxide synthase  (iNOS) [6]. Whilst NO is an important immune 
modulator, high and persistent levels can lead to cellular and DNA mutagenesis and 
damage [7, 8]. The ability of phytochemicals to confer health benefits is evident in 
studies that correlate diets rich in fruit and vegetables with a lower risk of hypertension, 
coronary heart disease, stroke [9] and reduced risk for cancer [10, 11]. The therapeutic 
potential of phytochemicals has also been highlighted in the treatment of chronic 
inflammatory disorders such as inflammatory bowel disease [12] and protection of the 
liver due to their hepatoprotective effects [13]. These phytochemical classes are also 
abundant in algae, and cultivated macroalgae has been highlighted as a potential source 
for these high value anti-oxidant and anti-inflammatory phenolics and pigments [14-18]. 
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Due to the high natural chemical variability of wild seaweeds, controlled cultivation is 
essential to deliver consistent biomass [19, 20]. Therefore the cultivation conditions that 
optimise the desired bioactive profile must be defined. It is known that microalgae can 
shift the type and contents of pigments and or phenolic compounds in culture [21], and 
this process has been commercialised for the production of pigments such as β-carotene 
and astaxanthin production by stressing cultures of Dunaliella salina or Haematococcus 
pluvialis, respectively [22]. In contrast, other studies have shown that optimal growth 
conditions of high light and high nutrients favour pigment profiles [23]. Whilst the 
effect of cultivation on pigment profiles has not been explored as comprehensively for 
macroalgae, such as Ulva spp. [24, 25], there are early findings consistent with 
improved pigment profiles with optimal nutrient and growth conditions. For example, 
improved pigment and anti-oxidant profiles for Ulva spp. has been shown for high light 
and high nutrient cultivation [26]. Specific responses to different culture media with 
subsequent shifts in pigments were also correlated to changes in anti-oxidant activities 
for an Ulva lactuca sample [27]. 
Ulva spp. are a source of both oxidant-scavenging phenolics (Table 21) and chlorophyll 
and carotenoid pigments [27, 28]. Evidence also shows that these profiles can be shifted 
in culture. For example regarding chlorophyll content, Ulva lactuca cultured in artificial 
seawater and low nutrients showed a loss of pigments, however the pigment 
concentration can be recovered with complete nutrient provision by nitrate and 
phosphate supplementation [29]. Similarly, Gómez Pinchetti et al. 1998 [30] found 
maximum chlorophyll content in nitrogen enriched cultivation conditions for Ulva spp. 
Variation in pigments have also been shown across species from different habitats. For 
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example a subtidal Ulva rotundata sample showed a three-fold increase in pigments 
(chlorophyll a, chlorophyll b and carotenoids) when compared to an intertidal Ulva 
olivascens sample [31]. Figueroa et al. 2003 [31] further showed that these two species 
had different phytochemical adaptive responses to ultraviolet light treatments.  
Whilst a number of studies have reported on the total phenolic content of Ulva (Table 
21), the effect of cultivation on total phenolics has been less investigated. Cabello-Pasini 
et al. 2011 [32] however did show a 60% increase in phenolics for Ulva rigida when 
cultured with high nitrate levels. Studied with other species of macroalgae have also 
shown that low-stocking densities of land-based cultivated Derbesia tenuissima (class 
Ulvophyceae) can boost anti-oxidant capacity by up to 88% with 22% higher phenolic 
content when compared to high-stocking densities [33]. This indicates a potential effect 
of internal fluctuating light intensities resulting from the different stocking densities 
[33]. 
Other important considerations in the determination of total pigments and phenolics are 
effects of the extraction process. Thus, it is important to select solvents and maintain 
consistent condition of the biomass prior to extraction (Table 21) as both variables have 
been shown to influence phenolic yields and anti-oxidant capacities [1]. In particular, 
freeze-dried biomass has been shown to better preserve phenolic content as opposed to 
oven-drying, and may explain the higher overall phenolic content observed for freeze-
dried Ulva lactuca as opposed to the air-dried Ulva rigida as evident in Table 21 [34]. 
Thus it is hard to compare across research findings when the methods of extraction are 
inconsistent. With regards to solvents, aqueous methanol, ethanol and acetone solutions 
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are commonly employed (Table 21). However, when compared to methanol, both 
acetone and ethanol have been shown to yield higher amounts of phenolics and 
flavonoids, with aqueous ethanol extracts showing the highest anti-oxidant activity [35]. 
Therefore, herein we have investigated the effects of cultivation and extraction solvents 
on the yields of broad pigment categories (chlorophyll a; chlorophyll b; carotenoids; 
phenolics and flavonoids) in one Australian species of Ulva. Two extraction solvents 
(acetone and 95% ethanol) were used on algal biomass from four cultivation conditions. 
The extracts were then tested across three basic assays for anti-oxidant, anti-
inflammatory and cell toxicity.  These results have the potential to aid in the 
implementation of future protocol systems of cultivation and production. This will help 
to deliver improved consistency in the functional aspects of algal-derived novel foods. 
This is the first screening study to explore the effect of cultivation conditions and the 
effect of extraction solvent on the pigments profiles and anti-oxidant and anti-
inflammatory bioactivities of a cultivated Ulva sp. 
.
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T
able 21 R
eported phenolic contents of various species of U
lva m
acroalgae (C
hlorophyta) expressed as m
g phloroglucinol (PH
G
E), m
g gallic acid (G
A
E) or µg pyrocatechol 
(PE) equivalents per gram
 of extract unless otherw
ise specified. 
Species 
L
ocation 
B
iom
ass 
E
xtract 
m
g PH
G
E
.g
−1 
m
g G
A
E
 g
-1 
µg PE
 g
-1 
U
lva rigida 
 
 
 
 
 
 
 
Tunisia 
A
ir-D
ried 
C
hloroform
 
13 ±1.1
a17 
 
 
 
Tunisia 
A
ir-D
ried 
Ethyl acetate 
19 ± 0.8
a 
 
 
 
Tunisia 
A
ir-D
ried 
B
utanol 
6 ± 0.3
a 
 
 
 
Tunisia 
A
ir-D
ried 
W
ater 
5 ± 0.6
a 
 
 
 
M
arm
ara sea 
Frozen 
M
ethanol 
 
0.73 ± 0.1
b* 
 
 
M
arm
ara sea 
A
ir-D
ried 
80%
 M
ethanol 
 
2 ± 0.3
c# 
 
U
lva lactuca 
 
 
 
 
 
 
 
A
driatic sea 
D
ried 
A
cetone 
 
 
58 ± 1.1
d 
 
C
om
m
ercial  
D
ried 
Ethanol 
 
6.0 ± 0.01
e 
 
 
Sitka A
laska 
Freeze-dried 
H
exane 
68.2
f 
 
 
 
Sitka A
laska 
Freeze-dried 
Ethyl acetate 
113.4
f 
 
 
 
Sitka A
laska 
Freeze-dried 
B
utanol 
56.8
f 
 
 
 
Sitka A
laska 
Freeze-dried 
W
ater 
81.7
f 
 
 
U
lva intestinalis 
 
 
 
 
 
 
 
Persian G
ulf 
A
ir-D
ried 
80%
 M
ethanol 
 
1  ± 0.1
g 
 
 
Persian G
ulf 
A
ir-D
ried 
80%
 M
ethanol 
 
2 ± 0.3
g 
 
U
lva clathrata 
 
 
 
 
 
 
 
Persian G
ulf 
A
ir-D
ried 
80%
 M
ethanol 
 
5 ± 0.7
g 
 
U
lva linza 
 
 
 
 
 
 
 
Persian G
ulf 
A
ir-D
ried 
80%
 M
ethanol 
 
2 ± 0.3
g 
 
U
lva flexuosa 
 
 
 
 
 
 
 
Persian G
ulf 
A
ir-D
ried 
80%
 M
ethanol 
 
3 ± 0.2
g 
 
*m
g gallic acid equivalents per 100-gram
 fresh tissue; #m
g gallic acid equivalent per gram
 dry w
eight pow
der 
                                        
        
17 a Trigui et al. 2013 [36]; b Y
ildiz et al. 2012 [37]; c Y
ildiz et al. 2014 [38]; d K
osanić et al. 2015 [39]; e B
oisvert et al. 2015 [40];  f K
ellogg and Lila 2013 [41]; g Farasat et al. 
2014 [42] 
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Materials and Methods 
Algal Samples and Cultivation  
The Ulva samples were provided as a dried commercially milled powder from Venus 
Shell Systems Pty. Ltd., Mundamia, New South Wales, 2540, Australia. Samples were 
from controlled scaled, cultivated stock and conditioned either in the presence of high 
nutrients (natural sunlight with ammonia enriched media, control regime), low nutrients 
(natural sunlight with reduced nutrients), low light (reduced natural sunlight with 
ammonia enriched media) or added acetic acid (natural sunlight with ammonia enriched 
media and added acetic acid supplementation). 
Extraction  
All samples (250 mg) were extracted in triplicate in 95% ethanol or 100% acetone (3 x 
3 ml; total volume 9 ml) with brief vortexing followed by centrifugation (3000 rpm, 10 
mins, rt). The extracts were immediately analysed for pigments and a portion of the 
extract set aside for determination of phenolic and flavonoid contents and testing of 
anti-oxidant activity. 
Total Phenolic Content 
Total phenolic content was determined as per the 96-plate method described by Herald 
et al. 2012 [43]. Extracts or standards were diluted 1:4 with Milli-Q (75 µl Milli-Q; 25 
µl) and mixed thoroughly with 25 µL of diluted Folin-Ciocalteu (1:1 with Milli-Q) 
reagent using a multi-channel pipette. After 6 minutes, 100 µL of Na2CO3 was added to 
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each well and the plate incubated for 90 minutes in the dark, after which absorbance 
was read at 765 nm (SpectraMax). The values were determined from a calibration curve 
prepared with gallic acid (0 - 500 µg.mL-1) and results expressed µg gallic equivalents 
per mL extract (µg quercetin.mL-1) and µg gallic equivalents per g dry weight (µg 
quercetin.g-1 d.w.). Each extracted sample was analysed in triplicate with each set of 
cultivation data having a sample number (n) of 9. 
Total Flavonoid Content 
Total flavonoid content was determined as described by Santas et al. 2008 [44]. In brief, 
100 µL of extract was diluted (1:1) with Milli-Q water and 200 µL of a 2% AlCl3 in 
methanol solution was added (5% acetic acid in methanol). The plate was left to 
incubate for 10 mins at room temperature before absorbance was read at 430 nm 
(SpectraMax). The values were determined from a calibration curve prepared with 
quercetin (0 - 500 µg.mL-1) and results expressed as µg quercetin equivalents per mL 
extract (µg quercetin.mL-1) and µg quercetin equivalents per g dry weight (µg 
quercetin.g-1 d.w.). Each extracted sample analysed 6 individual times with each set of 
cultivation data having a sample number (n) of 18. 
Total Chlorophyll and Carotenoid Content 
Total chlorophyll and carotenoid content were determined by ultraviolet–visible 
spectroscopy as per Foo et al. 2015 [45] and Kumar et al. 2010 [46] utilising the 
equations described by Lichtenthaler 1987 [47]. If necessary the samples were diluted to 
fall within the absorbance range of 0.3 and 0.85 [48]. Total content of chlorophyll a, 
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chlorophyll b and carotenoids (xanthophylls and carotenes) determined for both ethanol 
95% (v/v) and acetone 100% (v/v) using the following equations and then results 
expressed as µg.g-1 dry weight (d.w.). 
 
Equations for determination of pigments in 95% ethanol: 
µg.mL-1 Chlorophyll a  = 13.36A664.2 - 5.19A648.6 
µg.mL-1 Chlorophyll b = 27.43A648.6 - 8.12A664.2. 
µg.mL-1 Total chlorophylls = 5.24A664.2 + 22.24A648.6 
µg.mL-1 Total carotenoids = 1000A470 - 2.13Ca - 97.64Cb/209. 
Equation for the determination of pigments in 100% acetone: 
µg.mL-1 Chlorophyll a  = 11.24A661.6 - 2.04A644.8 
µg.mL-1 Chlorophyll b = 20.13A644.8 - 4.19A661.1 
µg.mL-1 Total chlorophylls = 7.05A661.6 + 18.09A644.8 
µg.mL-1 Total carotenoids = 1000A470 - 1.90Ca - 63.14Cb/214. 
Assessment of Antioxidant Activity via 1,1-Diphenyl-2-picryl-hydrazyl (DPPH) Assay 
After extraction, the extracts were directly assessed for their free radical scavenging 
activity for correlation against phenolic and flavonoid content. The anti-oxidant activity 
was assessed by the 96-plate DPPH method as described by Herald et al. 2012 [43] with 
some modifications [49]. In brief, 200 µl of 150 µM DPPH solution in ethanol is added 
to 25 µL of extract or blank. The blank is left to incubate in the dark for up to 6 hours 
and absorbance read at 517 nm (SpectraMax). The percentage (%) of DPPH scavenged 
is calculated as the following equation:  
Absorbance of the Control - Absorbance Sample / Absorbance Control x 100 
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Each extracted sample was analysed in triplicate with each set of cultivation data having 
a sample number (n) of 9.  
Assessment of Cytotoxicity  
After phytochemical analysis the triplicate extractions for each sample were combined 
and dried under nitrogen and 10 mg.g-1 stocks in 100% dimethyl sulfoxide were 
prepared for biological evaluation. The extracts were assessed for cytotoxity (100 
µg.mL−1) on Abelson murine leukaemia virus-induced tumour macrophage (RAW 
264.7) cell lines as described previously [50, 51]. The cytotoxicity of the extracts was 
calculated as the % inhibition of cell proliferation against controls (24 hour incubation) 
using 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-
tetrazolium inner salt (MTS) reagent (Promega). Data was normalised against a control 
for analysis. 
Assessment of Anti-inflammatory Activity  
The anti-inflammatory activity was assessed as the percent (%) reduction of nitrite 
(NO2-) in the cell supernatants determined spectrophometrically using Griess reagent (1 
% sulphanilamide and 1 % N-(1-naphthyl)ethylenediamine dihydrochloride solution) as 
previously described [51]. In brief, RAW 264.7 macrophage cells were co-incubated 
with 1 µg.mL−1 lipopolysaccharides (LPS) and algal extract (100 µg mL−1) for 24 h (37 
°C, 5 % CO2), including controls in 24-well plates. After incubation an equal volume of 
Griess reagent was added to 50 µL of cell supernatant or standard (0 - 1000 µg.mL-1 
sodium nitrite) and mixed thoroughly. After 10 minutes the absorbance was measured at 
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550 nm with a baseline correction at 650 nm [52] and the amount of nitrite determined 
using a standard curve (0 - 100 µM sodium nitrite). Data expressed as a % reduction of 
nitrite compared to controls. 
Statistical and Data Analysis 
Two-way ANOVA and Tukey’s multiple comparisons were used to determine 
significantly different means using GraphPad Prism version 6.00. 
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Results and Discussion 
Pigments 
The pigments of chlorophyta species consist mainly of chlorophyll a and b, β-carotenes, 
lutein and several xanthophylls [53]. A significant effect of the Ulva cultivation 
treatment was observed on the pigment profiles when extracted with acetone (F (3, 32) 
= 2486, P < 0.0001) (Figure 25). Low nutrient conditions (-N) showed the lowest total 
chlorophyll content (17.1 µg.g-1 d.w.) and total carotenoids (2.6 µg.g-1 d.w.) in both 
extraction solvents, which is consistent with reported environmental stress effects such 
as nitrogen limitation [54-56]. In contrast, the high nutrient regime (+N) showed a 
dramatic 57-fold increase in total chlorophyll content (990.9 µg.g-1 d.w.) and 37-fold 
increase in total carotenoid content (102.8 µg.g-1 d.w.) (Figure 25).  
Cultivation with high nutrients under shaded conditions (-L) significantly reduced the 
level of total chlorophyll by 49% and carotenoid content by 73% when compared to the 
high nutrients with natural sunlight. Acetic acid (+AA) cultivation reduced the acetone 
yields for total chlorophyll and carotenoids by 66% and 78% to 336.7 µg.g-1 and 22.3 
µg.g-1 d.w., respectively. Whilst supplementation with an organic carbon source was 
investigated herein, supplementation with an inorganic carbon source (elevated carbon 
dioxide (CO2) has also been shown to decrease total chlorophyll and carotenoid content 
in cultures of Ulva rigida relative to a normal CO2 control [55]. Ethanol extracts (95% 
v/v), showed similar trends as for the acetone extracts across the different cultures with 
significant differences across culture treatments (F (3, 32) = 1101, P < 0.0001) (Figure 
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25). For both acetone and 95% ethanol extracts, high nutrients delivered the highest 
combined yield for pigments  (2085 µg.g-1 d.w. acetone; 3045 µg.g-1 d.w. 95% ethanol). 
Significantly higher yields of total chlorophylls (1480.5 µg.g-1 d.w.) across all cultures 
were obtained with ethanol extracts while the highest yields of carotenoids across all 
cultures were obtained for the acetone extracts (chlorophyll a F (1, 16) = 150.7, p < 
0.0001; chlorophyll b F (1, 16) = 226.8, p < 0.0001; total chlorophyll F (1, 16) = 211.0, 
p < 0.0001 and; total carotenoids F (1, 16) = 12.33, p = 0.0029). This is likely due to 
major carotenoids such as β-carotene and lutein having a higher solubility in acetone 
compared to ethanol [57].   
The increase in carotenoid levels for the high nutrients with natural sunlight may be an 
acclimation response for high sun exposure as carotenoids prevent chlorophyll 
photoxidation [54, 58]. The resulting higher a/b ratio is also indicative of the higher 
chlorophyll a content responsible for light processing, in contrast to the accessory 
chlorophyll b pigment responsible for light harvesting. Continual low light conditions 
did not accumulate a pigment concentration beyond that achieved with full sunlight 
with natural fluctuations. Accumulation of light harvesting pigments is one adaption of 
low light plants in an attempt to maintain a high efficiency of light absorbance [59] and 
Ulva has been shown to exhibit adaptive responses to ultraviolet light treatments [31]. 
However, limited studies have compared the effect of natural sunlight versus continual 
shaded (low light) conditions for large-scale open pool cultivations of Ulva. 
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Figure 25 Total chlorophyll, carotenoid content (µg.g
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A
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natural sunlight and acetic acid supplem
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Light quality on the other hand, has been investigated for Ulva lactuca, but with no 
significant effects on pigment concentration [56] while high nutrients significantly 
increased levels of pigments [56]. Exposed wet thalli of Ulva fasciata, U. lactuca and 
U. reticulata have shown a decrease in total pigments in response to ultraviolet B 
radiation exposure over time [60]. However, this is not representative of true cultivation 
conditions where algal cells can divide and acclimate and is likely the result of pigment 
photoxidation. Sand-Jensen 1988 [59] suggested that Ulva found naturally in high light, 
intertidal zones utilises other light adaptive mechanisms than a shade adaptive 
mechanism of increased pigments in low light; a selective advantage to natural 
fluctuating light conditions. Similarly, increasing chlorophyll content with increasing 
light intensity has been shown in microalgae [61, 62]. Results herein, along with the 
reported literature suggest that nutrients are the strongest determinant of pigment 
concentration in natural light conditions. 
Phenolics and Antioxidant Activity 
Acetone extracts 
For acetone extracts there was a significant effect of increased flavonoid content and 
DPPH activity for low nutrient cultures (F (3, 132) = 100.5, P < 0.0001) (Figure 26), 
while there were no significant differences in acetone-extracted phenolics across the 
different cultivation regimes (6.15 - 9.08 µg.mL-1 GAE). Low nutrients showed a 5-fold 
increased in flavonoid concentration (35.89 µg.mL-1 QE) when compared to the other 
treatment groups (3.95 - 6.96 µg.mL-1 QE). Low light (6.95 µg.mL-1 QE) and samples 
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supplemented with acetic acid (6.76 µg.mL-1 QE) also showed slightly elevated 
flavonoid content compared to natural sunlight (3.95 µg.mL-1 QE) but an interaction of 
this effect with nutrients was not tested and the scale was much smaller than that of 
nutrient depletion. 
As expected, acetone-extracted flavonoid content did not exceed phenolic content for 
the high nutrient regimes (+ N, - L and + AA) as the phenolic assay measures all 
compounds capable of reducing the Folin-Ciocalteu reagent, including flavonoids 
(Figure 26). However the flavonoid content of the nutrient-starved regimes was 
unusually higher than the phenolic content and requires further investigation. It may be 
possible that the low nutrient cultures increase the synthesis of flavonoids, including 
flavonols as a defence mechanism in response to environmental stress [63, 64]. The 
flavonoids may also be highly substituted thus limiting their ability to react with the 
Folin-Ciocalteu reagent. However the higher flavonoid content of the low nutrient 
conditioned biomass did not equate to higher anti-oxidant activity (7.2 % inhibition) 
compared to the high nutrients with natural sunlight (12.4 %) (P < 0.001).  
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Figure 26 (a) The phenolic (µg.mL-1 gallic acid equivalent), (b) flavonoid content (µg.mL-1 quercetin 
equivalents) and (c) relative DPPH free radical scavenging activity (% inhibition of DPPH free radical) of 
acetone and ethanol (95% v/v) extracts for Ulva biomass conditioned using four different cultivations 
treatments; nutrient-rich (+ N); nutrient-starved (- N), nutrient-rich; low-light (- L) and; nutrient-rich with 
added acetic acid supplementation (+ AA). 
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Ethanol Extracts 
A significant effect of cultivation on the phenolic content, flavonoid content and DPPH 
activity was observed for extracts from 95% ethanol compared to acetone extracts (F (3, 
132) = 36.23, P < 0.0001). Furthermore, when extracted with 95% ethanol there is also 
a significant effect of both solvent (F (1, 64) = 98.23, P < 0.0001) and cultivation (F (3, 
64) = 23.11, P < 0.0001) on phenolic yields, which was not observed for acetone (Figure 
26). Extraction with 95% ethanol for the high nutrient culture with natural sunlight 
resulted in a 4-fold increase in total phenolics when compared to acetone extracts (44.58 
c.f. 9.08 µg.mL-1 GAE respectively). Apart from phenolics, all other trends observed for 
the acetone extracts were maintained with the 95% ethanol extraction with the low 
nutrient regime showing a marked increase in flavonoid content (34.26 µg.mL-1 QE) 
when compared to the other regimes (6.23 - 9.66 µg.mL-1 QE) (Figure 26). Anti-oxidant 
activity was again highest in the high nutrient culture with natural sunlight and with 
ethanol extract (18.8% inhibition), which is potentially due to the significantly higher 
levels of phenolics (44.58 µg.mL-1 GAE).  
Comparison of the yields and activity of Ulva phenolics found here with reported 
literature is difficult due to the different standards (phenolic equivalents) used and 
different methods of reporting yields (Table 21). Table 22 shows the dry weight 
equivalents (mg.g-1 d.w.) for phenolic and flavonoid contents across the four cultivation 
regimes when extracted with either acetone or 95% ethanol. Yildiz et al. 2014 [38] 
reported a value of 1.7 ± 0.3 mg GAE per g of dry weight for a dried Ulva rigida 
sample extracted with 80% methanol, supporting our reported value herein of 1.58  ± 
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0.21 mg GAE per g of dry weight for the high nutrient culture with natural sunlight. 
However other studies with freeze dried material showed much higher levels of PHGE 
equivalents and these equivalents and pre-processing effects were not explored here. 
Herein our results indicate that high nutrients with natural sunlight is optimal for 
phenolics and antioxidant activity, relative to the other treatment regimes, however for 
more definitive, absolute amounts regarding total content, further investigations should 
be carried out to optimise the extraction for algal samples.  It is possible that higher 
yields may be obtained by extraction of fresh or freeze-dried material as opposed to 
oven-dried, as investigated herein [34, 65].  
Table 22 The phenolic total content (gallic acid equivalents, GAE) and flavonoid (quercetin equivalents, 
QE) content per gram of dried Ulva powder for acetone and 95% ethanol extracts from four different 
cultivations treatments (nutrient-rich, nutrient-starved, nutrient-rich low-light and nutrient-rich with 
added acetic acid supplementation). 
Acetone Phenolics (mg.g-1 d.w. GAE) Flavonoids (mg.g-1 d.w. QE equiv) 
Nutrient-starved (- N) 0.25 ± 0.01 1.27 ± 0.02 
Nutrient-rich (+ N) 0.32 ± 0.01 0.14 ± 0.02 
Low light (- L) 0.28 ± 0.01 0.25 ± 0.03 
+ Acetic Acid (+ AA) 0.22 ± 0.01 0.24 ± 0.02 
Ethanol (95% v/v)   
Nutrient-starved (- N) 1.04 ± 0.10 1.21 ± 0.07 
Nutrient-rich (+ N) 1.58 ± 0.21 0.22 ± 0.03 
Low light (- L) 0.39 ± 0.03 0.34 ± 0.02 
+ Acetic Acid (+ AA) 0.47 ± 0.07 0.33 ± 0.02 
The chemical nature of the algal phenolics themselves will also direct the choice of 
solvent-system so further solvents/solvent combinations should be investigated [1, 66]. 
For example Vijayavel and Martinez 2010 [67] reported appreciable NO, hydroxyl and 
superoxide radical scavenging dose responses for Ulva fasciata in 100% ethanol 
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extracts with corresponding total phenolic content of 0.21 mg GAE per g algal weight, 
an 87% decrease compared to the total content reported herein. Aqueous organic 
solvents, such 80% methanol or 95% ethanol have also been shown to extract higher 
quantities of phenolic compounds than pure organic solvents [68] suggesting that the 
acetone extraction herein may benefit by addition of a proportion of water. 
Anti-inflammatory and Cytotoxicity 
With regards to the inhibition of LPS-induced NO, no significant effects of cultivation 
were observed for either the acetone or 95% ethanol extracts (F (3, 24) = 0.3892, P = 
0.7618). All samples exhibited strong anti-inflammatory activity ≥ 76 % with no 
evidence of cell cytotoxicity (% inhibition on cell proliferation) (Figure 27). However, 
the extraction solvent did have a significant effect on the inhibition of NO (F (1, 24) = 
16.49, P = 0.0005) with acetone extracts exhibiting significantly higher inhibition of 
NO (94 - 97 %) than the 95% ethanol extracts (76 - 91 %) (Figure 27). It is unclear 
which phytochemical is responsible for the increased NO activity as there are no 
obvious differences in the profiles of the solvents that might explain this, other than that 
carotenoids were generally higher in the acetone extracts but mostly in the nutrient rich 
conditions (above). 
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Figure 27 The increase in cell proliferation (normalised to control) and corresponding % inhibition of 
nitric oxide (NO) for acetone and 95% ethanol extracts of Ulva from four different cultivations treatments 
(nutrient-rich, nutrient-starved, nutrient-rich low-light and nutrient-rich with added acetic acid 
supplementation). 
Kellogg and Lila 2013 [41] reported similar levels of NO inhibition, up to 92 % for 
hexane, ethyl acetate and water extracts from an Ulva lactuca. We have also previously 
reported strong NO inhibition (>76 %) for Ulva dichloromethane and ethyl acetate 
extracts [51]. This high NO inhibition across a variety of extracts with differing 
polarities suggests that the anti-inflammatory functionality of Ulva is likely due to a 
number of different structurally classed molecules such as fatty acids, phenolics, 
terpenoids with possible synergistic effects. This however would need to be defined 
through further purification and a bioassay guided fractionation approach. 
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With regards to cell toxicities of both extracts, there was no observed inhibition of cell 
proliferation. In contrast, cells incubated with Ulva acetone and 95% ethanol extracts 
(100 µg.mL-1) showed enhanced cell growth. When normalised against a control, both 
extracts indicated enhanced proliferation up to 1-fold. When normalised, significant 
differences between 95% ethanol and acetone extracts were observed (F (1, 56) = 395.9, 
P < 0.0001) (Figure 27). Ulva extracted with 95% ethanol showed a higher rate of cell 
proliferation. This may correlate with the increased phenolic and total chlorophyll 
content observed. Furthermore the increased NO inhibition observed for the acetone 
extracts may be indicative that there was less LPS induced cells producing NO. Future 
investigations should correct NO findings against a cell number or mg of cell protein 
[52]. With regards to cultivation, no significant differences were observed across the 
treatments for either the acetone or 95% ethanol extracts (F (3, 56) = 1.981, P = 
0.1272). It is possible that the extracts are conferring a significant protective effect that 
increases cell viability. Indeed Ulva rigida ethanol extracts have been reported to 
protect human carcinoma cells from death induced by oxidative stress due to H2O2 
exposure [69]. 
Conclusion  
In summary, across all samples investigated here, acetone extracts of high nutrient 
natural sunlight biomass showed the highest level of carotenoids and inhibition of NO 
(Table 23). Important carotenoids present in Ulva include β-carotene, lutein [70] and 
have been shown to influence important inflammatory mediators [71]. In contrast, the 
low pigment, low nutrient samples when extracted with acetone showed a higher 
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concentration of flavonoids. Flavonoids are also anti-oxidants, but they also exhibit a 
vast range of pharmacological activities including anti-inflammatory, anti-diabetic, 
hepato- and gastro-protective [72]. It has also been implied that the larger molecular 
weight flavonoids exert their beneficial effects through their interactions with gut 
microbiota [73]. However these biological activities were not measured or evident here. 
The high flavonoid content of low nutrient culture is highlighted as a key area to 
investigate using a bioassay guided fractionation approach to identify the metabolite 
that is being enhanced through nutrient-starved culture conditions and for considering 
further biological assays. However, the optimal cultivation condition of high nutrients 
and ethanol extractions provided for the highest chlorophyll and phenolic content with 
associated high anti-oxidant activity (Table 23). It will be important to build on these 
findings by increasing the identification of phytochemicals present in the diverse 
extracts and expanding the types of biological assays along with establishing 
concentrations at 50% inhibition (IC50) for purified fractions.  
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Increasingly consumers are being exposed to information regarding the link between 
diet and health. However, a proportion of the population will find it challenging to meet 
the simple dietary intake requirements for fresh fruit and vegetables [1]. Specifically, 
diets that are high in omega-6 and trans-unsaturated fatty acids have led to an increasing 
prevalence of non-transmissible diseases [2]. For example, allergies, asthma and 
inflammatory bowel, cardiovascular, metabolic and neurological diseases, all of which 
are characterised by a persistent underlying low-grade inflammation [3-5]. However, 
diets that are rich in plant phytochemicals and anti-inflammatory omega-3 fatty acids 
confer protective benefits against these inflammatory diseases [6-11]. These metabolite 
classes are abundant in algae and cultivated macroalgal crops have been highlighted as a 
potential source for these high value anti-oxidant and anti-inflammatory compounds 
[12-16]. 
A review of bioactive compounds in seaweed by Holdt and Kraan 2011 [17] 
demonstrates that, collectively, seaweeds are a valuable source of nutrition including 
essential dietary vitamins, minerals, fatty acids and amino acids. In addition, the 
functionality of seaweeds also extends beyond that of simply providing nutrition, as 
they are also a source of other functional compounds (Chapter 1). Northern hemisphere 
seaweeds dominate this field of research, and yet Australia has a unique flora of 
macroalgae in which the chemistry and biological activity is still poorly understood. 
Therefore a number of Australian seaweeds were investigated herein to establish their 
potential for cultivation for food and health markets (Chapter 3). These taxa included 
Hormosira banksii, Phyllospora comosa, Ecklonia radiata, Myriogloea sciurus, 
Solieria robusta and the green macroalgae Ulva spp.  In particular, the study focused on 
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dominant seaweed traits of interest, such as metabolites that function as anti-
inflammatories that could confer protection against underlying low-grade inflammation 
that characterises many lifestyle diseases.  
One anti-inflammatory class of molecules are polyunsaturated fatty acids (PUFA), in 
particular omega-6 (n-6) fatty acids, which are substrates for pro-inflammatory 
mediators and omega-3 (n-3) fatty acids, which are substrates for anti-inflammatory 
mediators [18]. This is why a reduced ratio of dietary inflammatory n-6 fatty acids to 
anti-inflammatory n-3 fatty acids (n-6/n-3) is considered important to suppress chronic 
inflammatory disease [9, 19]. Therefore characteristics of the fatty acid profiles for 
these Australian taxa were investigated. All six taxa had significantly different omega-6 
to omega-3 ratios, although the environmental conditions had a big influence on this 
too. However it was the green seaweed Ulva that was most nutritionally desirable, 
exhibiting a low n-6/n-3 ratio of 0.4 and the only species to contain the important 
omega-3 docosahexaenoic acid (DHA), albeit at low concentrations. The consumption 
of n-6 to n-3 in a typical Western diet is approximately 15:1, while ratios of between 
2.5-5 to 1 are desirable to reduce the risk of disease [9]. Furthermore, the non-polar 
(lipid rich) extracts of all six algal species strongly inhibited production of the 
inflammatory-mediator nitric oxide (Chapter 3). Investigations into cell toxicity also 
revealed that extracts of both the Ulva sp. and H. banksii showed selective cytotoxicity 
towards a human pancreatic cancer cell line, an interesting finding requiring further 
exploration in the future. 
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As a result, Ulva sp. and H. banksii and their extracts and fractions were identified as 
key candidates for further investigation. There is also a potential opportunity to pursue 
characterisation of the active component(s) as a new future research project emerging 
from the work described herein. Identification of a novel bioactive may further direct 
future anti-inflammatory drug design through a synthetic chemistry approach. However, 
the attribution of a biological activity to an extract is an important first step in 
characterising the functionalities of the biomass as a whole food matrix. Such 
information contributes to more immediately attainable goals in which seaweeds, as 
either a whole food, concentrated extracted or isolated class of metabolites have the 
potential to contribute to human and animal nutrition as dietary functional foods and/or 
ingredients with anti-inflammatory functionalities.  
Collaborations with industry partner Venus Shell Systems Pty. Ltd.18 enabled the 
analysis of biomass from large-scale cultivation experiments to further explore the fatty 
acid profiles and anti-inflammatory activity of the identified key candidate taxon Ulva 
sp. There have been a number of reports quite recently of promising results regarding 
large-scale cultivation of Ulva [20-23] and similar chlorophyta species such as Derbesia 
tenuissima [24, 25]. These studies contribute important knowledge of various aspects of 
cultivation (stocking density, seasonal productivities, harvesting and post-processing) 
for chlorophyta species to maximize biomass yields and quality. With regard to quality, 
they have focused on key compounds for biorefinery and commercial utilisation, such 
fatty acids and lipids [24], carbohydrates, amino acids [22], protein [23], mineral salt 
                                                
18Venus Shell Systems, Narrawallee, NSW, 2539, Australia  
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[20] and even phenolics and antioxidant activity [25]. On the basis of the results 
presented in Chapter 3, it was hypothesised that the presence of two metabolites 
classes are likely candidates for the strong anti-inflammatory activity of the extracts. 
These include lipids rich in polyunsaturated fatty acids and pigments (including 
phenolics). 
Ulva can readily adjust its metabolism under specific environmental conditions, wherein 
the lipids and fatty acids play an important role in this adaptation [26]. As such, the 
profiles of reported FA for Ulva can show a wide degree of natural variation 
(comprehensive review presented Chapter 4). Therefore, in complement to the reported 
cultivation studies of Ulva described above, Chapter 4 demonstrates that growth 
conditions are also an important consideration for biomass yield and quality. It was 
demonstrated that high nutrient growth conditions deliver the most desirable fatty acid 
profile for health with PUFA constituting 54% of the lipid extract. The n-6/n-3 was a 
very favourable low 0.2, and important omega-3 PUFAs comprised up to 9%, 2% and 
1% of stearidonic acid (SDA; C18:4n-3), eicosapentaenoic acid (EPA; C20:5n-3) and 
docosahexaenoic acid (DHA; C22:5n-6), respectively. A number of studies have shown 
potential for the rare stearidonic acid (C18:4 n-3) to boost tissues levels of the anti-
inflammatory eicosapentaenoic acid (EPA, C20:5 n-3) [27-29]. Furthermore, via a 
thorough a comparison of lipid extraction procedures and subsequent development of an 
optimised protocol for the extraction of fresh filamentous Ulva, a yield of 56 mg.g-1 dry 
weight equivalent could be achieved.  
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Chapter 5 explored the effect of environment on the distribution of these important 
polyunsaturated fatty acids across the phospholipid and neutral lipid fractions. These 
fractions perform important physiological roles in different cellular structures. In 
particularly the fatty acid composition of Ulva phospholipids, which constitute between 
10-50% of cell membranes and chloroplasts [30, 31] has been poorly explored [32], 
compared with the typically more abundant glycolipids [33-35]  
It is important to consider in which lipids the important omega-3 fatty acids are bound 
as this may have implications regarding bioavailability of the algal-derived oil. Fish 
derived PUFA from fish oil are commonly bound within triacylglycerides, however it 
has been postulated that they may not be as efficient as other lipids classes, such as 
triacylglycerides [14]. For example, Krill oil is unique in that as it has a substantial 
proportion of EPA and DHA in abundant phospholipids and this has been used in 
marketing to differentiate itself from the other typical fish oils. Whilst there is evidence 
to suggest that polar lipids have a higher bioavailability than nonpolar triacylglycerides 
further studies are required [15]. Nethertherless, for a marketable algal-derived oil this 
is an important consideration. Secondly, such information can direct future extraction 
protocols as different lipids have differing solubilities.  
 If was found herein that phospholipid fractions were characterised by the presence of 
five major fatty acids including 16:0, 16:1n-7, 18:1n-7, 18:2n-6 and 18:3n-3 and that the 
majority of important omega-3’s reside in the remaining neutral fractions 
(triacylglycerides and glycolipids). 
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Thus the neutral lipid fraction was highlighted as the richest fraction and target for a 
nutritionally potent PUFA extract and could direct the future choice of extraction 
protocol. For example, two feasible options for scaling the oil extraction include either a 
non-toxic solvent approach such as ethanol [36] or super-critical carbon dioxide, which 
offers a number of benefits over traditional solvent extractions including:19  
• Non-flammable, non-corrosive and inexpensive with no chemical residue; 
• Low critical temperature and decreased degradation of food components; 
• Higher diffusion coefficients and lower viscosity allowing for rapid matrix 
penetration and enhanced extraction efficiencies; and 
• Selective for compounds of interest and can be recycled.  
Phospholipids have a limited solubility in super-critical carbon dioxide thus requiring a 
co-solvent such as ethanol [38]. For example, a one-step neat super-critical carbon 
dioxide extraction without ethanol supplementation could optimise a sequential 
biorefinery process that concentrates the neutral lipids fractions, such as glycolipids, to 
deliver a nutritionally valuable high-end product with phospholipid by-product rich in 
alpha linolenic acid (18:3n-3) and linoleic acid 18:2n-6 [38]. It was further found herein 
that nitrogen-starvation could increase the yield for this neutral lipid compared to the 
high nutrient conditions, however this was at a detriment to the overall quality of the 
oil. Thus for products aimed at food and health markets it may be more important to 
optimise the high quality rather than the quantity of fatty acids through the optimised 
cultivation of Ulva. This understanding of the fatty acid distribution across different 
                                                
19 Rozzi, N.L. and Singh, R., K., Supercritical fluids and the food industry. Comprehensive reviews in 
food science and food safety, 2002. 1: p. 33-44 [37] 
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lipids can define future selective biorefinery processes. Future investigations of Ulva 
derived oils should further consider the fatty acid distributed across the different neutral 
lipid classes such as glycolipids and triacylglycerols. In particular, more chemistry-
oriented approaches should be employed to identify and quantify lipids, for example 
identification of phospholipid composition by electrospray mass spectrometry. 
The results presented across both Chapters 4 and 5 present the idea that an algal-
derived oil from Ulva spp. could offset a proportion of the demand for fish derived oils. 
Encapsulated omega-3 fish oils are highly promoted as part of a balanced diet, and 
rightly so due to their health benefits associated with foetal development, cardiovascular 
function, and Alzheimer’s disease [39]. Fish oil is also a valuable additive in feed for 
aquaculture to boost tissues levels of omega-3 and replacement oils have been sought 
due to declining wild fish stocks [40]. There is also particular promise for oils high in 
stearidonic acid (C18:4 n-3) [41], such as is the case with an Ulva derived oil. High 
levels of stearidonic fatty acids are found in seed based oils from Echium species, 
however these oils are deficient in other important omega-3 such as EPA and DHA 
[42]. Whether the omega-3 PUFA are delivered via the whole food matrix or as an 
extracted oil supplement, there is additional evidence to suggest the benefits of 
incorporating algae in aquaculture feeds. For example, the flavour of farmed 
barramundi was shown to be enhanced, with other organoleptic attributes with an algal 
diet (Ulva ohnoi) [43]. Macroalgal diets have also achieved high levels of important 
omega-3 fatty acids in abalone [44], along with higher growth rates and overall 
improved condition of the abalone [45]. Indeed, the latest report from the Food and 
Agriculture Organisation of the United Nations [46] identified a surging demand in fish 
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and fish products that can only be met by aquaculture, indicating a pressing need for 
sustainable sources of beneficial omega-3 PUFA. 
One particular limitation to our proposed algal-derived omega-3 oil from Ulva is the 
level of docosahexaenoic fatty acid (DHA), which is only present in trace amounts. In 
contrast to EPA, tissue levels of DHA can only be boosted with direct supplementation 
[47]. An interesting future project could consider options to boost the DHA content of 
the proposed algal-oil. Herein biomass was analysed from cultivations that differed in 
two growth variables (light and nutrients). Future considerations could consider 
exploring effects of salinity, pH, and temperature, however natural seasonal fluctuations 
of these variables were found not to significantly effect total lipids and fatty acid 
contents of a number of wild species including Ulva linza [48]. A more interesting and 
challenging project might be to explore co-culturing techniques with other algal species 
or even symbiotic bacteria [49]. A more simple option however may be to consider 
supplementation of the Ulva derived oil with cultured microalgal oils rich in EPA and 
DHA such as Synechocystis [50] and Isochrysis galbana [51], respectively. Regardless 
of the approach, if the both the EPA and DHA content can be successfully boosted 
beyond levels that are presented herein, or if supplementation to animal feeds becomes 
a more standard practice to boost tropic bioaccumulation, there is real possibility that an 
algal oil could offset a proportion of this demand for fish-derived oils in the future.  
With regards to human nutrition, the human consumption of seaweed, and thus its 
beneficial omega-3’s and other bioactive phytochemicals faces a bigger challenge for 
acceptance, than it does for simple supplementing fish feed. In Western cultures 
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seaweed as a recognisable whole food has struggled to expand significantly beyond 
Asian Markets [52]. In cultures that have a more limited tradition in the utilisation of 
seaweed, the consumption of algal-derived functional food ingredients and/or 
supplements might be a more feasible option to pursue for consumer acceptance and 
commercial success [14] (Figure 28). 
As mentioned earlier, a proportion of society’s population will struggle to meet dietary 
requirements for fresh fruit and vegetables. Fruit and vegetables are rich in 
phytochemicals [53] and include polyphenol compounds such as phenolic acids and 
flavonoids and terpenoid derived compounds such as carotenoids, lutein, lycopene and 
β-carotene [54]. Seaweeds are also a source of these beneficial and abundant bioactive 
phytochemicals [12, 13] and it was hypothesised based on the results of Chapter 3  that 
the presence of pigments and phenolics may have attributed to the high anti-
inflammatory activity observed. Therefore, upon completion of the cultivation 
investigation (Chapter 4 and 5), the harvested biomass was dried and milled and 
subsequently analysed for phenolics and pigments as a potential class of metabolites for 
biorefinery and utilisation.  
Whilst phenolics have been reported for Ulva within the literature (Chapter 6) little has 
been done to explore the effect of cultivation on the phytochemicals of Ulva. High 
nutrient conditions were again deemed optimal to deliver the highest yields of phenolic 
content, as well as anti-oxidant activity. Furthermore, a 4-fold increase in phenolic yield 
is obtained with ethanol extraction as opposed to using acetone as the extraction 
solvent.  In contrast, acetone extracts of high nutrient cultures exhibited the highest 
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carotenoid content and anti-inflammatory activity. Low nutrients cultures were also 
correlated to substantially increased flavonoid content. These results again have 
important implications that can direct future extraction protocols. Furthermore, whilst 
this thesis presents the characterisation of the anti-inflammatory and anti-oxidant 
functionalities at the level of extract there are further avenues to pursue and build upon 
these results through further purification via a bioassay guided fractionation approach 
combining both molecular and chemistry techniques. 
Although a direct cause and effect relationship was not pursued to the level of 
molecular fractions herein, the clear indications of in vitro anti-oxidative and anti-
inflammatory activities of phenolic/pigment rich macroalgae is an adequate position 
from which to consider applying these seaweeds in nutritional studies. However, how 
these activities should be applied in a nutritional sense to reduce the deficiencies in the 
western diet still needs to be considered thoroughly. If direct consumption of these 
seaweeds or their extracts is required, then the effects of any processing needs to be 
considered. Here the optimisation of protocols for quantifying bioactive metabolites 
will be of great use in pursuing this direction of research to quantify effects, as was 
done in Chapter 5 (further investigations) based on the drying process. 
In addition, any toxicity testing (Chapter 2) of the processed products will be of 
importance as commercially processed and whole biomass effects were not undertaken 
here. This area should be expanded upon to consider the content of trace elements and 
metals, which were not investigated here. A full investigation of these attributes should 
be used to characterise the seaweed biomass from a nutritional sense as well as for 
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safety. Following this, clinical testing of these seaweeds and their extracts as 
supplements or food needs to be undertaken to confer that the metabolite attributes and 
in vitro assays can be translated directly into benefits for humans and fortification of 
inflammatory western diets. 
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Conclusion  
In conclusion, this thesis presents, in journal article style, a combination of published 
and prepared manuscripts that screens the metabolite profiles and anti-inflammatory 
activities of a number of South Eastern Australian, macroalgal species. These included 
endemic and native species of Phaeophyta, Rhodophyta and Chlorophyta. All species 
screened here exhibited anti-inflammatory activity associated with at least one extract 
fraction, although there were clear characteristics in the anti-inflammatory activity and 
FA profiles across the level of phyla, as well as species. In terms of FA profiles, 
Hormosira banksii (Phaeophyta) is a promising candidate with high levels of PUFA, 
however Ulva sp. exhibited more favourable Omega-3 ratios, which is important for 
anti-inflammatory health applications. In addition, Ulva sp. exhibited selective cell 
toxicity against pancreatic cancer cells in vitro and was investigated further for pigment 
traits that can also explain anti-inflammatory activity.  Therefore a range of cultivation 
conditions and analytical methods were optimised to test the variability and actual 
content of metabolites with anti-inflammatory potential (Figure 29).  
An important requisite in the screening of new natural products is the toxicity for safety 
concerns. In addition, targeted toxicity assays towards cancerous cell lines is of interest 
and these aspects were explored in Chapter 2, published as “Bioassays for Anticancer 
Activities” in the book Metabolomics Tools for Natural Product Discovery Methods and 
Protocols. Using this screen for toxicity, as well as the FA profiles and anti-
inflammatory activities, Chapter 3, published in the Journal of Applied Phycology 
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(impact factor 2.372), identified the important candidates of anti-inflammatory 
compounds for further investigation aimed towards food and health markets.  
 
Figure 29 Graphical summary of the chapters and corresponding publications presented in this thesis. 
A challenge to the adoption of natural products is the establishment of quality-
controlled procedures that can provide a comprehensive comparative assessment of the 
FA of cultivated Ulva sp. via a consistent methodological approach. This was developed 
in Chapter 4, also presented as a published manuscript, which appeared in the journal 
Food Chemistry (impact factor 3.391). A thorough review of FA from the genus Ulva 
identified that there were inconsistencies in the published literature, and a focus on 
method optimisation targeting these inconsistencies delivered a validated and 
comprehensive approach to the analysis of FA in Ulva sp., taking into account the 
effects of biomass preparation and extraction protocols. This was essential for the 
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rigorous comparative work of Ulva biomass, which was cultivated in different 
conditions to determine the effects on FA profiles presented in Chapter 5. 
As a result of the findings presented in Chapters 4 & 5, a food safe solvent extraction 
for FA was explored and it was found that Ulva sp. cultivated under optimal growth 
conditions (high nutrients) can yield 4.1% dry weight (d.w.) of total FA. This is an 
important finding and represents a doubling of the average reported lipid yield for Ulva 
spp. in the literature (~2% d.w.). Due to this finding and the fact that ethanol as a 
solvent extracts are also rich in pigments and phenolics, the characterisation of these 
metabolite classes were explored. This investigation of the phenolics and pigments of 
cultivated Ulva sp., along with associated anti-oxidant and anti-inflammatory activities, 
is presented as a prepared full research manuscript in Chapter 6. The results presented 
in Chapter 6 establish that Ulva sp., when cultivated under optimal conditions, delivers 
a high yield of Omega-3 rich FA, pigments and phenolics, with associated anti-
inflammatory and anti-oxidant activity.  
Thus, as Aristotle once said “in all things of nature there is something of the 
marvelous” and indeed Australia’s unexplored bounty of endemic macroalgae has a 
promising future of marvellous discovery. 
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Appendix B 
 
Protocols for Abelson murine leukaemia virus-induced tumor macrophage (RAW 267.4 
cells)20 
 
Protocol for Thawing Raw 264.7 cells 
1. Cells are stored in media with 20% DMSO (which helps with freezing down). 
Therefore there is a need to work quickly. Prepare your biological safety cabinet 
(BSC) and equipment. 
2. Prepare tissue culture media RPMI-1640 with 10% fetal calf serum and 1% 
GlutaMAX with penicillin (100 U/mL) and streptomycin sulphate (100 µg/mL). 
a. Note: Have found that High Glucose DMEM media with 10% FBS 
(without added Glutamax) works just as well or even better I also found 
that you so do not need antibiotics 
3. Pre-warm media and thaw cryovial of cells in water bath (37 °C) 
4. Add 40 ml of culture media to a 50 mL falcon tube. Add whole contents of 
cryovial (1 mL) to the 40 ml of culture media to dilute DMSO (syringe works 
well). Spin at 1500 rpm for 5 mins. Pour off supernatant. Using a syringe, 
resuspend in 2 mL of culture media 
                                                
20Modifications of methods and feedback originally provided by Associate Professor Ronald Sluyter, 
School of Biological Sciences, Faculty of Science, Medicine and Health, University of Wollongong, 
Wollongong, NSW, 2522, Australia 
 
 
Appendices 
 225 
5. Add approximately 23 mL media to 75 cm2 tissue culture flask (total volume 25 
mL) than add the 2 mL of resuspended cells.  
6. Place in incubator with 5% CO2 at 37 °C. 
Protocol for Passaging Raw 264.7 cells  
1. Prepare BSC and equipment. 
2. Pour off supernatant in tissue culture flask and add ~10 mL fresh media. 
3. Scape cells off bottom of flask with tissue culture scraper.  
a. Note: Contamination can easily occur with this step. Clean scraper 
packet with ethanol thoroughly before putting in BSC. Be careful when 
opening to ensure aseptic technique as plastic packet rips off-centre very 
easily and tears). 
4. Swirl flask to make homogenous. 
5. Add 2ml of scraped cells suspension to new 75 cm2 flask with ~ 23 ml fresh 
media. 
Protocol for Freezing down Raw 264.7 cells 
1. The day before put a cryovial container in the -80 °C freezer to cool. 
2. Prepare 10 ml of a 20% DMSO solution in culture media in a 50 ml falcon tube 
(2 ml 100% DMSO in 8 ml culture media). Put on ice. 
3. Harvest flasks (5 x 75 cm2 flasks by first pouring off supernatant. Add fresh 
culture media (~8 ml), scrape and pool into a 50 ml falcon tube. Spin for 5 mins 
at 1500 rpm. 
4. Pour off supernatant, resuspend in 10 ml culture media. Put on ice. 
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5. Label 10 cryovials (2 cryovials per 75 cm2 flask) and removed the cryovial 
container from the -80 °C freezer. 
6. Add the cells slowly (drop wise), whilst continually stirring, to the 20% DMSO 
solution in CM. This will now be a cell suspension in 10% DMSO in culture 
media. 
7. Aliquot ~1.8 ml of cell suspension in 10 % DMSO in culture media to each 
cryovial (do not completely fill to the 2 ml mark) to  
8. Put into the cryovial container and place container back in --80 °C freezer for 24 
hours before storing in liquid nitrogen. 
Preparation Phosphate Buffered Saline21 
 
Table 24 Preparation for 1X and 10X phosphate buffered saline stock solutions. 
Reagent Amount to add 
(for 1X solution) 
Final concentration 
(1X) 
Amount to add 
(for 10X stock) 
Final concentration 
(10X) 
NaCl 8 g 137 mM 80 g 1.37 M 
KCl 0.2 g 2.7 mM 2 g 27 mM 
Na2HPO4 1.44 g 10 mM 14.4 g 100 mM 
KH2PO4 0.24 g 1.8 mM 2.4 g 18 mM 
If necessary, PBS may be supplemented with the following: 
CaCl2•2H2O 0.133 g 1 mM 1.33 g 10 mM 
MgCl2•6H2O 0.10 g 0.5 mM 1.0 g 5 mM 
1. Dissolve the reagents listed above in 800 mL of H2O. Adjust the pH to 7.4 with 
HCl, and then add H2O to 1 L. 
2. Put the lid on the bottle loosely with autoclave tape and then autoclave it. 
Lipopolysaccharide (LPS) Preparation 
                                                
21Provided courtesy of Nathanial Harris, PhD Candidate, Supervisor: Prof. Marie Ranson, School of 
Biological Sciences, Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, 
NSW, 2522, Australia 
Appendices 
 227 
1. Sample supplied as 1 mg lyophilised powder. Resuspend in 1 ml phosphate 
buffered saline or tissue culture media (1 mg.mL-1 stock solution).  
a. Note: a significant amount of LPS may be on the underside of the rubber 
lid so add 1 ml of PBS, recap and invert to mix. LPS dissolves rapidly.  
2. Prepare 25 diluted aliquots in eppendorf tubes by taking 40 µL of stock solution 
and make up to 1 mL (0.04 mg.mL-1). Store in -20 freezer. Avoid thaw and 
freeze cycles.  
3. For testing, one 1mL eppendorf is thawed and 25 µL is then added to each well 
on a 24 well plate for a total volume of 1 mL. Volume required per plate 25 µL. 
This gives a testing concentration of 1 µg.mL-1. 
a. Note: if using a 96 well plate add 3 mL of sterile PBS to the 1 mL aliquot 
and add 10 µL of diluted LPS solution per well to give a final testing 
concentration of 1 µg.mL-1 
b. Notes 2: I have found that for the determination of nitric oxide in LPS 
stimulated RAW264.7 cells that 24 well plate method give much more 
consistent results across replicate plates and replicate trials 
1. Prepare 10 mg.mL-1 stocks of your test compound in 100% DMSO. 
a. Note: Weigh your pre-labelled vial (with lid), add portion of extract and 
evaporate down. Re-weigh you vial (with lid) and prepare your 10 
mg.mL-1 using this extract weight and avoid trying to prepare a set mg 
amount of extract. 
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b. Note 2: Sample vials will be sprayed with ethanol before going into the 
BSC so use proper labelling and not just marker for labelling your vials. 
Also make up your stock solutions in the BSC. 
c. Notes 3:I have found that using brand new vials and preparing stock 
solution in 100% DMSO in the BSC suffice for sterility. Water soluble 
samples will need further preparation to ensure they are sterile (sterile 
filtering or autoclave (solution) 
2. Prepare a dilution plate using a standard 96 well plate. Pipette 10 µL sample into 
90 µL media (1/10 dilution to give a 1 mg.mL-1 solution in 10% DMSO). 
3. This 100 µL of 1 mg.mL-1 solution in 10% DMSO will then further be diluted 
1/10 when added to the cells to give a final testing concentration of 100 µg.mL-1 
in 1% DMSO. This achieved by added 100 µL of 1 mg.mL-1 solution to 875 µL 
cells (1.5 x 105 cell.mL-1) and 25 µL of LPS (24 well plate method, adjust 
accordingly if needed for 96 well plate assay) 
4. Test each sample in duplicate (minimum) which allow for four text samples per 
24 well plate (Figure 30) 
a. Note: With microplate (96-well plate) preparation it is standard practice 
to avoid use of the outside well due to the “edge effect”. Therefore 
avoiding the outside perimeter wells should be considered when 
modifying this example set up for a 96 well plate assays. 
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S1	+	LPS S1	+	LPS S1 + PBS S1 + PBS 1%	DMSO	+	LPS 
S2	+	LPS S2	+	LPS S2 + PBS S2 + PBS 1%	DMSO	+	LPS 
S3	+	LPS S3	+	LPS S3 + PBS S3 + PBS 1%	DMSO	+	PBS 
S4	+	LPS S4	+	LPS S4 + PBS S4 + PBS 1%	DMSO	+	PBS 
Figure 30 Example preparation for a 24 well plate for the testing of four samples at one concentration. 
n S1-S4 Test sample with LPS; n S1-S4 Test sample with PBS (Blank); n Positive control (100% 
LPS-stimulated nitric oxide production) n Negative control (Blank, 100% normal nitric oxide 
production in non LPS-stimulated cells. 
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Abstract Increasingly, macroalgae are being recognised as a
growth opportunity for functional foods and nutritional secu-
rity in the future. Dominating traits of interest are metabolites
that function as anti-inflammatories and are antiproliferative.
However, seaweeds from the northern hemisphere dominate
this field of research. Australia has a unique flora of
macroalgae, and it is poorly understood which species should
be targeted for cultivation towards food and health markets.
Here, six Australian marine macroalgae were selected for
screening of one anti-inflammatory group; n-3 polyunsaturat-
ed fatty acids (PUFA). PUFA profiles were determined using
gas chromatography-mass spectrometry and multivariate
analysis. Thirty-one fatty acids (FA) were identified across
the six macroalgal species with C16:0 the dominant FA in all
samples, variations across taxa in the saturated FA C10:0,
C14:0, C16:0, C18:0 and C20:0 and variations in monounsat-
urated FA attributed to C16:1 n-7 and C18:1 n-9. For PUFA
profiles, all six species had significantly different n-6/n-3
ratios, while the green seaweed Ulva species possessed the
lowest n-6/n-3 ratio of 0.4, along with a 2-fold higher C18:3 n-
3 to C18:2 n-6 content. Ulva sp. was the only species that
contained docosahexaenoic acid. Extracts of both theUlva sp.
and Hormosira banksii showed selective cytotoxicity towards
a human pancreatic cancer cell line, while the nonpolar ex-
tracts of all six algae species strongly inhibited production of
the inflammatory-mediator nitric oxide.
Keywords Seaweeds . Fatty acid profiles . PUFA .
Omega-3 . Inflammation . Functional foods
Introduction
Macroalgae are a large and growing multibillion dollar food
and biotechnology industry (FAO 2012; Bixler and Porse
2011; Mazarrasa et al. 2013). Increasingly, they are being
recognised as a rich source of biologically active metabolites
for utilisation in functional foods, nutritional supplements
and/or pharmaceuticals (Stengel et al. 2011). This is due to
important functional roles of these metabolites in a range of
biological processes including cell mediation and immune
responses (Warude and Joshi 2006; Rubio-Rodríguez et al.
2010; Calder and Yaqoob 2009; Kumari et al. 2010;
Mohamed et al. 2012; Smit 2004). Research in medical and
health applications of seaweed metabolites now dominate the
publication of phycology-related scientific literature (Winberg
et al. 2014). There is particular promise for chronic inflam-
matory diseases and cancers of the digestive system (Vo et al.
2012; O’Sullivan et al. 2010) (Fig. 1). Metabolites that con-
tribute to anti-inflammatory function include essential poly-
unsaturated fatty acids (PUFA) such as alpha-linolenic acid
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Appendix D  
Supplementary Methods 
Thin Layer Chromatography (TLC) 
For the preliminary assessment of extracts and to determine the solvent system for 
purification by flash chromatography, thin layer chromatography was used. TLC plates 
(3.5 cm × 9.0 cm) were cut from commercially available aluminum backed sheets of 
Silica Gel 60 F254 plates. The crude extracts (approx. 25 mg/ml) were transferred onto 
the plates by capillary action and the plates were eluted in a closed chamber with 
various mobile phases. After drying, the retention factors (rf) for any visible or UV 
active components were recorded. The plates were then further stained using iodine 
vapor, Hanessian’s stain (comprising 90 mL water, 5 g ammonium molybdate, 1 g 
cerium sulfate and 10 mL concentrated sulfuric acid) and an anti-oxidant stain 
(comprising of 0.2% w/v 2,2-diphenyl-2-picrylhydrazyl (DPPH) in methanol). 
Flash Column Chromatography 
Flash column chromatography using silica gel was used to purify extracts. Solvent 
system chosen based on TLC (Table 25). Column fractions combined on the basis of 
TLC and dried on the rotatory evaporator (Table 26). Weight recorded for each dried 
fraction to determine mass recovery (Table 27). Combined dried fractions were tested for 
biological activity and only the high yielding fractions with strong activity where 
analysed by reverse-phase high-pressure liquid chromatography (RP-HPLC). 
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Table 25 Solvent system chosen for flash column chromatography for Hormosira banksii ethyl acetate 
extract based on thin layer chromatography (TLC) 
Species Extract Solvent System 
Hormosira banksii Ethyl Acetate Chloroform (100 %): Methanol (50 %): 
Chloroform/Methanol/Water (6/4/1): Methanol (100 %) 
 
 
Table 26 Summary of combined fractions after flash column chromatography of Hormosira banksii ethyl 
acetate extract. Fractions combined based on TLC. 
Species Extract Fraction # Combined 
Column 
Fraction 
Eluent 
 
# Spot TLC Mass (mg) 
Hormosira 
banksii 
Ethyl 
Acetate 
1 #1-10 95% CHCl3 2 37.2 
  2 #11-27 92.5% 
CHCl3 
2 27.6 
  3 #28-40 90% 
CHCl3:  
1 36.3 
 
  4 #41-51 80% CHCl3 1 22.2 
  5 #52-54 70% CHCl3 2 15.4 
  6 #55-60 50% CHCl3 1 16.8 
  7 #61 Magic 1 1.8 
  8 #62-64 Magic 1 37.5 
  9 #65 Magic 2 23.4 
  10 #66-67 Magic 2 36.9 
  11 #68 Magic 4 7.2 
  12 #69-71 Magic 3 70.6 
  13 #72 Magic 1 12.3 
  14 #73 Magic 2 14.3 
  15 #74-75 Magic 3 31.3 
  16 #76-77 Magic 1 26.3 
  17 #78-79 Magic 1 5.9 
  18 #80-81 Magic 1 3.8 
  19 #82-83 Magic 1 4.7 
  20 #84-86 Magic 1 2.7 
  21 #87-88 Magic 2 5.8 
  22 #89 Magic 1 7.8 
  23 #90 Magic 1 3.5 
  24 #91-93 Magic 1 3.8 
  25 #94 Magic 1 1.7 
  26 #95-97 Magic 1 1.8 
  27 #98 Magic 1 1.4 
  28 #99 Magic 2 0.8 
  29 #100-134 Magic  9.7 
  30 #135-147 Magic 1 3.1 
  31 #148 Magic 1 25.9 
  32 #149 Magic 1 12.6 
  33 #150 Magic 1 2.4 
  34 #151-159 Magic 1  
  35 #160-161 Magic 1  
  36 MeOH wash 0% MeOH 1  
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Table 27 The mass recovery for Hormosira banksii ethyl acetate extract for the combined 36 fractions 
after flash column chromatography on silica gel. 
Species Extract Initial Weight 
(mg) 
# Combined 
Fractions 
Mass Combined 
Fraction (mg) 
% Recovery 
Hormosira 
banksii 
Ethyl 
Acetate 
610 mg 36 577.7 95 
 
 
Reverse-Phase - High Pressure Liquid Chromatography (RP-HPLC) 
Analytical RP-HPLC was performed on a Shimadzu system with either a dual UV 
detector or PDA detector and Phenomenex Luna C18 column (4.6 mm x 250 mm). 
Preparative RP-HPLC was performed on a Waters system with dual UV detector using 
a Waters C18 column (19 x 150 mm). Mobile phase for both analytical and preparative 
RP-HPLC outlined in Table 28. 
 
Table 28 Solvent system used for both preparative and analytical -HPLC 
Species Extract Solvent System 
Hormosira banksii Ethyl Acetate  Water (100%): Methanol (100%) (Increasing gradient over 
40 mins run time) 
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Appendix E  
Supplementary results  
 
 
Figure 31 Analytical RP-HPLC trace for Hormosira banksii ethyl acetate extract, fraction # 10 
 
 
Figure 32 Analytical RP-HPLC trace for Hormosira banksii ethyl acetate extract, isolated peak 8 (via 
preparative RP-HPLC) from fraction # 1
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a b s t r a c t
The fatty acids (FA) of Ulva have potential to contribute to nutrition. However the large variability of FA
profiles of Ulva species; thus the quality and quantity of FA in relation to nutrition is poorly defined.
Herein we investigate the FA profile of 74 cultured Ulva samples crossing five culture regimes, six extrac-
tion regimes and four post-harvesting processes. This is compared alongside a comprehensive review of
FA profiles of Ulva spp. With regard to the literature, Ulva is characterised by C16:0 (30.5 ± 11.5%), C18:3
n-3 (14.5 ± 6.3%), C18:4 n-3 (12.5 ± 5.4%), C16:4 n-3 (8.9 ± 4.8%) and C18:1 n-7 (10.1 ± 4.0%). The inves-
tigated Ulva fell within the reported range of specific FA. High nutrient conditions showed the most desir-
able FA profile for health, along with the highest total FA content (56 mg g!1 dry weight equivalent) when
extracted with an optimised protocol.
! 2016 Elsevier Ltd. All rights reserved.
1. Introduction
The marine macroalgal genus Ulva (Chlorophyta) is a source of
valuable long-chain polyunsaturated fatty acid (LC-PUFA) profiles,
in particular the biologically important eicosapentaenoic acid
(C20:5 n-3, EPA) (Holdt & Kraan, 2011). Ulva spp. also show the
presence of trace amounts of docosahexaenoic acid (C22:6 n-3,
DHA), however more abundant LC-PUFA include the DHA precur-
sor, docosapentaenoic acid (C22:5 n-3, DPA), along with the more
unique C18:4 n-3 and C16:4 n-3 PUFA (Holdt & Kraan, 2011). Ulva
grows abundantly in waters enriched by nutrients and is fre-
quently involved in green tides in eutrophicated coastal areas pro-
ducing a high quantity of biomass (Leliaert et al., 2009). This
characteristic of Ulva means that it is well suited for cultivation.
Therefore as whole biomass or as part of a sequential biorefinery
system of production, cultivated Ulva biomass has the potential
to offer a sustainable source of essential FA for human and animal
consumption and nutrition.
The feasibility of cultivatingmarinemacroalgae, as a sustainable
source of high value products is largely dependent on the cost-
effectiveness and scalability of cultivation to deliver high yields of
quality controlled biomass. Ulva is a cosmopolitan genus (Fig. 1)
and can readily adjust its metabolism under specific environmental
conditions, wherein the lipids and FA play an important role in this
adaptation (Nesterov, Rozentsvet, & Bogdanova, 2013). As such, the
profiles of reported FA for Ulva show a wide degree of natural vari-
ation. For example Ulva intestinalis has demonstrated an increase in
unsaturation with increasing mineralisation in a study of a number
of abiotic factors (Nesterov et al., 2013). Seasonal comparison of
Ulva lactuca samples collected inWestern Ireland showed a notable
decrease in the n-6/n-3 ratio when collected in November (cf. June)
(Schmid, Guihéneuf, & Stengel, 2014). Furthermore, the range of
reported n-6/n-3 values were alsomore favourable when compared
to an U. lactuca specimen collected fromNorthern Chile (Ortiz et al.,
2006). However, one of the appeals of Ulva in particular as a target
genus, is its ability to be grown effectively and rapidly in culture,
while tailoring PUFA profiles through nutrient replete conditions,
which have been demonstrated on the laboratory scale (Ak,
Öztas!kent, Özüğru, &Göksan, 2015). It has also been shown that cul-
ture conditions including temperature (An et al., 2013), pH (Spilling,
Brynjólfsdóttir, Enss, Rischer, & Svavarsson, 2013) and nutrient
availability along with the presence of organic carbon (Ak et al.,
2015), will also influence the lipid profile of many algae including
Ulva spp. Despite this, there are species-specific patternswithin that
variability that can be determined with experimental means and
http://dx.doi.org/10.1016/j.foodchem.2016.04.039
0308-8146/! 2016 Elsevier Ltd. All rights reserved.
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